Resident Poster Listing by Primary Author Last Name ...2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT...

2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME (REVISED 11/7/15)

Page | 1

Resident Poster Presenters:

Congratulations! Below is your scheduled poster presentation time and board number. This list is sorted

by the Last Name of the Primary Author —not by presentation time. You may also search the list by

using your Submission ID. If you have trouble locating your poster, please send an email to

[email protected].

Allow three business days for a response. Date, time, and board number cannot be changed. ASHP will

not edit titles, abstracts, or presenters. If you wish to withdraw your poster, please contact

[email protected]. Be sure to read the Poster Presenter Handbook located at

http://www.ashp.org/Get_Involved for additional instructions.

We’ll see you in New Orleans!

Educational Services Division

NEW***We have added a poster session on SUNDAY!***

Presenters who are scheduled to present their poster during this session will receive an email with more

detailed information.

PLEASE NOTE: Due to space limitations, all Federal Residents may not be able to participate in the “Federal Forum: Meet the Researchers Poster Presentations”, and will therefore be scheduled to

present during the regular Resident Poster session on Wednesday, December 9. Please keep in mind

that due to the number of poster presentations, we are unable to accommodate any special

scheduling requests.


Page | 2

Session ID

PA Full Name Session‐Board Number

Title Date Time

387672 Phuong Abbott 1‐062 Impact of early initiation of hydrocortisone therapy in severe sepsis and septic shock patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388064 George Abdallah 1‐063 Evaluation of clinical and safety outcomes in critical care patients treated with a phenobarbital based alcohol withdrawal protocol

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386650 Mohammed Abdulwahhab

10‐139 Impact of discharge counseling for chronic obstructive pulmonary disease (COPD) patients on 30‐day hospital readmission rate

Wednesday, December 9

12:30 p.m. ‐ 1:30 p.m.

388525 Justine Abella 9‐057 Association of sodium bicarbonate with return to spontaneous circulation (ROSC) in cardiopulmonary arrest patients at UC San Diego Health


11:15 a.m. ‐ 12:15 p.m.

389192 Paola Acevedo 9‐247 Evaluating the inpatient use of epoetin alfa in non‐hemodialysis patients in a community teaching hospital


11:15 a.m. ‐ 12:15 p.m.

387449 Emily Acker 11‐031 Impact of Penicillin Allergy on Empiric Carbapenem Therapy in Patients with Community‐Onset Gram‐Negative Bacteremia


1:45 p.m. ‐ 2:45 p.m.

388571 Catalina Acosta 10‐220 Utilization of meropenem at a multi‐center community health system


12:30 p.m. ‐ 1:30 p.m.

386982 Michelle Adamczyk

1‐064 Implementation of an antimicrobial stewardship protocol for urinary tract infections in the emergency department (ED) and its impact on prescribing habits

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 3

Session ID


Title Date Time

385421 Ashley Adams 10‐299 Implementation and evaluation of targeted interventions for reducing missing dose requests within an academic veterans affairs medical center


12:30 p.m. ‐ 1:30 p.m.

386161 Kathleen Adams 9‐031 Implementation of an inpatient pharmacist‐managed warfarin dosing protocol


11:15 a.m. ‐ 12:15 p.m.

386332 Rebekka Adamson

9‐099 Prevalence of drug‐drug interactions with the novel oral anticoagulants


11:15 a.m. ‐ 12:15 p.m.

388707 Manali Adani 9‐005 Assessing the effectiveness of a network pharmacy renal dose policy: a pharmacy resident analysis


11:15 a.m. ‐ 12:15 p.m.

386614 Kate Adcock 12‐001 Development of institutional antibiotic dosing guidelines in critically ill patients undergoing continuous renal replacement therapy


3:00 p.m. ‐ 4:00 p.m.

388974 Jennifer Addo 8‐074 Bloodstream infections in patients with cirrhosis: etiologic agents, risk factors for multidrug resistant organisms, and patient outcomes


10:00 a.m. ‐ 11:00 a.m.

388586 Aderonke Adeboye

11‐275 Evaluating Georgia State Protocol Immunizations in the Community Pharmacy


1:45 p.m. ‐ 2:45 p.m.

387729 Mary Afrane 11‐195 Evaluating time to therapeutic vancomycin trough levels in a community teaching hospital


1:45 p.m. ‐ 2:45 p.m.

388116 Clifford Aguele 8‐015 Optimization of medication alerts Wednesday, December 9

10:00 a.m. ‐ 11:00 a.m.


Page | 4

Session ID


Title Date Time

388826 Nabeela Ahmed 10‐053 Evaluation of immediate release (IR) nifedipine use at a large academic medical institution


12:30 p.m. ‐ 1:30 p.m.

389424 Gresa Ajeti 1‐066 Evaluation of empiric treatment of urinary tract infections and urine‐culture follow‐up

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386172 Deanna Akinbajo 1‐067 Analysis of post‐operative outcomes with the use of continuous infusion local anesthetic in total knee arthroplasty and arthroscopic shoulder surgery

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389217 Tolulope Akinbo 9‐176 Implementation and evaluation of end‐tidal carbon dioxide (EtCO2) monitoring for the prevention of respiratory depression in patients receiving opioid therapy.


11:15 a.m. ‐ 12:15 p.m.

387035 Ukwen Akpoji 1‐068 Impact of Antimicrobial Dosing Guide on Initial Inpatient Antimicrobial Dosing Errors

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384578 Sultan Al Raddadi

8‐305 Is atorvastatin 80 mg as safe as atorvastatin 40 mg in Saudi patients with cardiac disease?


10:00 a.m. ‐ 11:00 a.m.

384504 Abdulrahman Al Turaiki

10‐259 Assessment of safety and efficacy of the oral multiple sclerosis medications


12:30 p.m. ‐ 1:30 p.m.

386098 Hana Alawy 8‐306 Appropriateness of Antiplatelet Therapy in Patients on Oral Anticoagulation


10:00 a.m. ‐ 11:00 a.m.


Page | 5

Session ID


Title Date Time

388986 Ryan Albers 1‐069 Medication use evaluation of ciprofloxacin for the treatment of urinary tract infections managed through an urgent care center in a Veterans Affairs outpatient setting

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387853 Christina Aldrich 9‐032 Retrospective drug use evaluation of DVT prophylaxis in patients on continuous veno‐venous hemofiltration


11:15 a.m. ‐ 12:15 p.m.

389483 Jason Val Alegro 9‐033 Multi‐year analysis of outcomes associated with a pharmacist‐managed outpatient parenteral antimicrobial therapy (OPAT) program within a Veterans Affairs Medical Center (VAMC)


11:15 a.m. ‐ 12:15 p.m.

388049 Osamah Alfayez 12‐190 Pharmacist impact on diabetes management as a member of an interprofessional team


3:00 p.m. ‐ 4:00 p.m.

386497 Ali Alharbi 9‐248 Adherence to an ICU sedation protocol at a community teaching hospital: Identifying the pharmacist's role


11:15 a.m. ‐ 12:15 p.m.

386517 Reem Alharbi 10‐221 Assessment of evidence‐based practice (EBP) among hospital pharmacists in Saudi Arabia: attitude, awareness and practice


12:30 p.m. ‐ 1:30 p.m.

388798 Doaa Aljefri 1‐070 Clinical Outcomes of Daptomycin Therapy Based on a Dosing Body Weight Calculation Versus Total Body Weight

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387198 Jennifer Allen 10‐024 Implementing a pain protocol in the palliative care setting of a rural hospital


12:30 p.m. ‐ 1:30 p.m.


Page | 6

Session ID


Title Date Time

389037 Monica Allen 8‐307 Impact of an antimicrobial stewardship intervention on uncomplicated skin and soft tissue infection treatment in the emergency department


10:00 a.m. ‐ 11:00 a.m.

388083 Kristin Allmaras 1‐071 Identify and explore potential opportunities for augmentation of pharmacy‐based clinical services within a tribal home‐based service (HBS) program

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388342 Ohoud Almalki 1‐072 Target‐specific oral anticoagulants for post‐surgical thromboprophylaxis in orthopedic patients: A network meta‐analysis

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387238 Saleh Almekhloof

12‐091 Implementation of clinical guidelines for the management of delirium in the intensive care unit of a community health system


3:00 p.m. ‐ 4:00 p.m.

386401 Nasser Al‐Qhtani 10‐222 Comparison of voluntarily reported medication errors between the icu and non‐icu setting in adult patients


12:30 p.m. ‐ 1:30 p.m.

387077 Yousef Al‐Rajhi 10‐054 Weekly Assessment of the therapeutic efficacy of different doses of Eprex for managing anemia in chronic kidney disease adult patients


12:30 p.m. ‐ 1:30 p.m.

385165 Abrar Alshehri 11‐057 Evaluation of the use of granulocyte‐colony stimulating factor factors (G‐CSFs) as neutropenia primary prophylaxis in solid tumors at KAMC‐WR: retrospective study


1:45 p.m. ‐ 2:45 p.m.


Page | 7

Session ID


Title Date Time

386472 Khalid Alsulaiman

11‐098 Evaluation of prescribing medication errors in pediatric outpatient pharmacy


1:45 p.m. ‐ 2:45 p.m.

388472 Abdulhmid Althaghfi

8‐213 Hospital Readmission Rates Following Implementation of an Antimicrobial Stewardship Intervention on the Acute Inpatient Psychiatric Units


10:00 a.m. ‐ 11:00 a.m.

387069 Ahlam Althobaiti 12‐027 Impact of antibiotic use on valve survival in rheumatic heart disease patients post‐valve replacement


3:00 p.m. ‐ 4:00 p.m.

387437 Luisa Alvarado 9‐249 Impact of a pharmacist‐driven antimicrobial de‐escalation protocol on the duration of parenteral antimicrobials in community‐acquired pneumonia


11:15 a.m. ‐ 12:15 p.m.

386293 Kathryn Alver 1‐074 A retrospective review of ticagrelor versus clopidogrel after acute coronary syndromes in a veteran population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386432 Safa Alyamani 8‐214 Impact of a pharmacy driven antibiotics de‐escalating guidelines as a part of antimicrobial stewardship program (ASP) in a community hospital health‐system.


10:00 a.m. ‐ 11:00 a.m.

385239 Saeed Alzghari 9‐058 Retrospective comparison of low molecular weight heparin versus warfarin versus oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients


11:15 a.m. ‐ 12:15 p.m.


Page | 8

Session ID


Title Date Time

383090 Erin Amadon 11‐276 Venous thromboembolism (VTE) prophylaxis core measures: A retrospective medication‐use evaluation


1:45 p.m. ‐ 2:45 p.m.

382625 Kallie Amer 10‐025 Evaluation of regadenoson versus dipyridamole evaluation in myocardial perfusion imaging


12:30 p.m. ‐ 1:30 p.m.

389283 Priti Amin 8‐016 Comparison of risk of readmission scoring tools and readmission rates


10:00 a.m. ‐ 11:00 a.m.

388286 Francine Amoa 1‐075 Comparing time in therapeutic range (TTR) among patients on warfarin managed via face‐to‐face (FF) or telephone based (TELE) at the VAPIHCS

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389514 Brandon Anderson

1‐076 Investigation of a pharmacist led chronic pain clinic impact on pain management outcomes

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385665 Holly Anderson 8‐017 Utilization of pharmacist‐driven penicillin skin testing protocol to reduce unnecessary use of broad spectrum antibiotics


10:00 a.m. ‐ 11:00 a.m.

389185 Jessica Anderson 1‐077 Safety, efficacy, and cost savings of low dose alteplase (1mg/1ml) versus standard dose alteplase (2mg/2ml) for occluded central venous catheters

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

382595 Telyssa Anderson

9‐250 Incidence of coadministration of acid suppression therapy with tyrosine kinase inhibitors in patients with CML and Ph+ ALL


11:15 a.m. ‐ 12:15 p.m.


Page | 9

Session ID


Title Date Time

388077 Michelle Andress 9‐059 Assessing 30‐day readmissions and interventions provided by community and hospital pharmacy residents collaborating with a provider in a transitions of care clinic


11:15 a.m. ‐ 12:15 p.m.

388864 Nadia Aneese 11‐188 Evaluation of a pharmacist managed diabetes clinic


1:45 p.m. ‐ 2:45 p.m.

389297 Hans Ang 8‐215 Inpatient management of hyperglycemia in post‐operative kidney transplant recipients


10:00 a.m. ‐ 11:00 a.m.

386376 Louise Jeremia (Jeri) Angelo

1‐078 Observational lorazepam study: Prevalence of chronic lorazepam use at Seattle Cancer Care Alliance (SCCA) and risk factor identification

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385878 Nicole Anidiobi 11‐133 Evaluation of hospital readmission rates of patients treated with rivaroxaban versus warfarin in the treatment of venous thromboembolism


1:45 p.m. ‐ 2:45 p.m.

385285 Francisco Antigua

1‐079 Retrospective performance review of HIV linkage and retention to care in American Indian and Alaska Natives at Phoenix Indian Medical Center (PIMC)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387997 Nicole Apoian 1‐080 Impact bedside delivery has on patient satisfaction and financial benefits

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387075 Deylen Aponte‐Rosario

1‐081 Assessment of antibiotic prescribing patterns for pharyngitis in the ambulatory care clinics of a multi‐campus Veterans Affairs (VA) ambulatory care system

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 10

Session ID


Title Date Time

388059 Alenoush Aramian

12‐002 Development of an antibiotic stewardship program in the outpatient setting to decrease inappropriate antibiotic prescribing


3:00 p.m. ‐ 4:00 p.m.

388881 Ashley Arenson 12‐191 Evaluation and improvement of resident and prescriber knowledge of hospital‐based guidelines


3:00 p.m. ‐ 4:00 p.m.

385941 Gemma Arrufat Goterris

10‐006 Autoverification of medical order prescriptions: a strategy to improve pharmacists efficiency


12:30 p.m. ‐ 1:30 p.m.

388498 Allison Arterbury 1‐082 Evaluation of a pharmacist led mental health transitions of care program at a Veterans Affairs health care system

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

382938 Miranda Arthur 11‐001 Implementing a clinical pharmacist‐led COPD service in a primary care clinic


1:45 p.m. ‐ 2:45 p.m.

389614 Kofi Asante 10‐140 Impact of medication therapy management with an active follow‐up, on improving medication adherence in patients with diabetes


12:30 p.m. ‐ 1:30 p.m.

389007 Steven Asbill 8‐216 Evaluation of tolvaptan usage for the management of hyponatremia at a community health system


10:00 a.m. ‐ 11:00 a.m.

386615 Saira Ashraf 8‐217 Evaluation of efficacy of joint replacement pain management protocol using an intra‐op periarticular mixture at a large tertiary care hospital


10:00 a.m. ‐ 11:00 a.m.

385133 Tahir Ashraf 8‐092 Bacteremia due to group viridans streptococci in neutropenic patients on fluoroquinolone prophylaxis


10:00 a.m. ‐ 11:00 a.m.


Page | 11

Session ID


Title Date Time

387180 Sara Asif 9‐177 Description and preliminary results of a managed care plan initiative to increase access and adherence


11:15 a.m. ‐ 12:15 p.m.

386705 Zinkeng Asonganyi

1‐083 Estimated financial benefit of opening a hospital‐owned outpatient pharmacy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388640 Lynnly Assavavallop

11‐214 Impact of a discharge concierge pharmacy service on high‐risk patients


1:45 p.m. ‐ 2:45 p.m.

388490 Amanda Atherton

1‐084 Evaluation of patient outcomes in a pharmacist‐managed hypothyroid clinic

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386818 Matthew Atkinson

11‐002 Implementing and evaluating a pharmacist procalcitonin protocol for use in low acuity patients with concern for respiratory tract infection


1:45 p.m. ‐ 2:45 p.m.

385709 Kimberly Augustyn

12‐171 Medication use evaluation of activated prothrombin complex concentrate for direct oral anticoagulation reversal


3:00 p.m. ‐ 4:00 p.m.

387218 Whitney Aultman

8‐093 Evaluation of compliance to an intravenous insulin infusion protocol in the management of diabetic ketoacidosis


10:00 a.m. ‐ 11:00 a.m.

389135 Amy Aumann 11‐277 Pharmacist owned discharge medication reconciliation and patient education in a community hospital setting


1:45 p.m. ‐ 2:45 p.m.

389118 Frances Aune 9‐006 Acute kidney injury associated with vancomycin and beta‐lactams: piperacillin‐tazobactam versus cefepime


11:15 a.m. ‐ 12:15 p.m.

387043 Phyo Aung 1‐085 Impact of transitions of care pharmacy medication education on pneumonia readmissions

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 12

Session ID


Title Date Time

387328 Paul Avenoso 10‐007 Evaluation of newly implemented adult febrile neutropenia antimicrobial protocol in liquid tumor malignancy and bone marrow transplant patients


12:30 p.m. ‐ 1:30 p.m.

389435 Sindhuri Avula 9‐251 Evaluation of the appropriateness and safety of intravenous nicardipine use at a large community hospital


11:15 a.m. ‐ 12:15 p.m.

388324 Amy Awker 1‐086 Evaluation of a protocol for management of periprocedural anticoagulation at the Minneapolis Veterans Affairs Health Care System (MVAHCS)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389171 Adepeju Awodipe

9‐252 Pharmacist‐Led Discharge Counseling vs. Nursing Discharge Education on Readmission Rates and Patient Hospital Experience


11:15 a.m. ‐ 12:15 p.m.

385364 Mike Axelsen 11‐003 Evaluation of long‐acting injectable antipsychotics and their impact on patient length of stay and readmission rates in an adult acute psychiatric care unit


1:45 p.m. ‐ 2:45 p.m.

386676 Sara Ayele 1‐087 Characterization of budesonide/formoterol inhaler prescribing at hospital transitions of care in a Veteran population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387240 Dina Azar 1‐088 Factors that Influence Time to Start Oral Chemotherapy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387156 Andrew Aziz 8‐001 Prescriber satisfaction with medication history technicians within a transitions of care program


10:00 a.m. ‐ 11:00 a.m.


Page | 13

Session ID


Title Date Time

386740 Asal Azizoddin 12‐028 Comparison of additional oncology pharmacy counseling services through electronic interface versus only face‐to‐face nurse counseling.


3:00 p.m. ‐ 4:00 p.m.

385406 Timothy Bach 8‐094 Treating hepatitis c virus (HCV) genotypes 1‐4 in a large multisite ambulatory care practice setting: outcomes with oral direct‐acting antiviral (DAA) regimens


10:00 a.m. ‐ 11:00 a.m.

384563 Rachel Bacher 10‐055 Evaluation of intravenous nicardipine at an academic medical center


12:30 p.m. ‐ 1:30 p.m.

386635 Justin Bagby 11‐134 Reduction in potential medication errors through pharmacist collected medication histories in a community hospital


1:45 p.m. ‐ 2:45 p.m.

388551 Jasmine Bailey 12‐214 Impact Of A Peer‐Led and Interprofessionally Developed Community‐Based Weight Loss Intervention Program: A Pilot Study


3:00 p.m. ‐ 4:00 p.m.

387097 Kaitlin Baisden 1‐089 Evaluation of vasopressin use in patients with septic shock

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387619 Madeeha Baker 12‐029 Implementing emergency department pharmacist‐driven first antibiotic dose initiative


3:00 p.m. ‐ 4:00 p.m.

389389 Danielle Ball 10‐300 Evaluation of hematuria in pediatric surgical patients


12:30 p.m. ‐ 1:30 p.m.

386822 Austin Ballew 11‐135 Comparison of diabetes control in patients managed by Pharmacist Clinicians in a collaborative care model versus patients managed without Pharmacist Clinician collaboration.


1:45 p.m. ‐ 2:45 p.m.


Page | 14

Session ID


Title Date Time

387980 Temitayo Banjo 11‐120 Guardian knowledge and perception of human papillomavirus vaccine at the community pharmacy


1:45 p.m. ‐ 2:45 p.m.

389272 Jason Barca 1‐090 Glycemic control in Native American patients: comparison of two insulin detemir delivery techniques

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387114 Russell Bardsley 8‐075 Urinary tract infections in males: are shorter courses of therapy feasible?


10:00 a.m. ‐ 11:00 a.m.

389500 Jennifer Baric 12‐030 Evaluation of intravenous fosphenytoin versus intravenous phenytoin at a community health system


3:00 p.m. ‐ 4:00 p.m.

386483 Sophia Barker 1‐091 Increasing the availability of decentralized clinical pharmacy services in a team‐based healthcare outpatient department

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384634 Ghazaleh Barkhordarian

11‐215 Implementation and evaluation of a pharmacist‐endocrinologist collaborative practice for outpatient diabetes management


1:45 p.m. ‐ 2:45 p.m.

388475 Valerie Barnett 8‐308 Inpatient monitoring of procalcitonin to determine appropriate antibiotic treatment of lower respiratory tract infections in American Indians and Alaska Natives at a 72 bed hospital


10:00 a.m. ‐ 11:00 a.m.

388719 Jaime Baron 8‐309 Retrospective Review of the Treatment Rate of Asymptomatic Bacteriuria


10:00 a.m. ‐ 11:00 a.m.

388505 Erica Barr 11‐032 Effects of discharge counseling by a pharmacist on select HCAHPS scores


1:45 p.m. ‐ 2:45 p.m.


Page | 15

Session ID


Title Date Time

386179 Kyle Barron 1‐092 Assessment of fish oil utilization within a multi‐campus Veterans Affairs (VA) ambulatory care clinic

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386034 Linda Barstow 8‐095 Assessment of emergency department antibiotic discharge prescription dosing errors for pediatric patients in a community hospital health system


10:00 a.m. ‐ 11:00 a.m.

387312 Robley Bartholomew

8‐018 Impact of antimicrobial stewardship program initiation on patients with healthcare‐associated pneumonia


10:00 a.m. ‐ 11:00 a.m.

384667 Stella Basalilov 11‐004 Assessment of the efficacy and saftey of fascia iliaca blocks for the treatment of pain associated with hip fractures in geriatric patients


1:45 p.m. ‐ 2:45 p.m.

384798 Danny Basri 8‐310 Evaluation of the use of intravenous antihypertensives in a tertiary care teaching hospital


10:00 a.m. ‐ 11:00 a.m.

387223 Andrea Bastiaanse

1‐093 Development and Implementation of a Pharmacy to Dose Warfarin Consult Service: Part One: Evaluating Current Prescribing Habits

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389359 Matthew Batchelder

9‐100 An evaluation of pharmacokinetic dosing of vancomycin and aminoglycosides in obese adult patients


11:15 a.m. ‐ 12:15 p.m.

387182 Jessica Bates 9‐178 Needs analysis for a rural drug information center


11:15 a.m. ‐ 12:15 p.m.


Page | 16

Session ID


Title Date Time

388700 Madelyn Batey 9‐060 Effect of direct acting oral anticoagulants (DOACs) on mortality in traumatic brain injury patients


11:15 a.m. ‐ 12:15 p.m.

385380 Sundeep Bath 12‐031 Evaluation of goal tacrolimus trough levels and impact on kidney transplant rejection.


3:00 p.m. ‐ 4:00 p.m.

385799 Simarjit Batth 8‐218 Impact of clinical pharmacists interventions on patients knowledge of direct oral anticoagulants


10:00 a.m. ‐ 11:00 a.m.

388273 Amanda Bauerle 9‐167 Evaluation of injectable acetaminophen usage appropriateness and potential cost savings from using alternate therapy


11:15 a.m. ‐ 12:15 p.m.

389586 Christopher Baughman‐Oprica

1‐094 Analysis of metabolic monitoring in patients prescribed antipsychotics at the Providence VA Medical Center: a pilot study

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386396 Thomas Baumann

1‐095 Impact of pharmacist‐led methicillin‐resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) nasal screening on de‐escalation of empiric treatment for suspected MRSA pneumonia

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386972 Caitlin Beale 11‐216 Transdiciplinary team approach to reduce 30‐day re‐hospitalization rate in chronic obstructive pulmonary disease patients: impact of pharmacist‐provided standard discharge initiative


1:45 p.m. ‐ 2:45 p.m.


Page | 17

Session ID


Title Date Time

386194 Danielle Beale 12‐172 Safety and efficacy of anti‐factor xa versus activated partial thromboplastin time monitoring in patients receiving intravenous unfractionated heparin therapy: a retrospective review


3:00 p.m. ‐ 4:00 p.m.

387936 Andrew Beaty 12‐003 Phenytoin versus levetiracetam as first‐line treatment for new onset seizures


3:00 p.m. ‐ 4:00 p.m.

388362 Carson Bechtold 1‐096 Assessing the impact of anticoagulation on atrial fibrillation patients with a CHA2DS2‐VASc score of 1 due to hypertension

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387484 Jacob Beck 11‐217 : Evaluation of Optimal Vancomycin Dosing in Young Children


1:45 p.m. ‐ 2:45 p.m.

386643 Abigail Becker 10‐280 Evaluation of the frequency of adverse events from dofetilide therapy in obese patients


12:30 p.m. ‐ 1:30 p.m.

388776 Eyerusalem Befkadu

10‐008 The effect of appropriate empirical therapy on hospital mortality in patients with candidemia in an urban teaching hospital


12:30 p.m. ‐ 1:30 p.m.

388066 Lauren Behrle 11‐058 Incidence and clinical outcomes of off‐label oral anticoagulant dosing in nonvalvular atrial fibrillation within a community hospital health system


1:45 p.m. ‐ 2:45 p.m.

388300 Ainhoa Belaustegui

1‐097 Long acting release octreotide in the treatment of recurrent bleeding from intestinal angiodysplasia: evaluation of safety and efficacy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 18

Session ID


Title Date Time

388312 Brian Bell 8‐096 Targeted discharge counseling in high risk patient populations


10:00 a.m. ‐ 11:00 a.m.

389293 Kristin Bell 1‐098 Assessment of psychotropic medication use in a veteran affairs nursing home pre and post pharmacist led intervention

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387645 Morgan Belling 12‐215 Incidence of documented administration stop times for IV infusions in an outpatient cancer center


3:00 p.m. ‐ 4:00 p.m.

385159 Kasie Bellmann 11‐099 Evaluating the effect of an order set on the treatment of asymptomatic bacteriuria in the emergency department


1:45 p.m. ‐ 2:45 p.m.

386505 Victoria Belousova

8‐097 Sustainability of a pharmacist driven, practice‐embedded medication management service


10:00 a.m. ‐ 11:00 a.m.

387817 Lauren Belt 12‐032 Pharmacist interventions for adherence and safety in patients being treated with oral chemotherapy agents at an outpatient cancer center


3:00 p.m. ‐ 4:00 p.m.

387851 Jason Bena 1‐099 Measuring value associated with end of life oncologic therapy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387913 Grace Benanti 11‐005 A Single Center Evaluation of the ABCDE Bundle Implementation


1:45 p.m. ‐ 2:45 p.m.

386178 Lydia Benitez 11‐278 Olanzapine for the prevention of emesis in patients with multiple myeloma receiving high dose melphalan prior to autologous transplantation


1:45 p.m. ‐ 2:45 p.m.


Page | 19

Session ID


Title Date Time

388602 Denise Bentley 1‐100 Impact of a pharmacy led pain management service with a focus on patient controlled analgesia in a community hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388411 Sarah Berger 8‐019 Assessment of current prevention and treatment strategies for pediatric opioid‐associated constipation


10:00 a.m. ‐ 11:00 a.m.

388840 Sean‐Paul Bergeron

10‐141 Implementation and Evaluation of Updated Severe Sepsis/Septic Shock Standing Orders: Effective Medication Therapy and Improvement in Patient Outcomes


12:30 p.m. ‐ 1:30 p.m.

389043 Delaney Berggren

10‐056 Rate of cefepime de‐escalation in hospitalized patients with positive cultures


12:30 p.m. ‐ 1:30 p.m.

387427 Biniam Berhane 1‐101 Evaluation of fosphenytoin and valproate loading doses for status epilepticus patients in the emergency department at an urban community hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387155 Brittany Berry 1‐102 Evaluation of long‐acting injectable antipsychotic medications in Medicare beneficiaries: a utilization review and cost analysis

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385735 Holly Berry 11‐100 Work Flow Optimization of a Decentralized Pharmacy Technician to Increase Pharmacy Provided Medication Reconciliation in a Community Teaching Hospital


1:45 p.m. ‐ 2:45 p.m.


Page | 20

Session ID


Title Date Time

389599 Bethany Bersani 11‐218 Evaluating risks of harm in patients with atrial fibrillation on chronic warfarin who undergo temporary discontinuation of oral anticoagulation for a planned elective procedure


1:45 p.m. ‐ 2:45 p.m.

388530 Elizabeth Bertran 1‐103 Effects of dapagliflozin on energy intake and appetite in healthy subjects

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388879 Michael Beshir 12‐173 Necessity for Beta‐Lactam Allergy Guidelines at a Large Academic Medical Center


3:00 p.m. ‐ 4:00 p.m.

388499 Ena Besic 11‐279 Evaluation of pharmacy involvement in heparin infusion protocol


1:45 p.m. ‐ 2:45 p.m.

385694 Ashley Besignano

11‐136 Reversibility of Renal Dysfunction After Discontinuation of Tenofovir


1:45 p.m. ‐ 2:45 p.m.

388625 Tatiana Betancor 8‐058 Total parenteral nutrition: do we accomplish the recommendations?


10:00 a.m. ‐ 11:00 a.m.

387544 Kristina Bettencourt

12‐296 Implementation of pharmacists in patients with congestive heart failure at hospital discharge


3:00 p.m. ‐ 4:00 p.m.

389430 Jaimie Bhagat 9‐179 Evaluation of the utilization of intravenous lipid emulsions in the treatment of drug overdose


11:15 a.m. ‐ 12:15 p.m.

386386 Nisha Bhide 10‐026 Leadership in Pharmacy Wednesday, December 9

12:30 p.m. ‐ 1:30 p.m.

387540 Stephen Bienemann

11‐280 Taking an antibiotic time out: impact of a seven day stop order on duration of antibiotic therapy


1:45 p.m. ‐ 2:45 p.m.


Page | 21

Session ID


Title Date Time

388111 Anna Bieniek 8‐098 Alaris library gap analysis: standardization in an expanding health‐system


10:00 a.m. ‐ 11:00 a.m.

387658 Sebastian Biglione

9‐061 Outcomes of a steroid‐free protocol in living donor liver transplant recipients


11:15 a.m. ‐ 12:15 p.m.

388458 Sarah Billman 9‐253 Pharmacoeconomic analysis of intravenous acetaminophen in colorectal surgery patients


11:15 a.m. ‐ 12:15 p.m.

387099 Connor Birkel 11‐219 Development, implementation and evaluation of a perioperative blood glucose management protocol in diabetic general surgery patients.


1:45 p.m. ‐ 2:45 p.m.

386603 Kylee Bitner 11‐196 Role of bedside preparation in reducing door‐to‐drug tissue‐type plasminogen activator (tPA) administration times and association with patient outcomes


1:45 p.m. ‐ 2:45 p.m.

387779 Courtney Black 11‐033 Assessing the frequency in which medication is a reason for earlier than desired cessation of breastfeeding


1:45 p.m. ‐ 2:45 p.m.

388325 Regina Blackley 9‐254 Effectiveness and safety of an inpatient clinical pharmacist‐managed warfarin consult service


11:15 a.m. ‐ 12:15 p.m.

388778 Samantha Blackmon

12‐004 Initiation and evaluation of a standardized stroke protocol upon hospital admission


3:00 p.m. ‐ 4:00 p.m.

388401 Joshua Blackwell 10‐142 Impact of utilizing technology to improve pharmacist‐driven medication reconciliation for transplant patients


12:30 p.m. ‐ 1:30 p.m.


Page | 22

Session ID


Title Date Time

389367 Katherine Blain 8‐099 Pharmacist dispensed naloxone in Kentucky: implementing services in a large chain community pharmacy and measuring pharmacist perceptions


10:00 a.m. ‐ 11:00 a.m.

389396 Fernando Blanco 8‐100 Prescriber adherence to intravenous acetaminophen drug use policy: a medication‐use evaluation


10:00 a.m. ‐ 11:00 a.m.

385276 Kristina Blanquiz 11‐137 Implementation and evaluation of a pharmacist‐run metabolic risk reduction clinic in the ambulatory care setting


1:45 p.m. ‐ 2:45 p.m.

389256 Maria Blaze 1‐105 Effectiveness of the Inpatient to outpatient transition program (IOTP) in improving adherence to psychiatric pharmacotherapy and follow‐up appointment attendance at VAWNY Healthcare System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388025 Candace Bloomer

10‐143 Comparison of antimicrobial related interventions and acceptance rates between a pharmacist versus a pharmacist in collaboration with a physician specializing in infectious diseases.


12:30 p.m. ‐ 1:30 p.m.

382703 Presley Blount 1‐106 Theoretical cost savings analysis through a formulary interchange between basal insulin products

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386209 Bridget Blowey 8‐020 Characterization of antithrombin concentrate utilization at a pediatric hospital


10:00 a.m. ‐ 11:00 a.m.


Page | 23

Session ID


Title Date Time

385945 Samantha Bochenek

9‐101 Evaluation of calcitonin utilization at a large, academic medical center applying lean thinking


11:15 a.m. ‐ 12:15 p.m.

388422 Viola Bockenfeld 8‐101 Evaluation of de‐escalation strategies for empiric intravenous vancomycin therapy in patients with healthcare associated pneumonia (HCAP)


10:00 a.m. ‐ 11:00 a.m.

388913 Joe Bodkin 9‐034 Comparison of pharmacist versus nurse managed heparin titration


11:15 a.m. ‐ 12:15 p.m.

388672 Andrew Bohrer 10‐144 Daptomycin dosing based on ideal body weight versus actual body weight: a study on clinical outcomes and safety


12:30 p.m. ‐ 1:30 p.m.

386569 Christina Bonanno

1‐107 Clinical consequences of disruption in psychiatric medications upon hospitalization at Veterans Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389003 Maria Bondar 10‐145 Impact of pharmacist involvement on the utility of Verigene rapid identification assay on antimicrobial usage for gram positive blood cultures in a community hospital


12:30 p.m. ‐ 1:30 p.m.

388329 Angelica Borrero Olan

8‐219 Development of a quality metrics dashboard for clinical pharmacists intervention in ambulatory care


10:00 a.m. ‐ 11:00 a.m.

387397 Michael Botros 11‐281 Drug‐drug interactions among non‐vitamin K oral anticoagulants in geriatric patients, seventy‐five years and older


1:45 p.m. ‐ 2:45 p.m.


Page | 24

Session ID


Title Date Time

387431 Joshua Bouffard 12‐216 Tobacco cessation treatment program: analysis of current practice in the behavioral health population


3:00 p.m. ‐ 4:00 p.m.

384392 Aimee Bower 8‐102 Effect of a standardized order set on adherence to treatment guidelines in patients with clostridium difficile infection


10:00 a.m. ‐ 11:00 a.m.

386885 Kathryn Bowerman

12‐005 Impact of a resident pharmacist on medication reconciliation at admission in high‐risk patients


3:00 p.m. ‐ 4:00 p.m.

385972 Riley Bowers 10‐146 Systemic glucocorticoid usage in acute COPD exacerbations in hospitalized patients: A retrospective medication‐use evaluation


12:30 p.m. ‐ 1:30 p.m.

389321 Brandi Bowman 12‐006 Perioperative use of intravenous acetaminophen in pediatric adenotonsillectomies


3:00 p.m. ‐ 4:00 p.m.

389027 Hilary Box 11‐034 Access to Hepatitis C Medications in a Community Pharmacy Setting


1:45 p.m. ‐ 2:45 p.m.

386685 Anthony Boyd 10‐001 Risk factors for cefepime‐non‐susceptible gram‐negative infections in hematopoietic cell transplant (HCT) recipients


12:30 p.m. ‐ 1:30 p.m.

385886 Amanda Boykin 8‐076 Implementation of pharmacist‐provided chronic obstructive pulmonary disease (COPD) education in a community hospital


10:00 a.m. ‐ 11:00 a.m.

387537 Crystal Boykin 10‐147 Evaluation of medication adherence among veterans enrolled in an ambulatory intensive case management program


12:30 p.m. ‐ 1:30 p.m.


Page | 25

Session ID


Title Date Time

386608 Paul Boylan 9‐102 Incidence of acute kidney injury in patients receiving intravenous vancomycin in combination with piperacillin‐tazobactam or cefepime


11:15 a.m. ‐ 12:15 p.m.

386788 Julia Boyle 1‐108 Medication use evaluation of concomitant selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) at a Veterans Affairs hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385830 Lynnea Braden 8‐103 Evaluating the safety and efficacy of dornase alfa in non‐cystic fibrosis pediatric patients


10:00 a.m. ‐ 11:00 a.m.

385203 Melina Braly 10‐301 Development of a heparin induced thrombocytopenia (HIT) diagnosis and treatment algorithm for post open heart surgical and transcatheter aortic valve replacement (TAVR) patients.


12:30 p.m. ‐ 1:30 p.m.

383304 Teia Brandenburg

10‐057 Effects of implementing delirium screening in a pediatric intensive care unit


12:30 p.m. ‐ 1:30 p.m.

388394 Courtney Brandow

10‐002 Impact of pharmacy interventions in glycemic control in patients receiving correctional insulin only in a community hospital setting


12:30 p.m. ‐ 1:30 p.m.

387861 Andrea Brandt 1‐109 Impact of delay in treatment on clinical outcomes in patients with hepatitis C virus infection

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 26

Session ID


Title Date Time

385368 Caitlin Brant 1‐189 Dual anti‐platelet therapy after coronary stent placement: impact of duration on mortality, major cardiac events and adverse events

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387139 Cynthia Brasher 11‐138 Economic feasibility assessment for a specialty pharmacy in a not‐for‐profit community health system


1:45 p.m. ‐ 2:45 p.m.

382634 Joseph Bratsch 9‐103 Evaluation of tranexamic acid and the incidence of post‐operative thromboembolic events in hospitalized adult patients


11:15 a.m. ‐ 12:15 p.m.

384650 James Braun 11‐139 Benzodiazepine Use for Status Epilepticus in an Academic Medical Center Emergency Department


1:45 p.m. ‐ 2:45 p.m.

389603 Thomas Brazeal 9‐180 Role of clinical pharmacists in managing chronic obstructive pulmonary disease (COPD) patients with multiple comorbidities


11:15 a.m. ‐ 12:15 p.m.

389580 Kaitlin Bresnahan

8‐077 Impact of an algorithm to guide medication therapy for acute agitation in behavioral health patients in the emergency department.


10:00 a.m. ‐ 11:00 a.m.

388457 Lindsey Briggs 8‐078 Evaluation of acute kidney injury and hyperkalemia with trimethoprim/sulfamethoxazole in a community hospital setting


10:00 a.m. ‐ 11:00 a.m.


Page | 27

Session ID


Title Date Time

388568 Emily Brinser 9‐181 Identification and evaluation of current practices and opportunities of emergency department pharmacists using clinical surveillance software (EDPharm)


11:15 a.m. ‐ 12:15 p.m.

385245 Celeste Briones 1‐110 Efficacy and safety of novel oral anticoagulants vs. warfarin in super geriatric patients with non‐valvular atrial fibrillation

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386905 Sara Britnell 10‐302 Evaluation of Clostridium difficile treatment outcomes based on the severity of illness and antibiotic treatment


12:30 p.m. ‐ 1:30 p.m.

386621 Michael Brocco 12‐217 Analysis of insulin detemir versus insulin glargine in a community hospital


3:00 p.m. ‐ 4:00 p.m.

388720 Kara Brockhaus 1‐111 Impact of a comprehensive approach for administration of surgical prophylaxis antimicrobials in patients with documented beta‐lactam allergies

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385400 Daniel Broderick 8‐220 Characterization of pharmacologic interventions to prevent shivering during therapeutic hypothermia following cardiac arrest in adults


10:00 a.m. ‐ 11:00 a.m.

387696 Amy Brotherton 10‐058 Evaluation of amiodarone and antifungal use: missed opportunities for antifungal stewardship


12:30 p.m. ‐ 1:30 p.m.

386944 Ashley Brown 1‐112 Evaluation of enoxaparin use in pediatric patients requiring treatment dosing

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 28

Session ID


Title Date Time

387455 Christopher Brown

8‐311 Medication use evaluation and cost minimization analysis of premixed nicardipine injectable solution versus compounded nicardipine injection in a community hospital


10:00 a.m. ‐ 11:00 a.m.

385794 Emily Brown 10‐059 Evaluation of vancomycin dosing for the treatment of Staphylococcus aureus infections in intravenous drug abusers


12:30 p.m. ‐ 1:30 p.m.

389461 Kellee Brown 1‐113 Attainment of target anti‐factor Xa levels in patients with acute kidney injury requiring continuous renal replacement therapy (CRRT)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386243 Kristin Brown 9‐168 The effects of a pre‐operative methicillin‐resistant Staphylococcus aureus (MRSA) screening and decolonization protocol on post‐operative MRSA infection rates


11:15 a.m. ‐ 12:15 p.m.

388090 Ryan Brown 11‐220 Assessing sedation practices and the incidence of ventilator‐associated pneumonia (VAP) in intensive care units


1:45 p.m. ‐ 2:45 p.m.

387174 Sara Brown 1‐114 Poractant alfa versus beractant for neonatal respiratory distress syndrome: a retrospective pharmacoeconomic and outcomes analysis

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388832 Andrew Bruce 12‐218 Evaluation of rasburicase use at a large community teaching hospital


3:00 p.m. ‐ 4:00 p.m.


Page | 29

Session ID


Title Date Time

383282 Andrew Brueckner

12‐192 Predictors of successful conversion from tacrolimus to sirolimus in kidney transplant recipients on a steroid free immunosuppressive regimen


3:00 p.m. ‐ 4:00 p.m.

385993 Kirsten Bruell 10‐148 Differences in type 2 diabetes medication intensification between a family medicine clinic and an endocrinology clinic


12:30 p.m. ‐ 1:30 p.m.

387283 Adam Brumfield 1‐115 Drug use evaluation of outpatient azithromycin prescribing at a Veterans Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388467 Allison Brunsman

8‐105 Daptomycin Stewardship at Transitions of Care


10:00 a.m. ‐ 11:00 a.m.

384325 Theresa Brush 8‐106 Evaluation of phytonadione usage and appropriateness in a community hospital


10:00 a.m. ‐ 11:00 a.m.

385582 Heather Bryan 9‐255 Retrospective analysis of inpatient pneumonia treatment


11:15 a.m. ‐ 12:15 p.m.

385661 Allison Bryce 9‐256 Evaluation of the clinical outcomes of Hepatitis C patients in a community owned healthcare setting


11:15 a.m. ‐ 12:15 p.m.

387503 Carl Buchwald 10‐223 Closing the gap: the impact of pharmacist intervention on forty‐eight hour ICU readmissions


12:30 p.m. ‐ 1:30 p.m.

388152 Kara Buck 8‐221 Efficacy of sodium polystyrene sulfonate for the treatment of acute hyperkalemia in hospitalized patients


10:00 a.m. ‐ 11:00 a.m.

389059 Anjuli Buechler 1‐116 Pharmacy Presence in a Veterans Affairs Urgent Care Clinic

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 30

Session ID


Title Date Time

386185 Janice Bueter 10‐281 Effect of computerized order entry on the process of inpatient chemotherapy order efficiency and medication error potential


12:30 p.m. ‐ 1:30 p.m.

387317 VIVIAN BUI 1‐117 New metformin prescribing recommendation: evaluating metformin use based on estimated glomerular filtration rate over traditional serum creatinine contraindications

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386715 Daniel Bulger 1‐118 Assessing the effectiveness of an automatic warfarin critical drug interaction consult

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388797 Sarah Buranich 8‐222 Evaluation of pharmacist‐led interventions in transition of care in an inpatient community hospital setting


10:00 a.m. ‐ 11:00 a.m.

388516 Jordan Burdine 1‐119 Inpatient palivizumab utilization post‐specialty pharmacy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386268 Chase Burkavage 9‐104 Evaluation of the management of enterococcal urinary tract infections (UTIs) and in‐vitro susceptibility of isolates at an urban community hospital


11:15 a.m. ‐ 12:15 p.m.

388454 Kelly Burke 8‐223 Hospital adverse drug event prevention: opioids and naloxone use


10:00 a.m. ‐ 11:00 a.m.

387185 Ruby Burks 9‐257 Coded adverse drug events after real‐time clinical surveillance tool implementation for pharmacists


11:15 a.m. ‐ 12:15 p.m.

385424 Vincent Burns 12‐033 Effect of sedation protocol revision on sedative use in the medical intensive care unit (MICU)


3:00 p.m. ‐ 4:00 p.m.


Page | 31

Session ID


Title Date Time

388808 Corey Burrelli 8‐021 Treatment outcomes with nafcillin versus cefazolin for methicillin‐susceptible Staphylococcus aureus bloodstream infections


10:00 a.m. ‐ 11:00 a.m.

389591 Sheena Burwell 11‐054 Implementation and evaluation of pharmacy services in an adult cystic fibrosis clinic


1:45 p.m. ‐ 2:45 p.m.

388648 Anna Bustin 9‐022 Drug use evaluation of anakinra in a pediatric population


11:15 a.m. ‐ 12:15 p.m.

386370 Caitlin Butler 11‐221 Evaluating the efficacy of liposomal bupivacaine in select surgical procedures at Boca Raton Regional Hospital (BRRH)


1:45 p.m. ‐ 2:45 p.m.

388734 Tierra Butler 11‐121 The Impact of Pharmacy Resident‐Led Transitions of Care Service in an Urban Family Medicine Clinic


1:45 p.m. ‐ 2:45 p.m.

385366 Amy Butz 1‐121 Evaluation of stimulant use and prescribing patterns at the Salt Lake City VA Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387414 Hillary Buzby 8‐224 Clinical and economic outcomes associated with the utilization of a bedside prescription delivery service at discharge


10:00 a.m. ‐ 11:00 a.m.

389439 Alexis Bylina 10‐060 Use of continuous unfractionated heparin for venous thromboembolism in cirrhosis


12:30 p.m. ‐ 1:30 p.m.

386762 Nicole Caffiero 11‐140 Implementation of a virtual renal care collaborative project (RCC) by an interdisciplinary nephrology team


1:45 p.m. ‐ 2:45 p.m.


Page | 32

Session ID


Title Date Time

388427 Bradley Cagle 11‐027 Creating reimbursement pathways for inpatient medication therapy management pharmacy services


1:45 p.m. ‐ 2:45 p.m.

389234 Jessi Cahoon 12‐219 Implementation of a Hepatitis C point‐of‐care testing program in rural Montana


3:00 p.m. ‐ 4:00 p.m.

389383 Jocelyn Calado 8‐225 Development of a process for privileging pharmacists as providers and its application for providing pharmacist diabetic services


10:00 a.m. ‐ 11:00 a.m.

386566 Lauren Caldwell 12‐174 Evaluation of the argatroban infusion protocol for systemic anticoagulation in adults with possible heparin‐induced thrombocytopenia


3:00 p.m. ‐ 4:00 p.m.

388995 Monique Calil 1‐122 Evaluation of the impact of liposomal bupivacaine on postsurgical analgesia in spinal surgical procedures

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387307 Austin Camp 9‐182 Postoperative blood glucose control in the cardiovascular intensive care unit after discontinuation of a continuous insulin infusion protocol


11:15 a.m. ‐ 12:15 p.m.

386760 Christopher Campbell

9‐035 Review of a hypoglycemia protocol at an academic medical center


11:15 a.m. ‐ 12:15 p.m.

388909 Rebecca Campbell

8‐107 Working beyond the single‐disease state model: optimizing use of ambulatory care pharmacists in the primary care setting through use of collaborative drug therapy management agreements


10:00 a.m. ‐ 11:00 a.m.


Page | 33

Session ID


Title Date Time

387046 Eris Cani 1‐123 Urinary tract infections (UTIs) in diabetic versus non‐diabetic patients: prevalence, clinical and microbiological outcomes

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

383297 Leann Cape 1‐073 Evaluation of adherence to osteoporosis screening recommendations in women veterans.

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385786 Amanda Capino 11‐059 Caregiver perception, self‐efficacy, and knowledge of methadone tapers for children with iatrogenic opioid abstinence syndrome


1:45 p.m. ‐ 2:45 p.m.

389328 Raquel Caporella 10‐009 Assessment of a pharmacist‐led medication counseling program on patient satisfaction scores in a hospital unit


12:30 p.m. ‐ 1:30 p.m.

387138 Todd Capron 9‐258 Meds‐To‐Go Program in a Community Hospital


11:15 a.m. ‐ 12:15 p.m.

382624 Stephanie Cardinale

12‐034 Medication utilization evaluation of oral antihyperglycemic medications in the elderly


3:00 p.m. ‐ 4:00 p.m.

388710 Dustin Carneal 10‐061 Implementation of a Pharmacist‐Coordinated Transitions of Care Service and the Utilization of a Patient Specific Medication Timeline within a Small Independent Non‐Profit Planetree Community Hospital


12:30 p.m. ‐ 1:30 p.m.

385723 Matthew Caron 1‐124 Evaluate the safety and efficacy of using lower doses of flumazenil for the reversal of benzodiazepine intoxication

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 34

Session ID


Title Date Time

385396 Mary Carpenter 10‐027 Impact of multidisciplinary care on readmission rates for patients discharged with congestive heart failure and chronic obstructive pulmonary disease


12:30 p.m. ‐ 1:30 p.m.

388916 Parrish Carpenter

1‐125 Jet‐injected lidocaine compared to vapocoolant spray for local anesthesia prior to peripheral intravenous catheter insertion in pediatric patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388861 Zachary Carrasco 11‐035 Evaluating use of sub‐dissociative ketamine in the ER at Mercy Health Muskegon


1:45 p.m. ‐ 2:45 p.m.

386796 Jessica Carrillo 8‐022 Effects of interdisciplinary education on treatment outcomes for oral anticoagulant induced intracranial bleeding and traumatic head injury in three community hospitals


10:00 a.m. ‐ 11:00 a.m.

388321 Anne Carrington 11‐036 Analysis of phytonadione utilization and prescribing patterns for appropriateness at a community teaching hosptial


1:45 p.m. ‐ 2:45 p.m.

386834 Courtney Carroll 11‐282 The impact of a pharmacy technician on the accuracy of a pediatric medication history at admission versus 24 hours post‐admission


1:45 p.m. ‐ 2:45 p.m.

386301 Eileen Carroll 1‐126 Comparison of continuous intravenous insulin order sets in the setting of hyperglycemic emergency

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 35

Session ID


Title Date Time

388466 Maxwell Cart 9‐169 Quality assurance assessment of peri‐procedural enoxaparin bridging provided by anticoagulation pharmacists in Veterans undergoing elective gastrointestinal procedures


11:15 a.m. ‐ 12:15 p.m.

387945 Charles Carter 11‐141 Improvements in pharmacist‐driven medication reconciliation and patient counseling: preoperative outpatient setting versus postoperative inpatient setting


1:45 p.m. ‐ 2:45 p.m.

385783 Kenneth Carver 11‐222 Use of real‐time decision support to identify opportunities for clinical pharmacist intervention


1:45 p.m. ‐ 2:45 p.m.

386739 Marissa Casagrande

8‐002 Impact of pharmacist‐driven discharge medication reconciliation at a community hospital


10:00 a.m. ‐ 11:00 a.m.

386726 Brian Case 10‐224 A retrospective review of an auto‐substitution of fosaprepitant for aprepitant in patients receiving highly or moderately emetogenic chemotherapy


12:30 p.m. ‐ 1:30 p.m.

387315 Benjamin Casey 11‐142 Procalcitonin‐guided discontinuation of antibiotic therapy in critically ill patients with pneumonia: An institutional review


1:45 p.m. ‐ 2:45 p.m.

387079 Michael Casias 12‐035 Impact of cepheid blood polymerase chain reaction (PCR) combined with antimicrobial stewardship intervention on Staphylococcus aureus bacteremia: A community hospital approach


3:00 p.m. ‐ 4:00 p.m.


Page | 36

Session ID


Title Date Time

389088 Sady Castane 10‐062 Impact of pharmacist post discharge follow up phone call program on adherence and medication related problems


12:30 p.m. ‐ 1:30 p.m.

386553 Michelle Castelli 1‐127 Implementation of the rivaroxaban patient assistance kit (R‐PAK): a one year update

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387819 Jessica Cate 1‐128 Establishing a pharmacist managed dementia medication monitoring clinic

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388757 Drew Cates 9‐183 PrEPing with PrEP: Pharmacy‐based Collaborative Care


11:15 a.m. ‐ 12:15 p.m.

388449 Lillian Caton 10‐149 Comparison of the use of methylnaltrexone bromide before and after protocol implementation


12:30 p.m. ‐ 1:30 p.m.

387039 Alanna Causebrook

8‐269 Pharmacist run oral chemotherapy clinic


10:00 a.m. ‐ 11:00 a.m.

385407 Jillian Cavallari 9‐089 The effect of tranexamic acid on mortality, use of blood products and vascular adverse events in resuscitation of trauma patients


11:15 a.m. ‐ 12:15 p.m.

385871 Joseph Cavanaugh

8‐227 Pharmacist impact on patient outcomes and ACLS compliance during in‐hospital cardiac arrest


10:00 a.m. ‐ 11:00 a.m.

386808 Zakary Cerminara

8‐079 A single center retrospective analysis of a protocol for high‐dose methotrexate and leucovorin rescue administration


10:00 a.m. ‐ 11:00 a.m.


Page | 37

Session ID


Title Date Time

388229 Ashley Ceryance 1‐131 Implementation of a standardized process for dispensing medications from a specialized spinal cord pharmacy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387386 Anwesa Chakrabarti

9‐184 Medication use evaluation of metronidazole for double anaerobic coverage and appropriateness of therapy


11:15 a.m. ‐ 12:15 p.m.

388402 Alexandra Chambers

11‐006 The clinical efficacy and cost effectiveness of Rasburicase, fixed dosing versus weight based dosing, in a multi‐institutional healthcare system


1:45 p.m. ‐ 2:45 p.m.

387446 Lauren Chambers

8‐059 Evaluation of antimicrobial de‐escalation in patients with suspected sepsis at a community teaching hospital


10:00 a.m. ‐ 11:00 a.m.

387430 Esther Chamorro‐de‐Vega

9‐062 Direct‐acting antiviral agents for the treatment of chronic hepatitis c virus infection: effectiveness and safety.


11:15 a.m. ‐ 12:15 p.m.

385882 Carol Chan 9‐105 Evaluation of adherence, safety, and efficacy of warfarin versus new oral anticoagulants in patients enrolled in a non‐profit health plan


11:15 a.m. ‐ 12:15 p.m.

387306 Churg Chan 8‐023 Evaluating a dosing protocol for tranexamic acid in a community teaching hospital


10:00 a.m. ‐ 11:00 a.m.

387217 Jason Chan 12‐220 Implementation and evaluation of a heparin dosing nomogram in a large urban healthcare system


3:00 p.m. ‐ 4:00 p.m.


Page | 38

Session ID


Title Date Time

389618 Kay Chan 1‐132 Feasibility study of implementing a pharmacist prescribed therapies program for acute conditions in community chain pharmacies

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388313 Mitchell Chan 9‐259 Implementation of a pharmacy‐lead vancomycin dosing protocol in the intensive care unit (ICU) at a small community hospital


11:15 a.m. ‐ 12:15 p.m.

386091 Yazmin Chan 1‐133 Pharmacists' collaboration to optimize transitions of care: improving the transition from inpatient to outpatient settings for heart failure patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386326 Chia‐Lin Chang 9‐260 Evaluating the impact of pharmacist intervention on Staphylococcal bacteremia utilizing real‐time surveillance technology


11:15 a.m. ‐ 12:15 p.m.

388128 Michelle Chang 10‐303 Evaluation of phenytoin and fosphenytoin pharmacy dosing guidelines


12:30 p.m. ‐ 1:30 p.m.

387294 Stephanie Chang 9‐261 Impact of an antimicrobial stewardship program on discontinuation of empiric anti‐MRSA therapy


11:15 a.m. ‐ 12:15 p.m.

385870 Ryan Chapin 1‐134 Formalization of an antimicrobial stewardship program at a rural hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389405 Kimberly Chapman

8‐228 Identification of neonatal exposure to medications via breast milk and impact of standardized medication recommendations on breast milk feeding rates in a pediatric hospital


10:00 a.m. ‐ 11:00 a.m.


Page | 39

Session ID


Title Date Time

387422 Julia Chase 10‐063 Hyperchloremic metabolic acidosis secondary to fluid resuscitation in patients diagnosed with sepsis in an intensive care unit setting


12:30 p.m. ‐ 1:30 p.m.

387576 Nadiyah Chaudhary

1‐135 Use of icatibant for ace‐inhibitor induced angioedema (AIIA)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388841 Shakira Chavis 11‐101 Recombinant human regular insulin U‐500 medication use evaluation


1:45 p.m. ‐ 2:45 p.m.

387639 Daniel Chen 12‐221 Evaluating the tolerability and efficacy of select dipeptidyl peptidase‐4 inhibitors compared to pioglitazone as optimal third agent of choice in veterans with type 2 diabetes


3:00 p.m. ‐ 4:00 p.m.

387716 Justin Chen 10‐225 Evaluation of rabbit anti‐thymocyte globulin for the treatment of acute renal allograft rejection in pediatric patients


12:30 p.m. ‐ 1:30 p.m.

387288 Victor Chen 11‐223 Double antifungal coverage with liposomal amphotericin B and voriconazole for persistent Candida parapsilosis fungemia


1:45 p.m. ‐ 2:45 p.m.

382962 Xinwei/Nancy Chen

12‐222 Assessing the Appropriate Administration of Kcentra, Profilnine, and NovoSeven in a Community Hospital


3:00 p.m. ‐ 4:00 p.m.

387809 Mikalla Cheney 8‐229 Assessing inpatient pharmacists role and competency in emergency codes.


10:00 a.m. ‐ 11:00 a.m.

387481 Rose Cheng 11‐224 Comparing body surface area formulas in patients receiving cancer chemotherapy


1:45 p.m. ‐ 2:45 p.m.


Page | 40

Session ID


Title Date Time

384803 Serena Cheng 8‐024 Influence of obesity on treatment outcomes in hospitalized patients with acute bacterial skin and soft structure infection


10:00 a.m. ‐ 11:00 a.m.

388086 Eunah Cheon 8‐108 Impact of pharmacists on the quality of anticoagulation management within a multidisciplinary healthcare team in a warfarin fast‐track service


10:00 a.m. ‐ 11:00 a.m.

384510 Ashley Cherniawski

9‐036 Hemodynamic effects of dexmedetomidine compared to propofol in critically ill adults


11:15 a.m. ‐ 12:15 p.m.

385155 Rachel Childers 1‐136 Utilization of electronic notifications as a reminder system to improve metabolic monitoring of patients on second‐generation antipsychotics

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388903 Kelly Chillari 1‐137 Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386933 Jacinta Chin 8‐025 Impact of antimicrobial stewardship pharmacist intervention using real‐time rapid pathogen identification via MALDI‐TOF MS on time to appropriate therapy for blood stream infections


10:00 a.m. ‐ 11:00 a.m.

385264 Jamie Chin 12‐223 Single center experience with apixaban


3:00 p.m. ‐ 4:00 p.m.


Page | 41

Session ID


Title Date Time

387030 Michael Chiou 9‐262 Assessment of clinical outcomes following implementation of a daily sedation interruption protocol in the intensive care unit at a community teaching hospital


11:15 a.m. ‐ 12:15 p.m.

385977 Danielle Chipchura

9‐185 Infections post kidney transplant after low dose rabbit anti‐thymocyte globulin induction therapy


11:15 a.m. ‐ 12:15 p.m.

387617 Allen Chirackel 8‐109 Evaluation of use of intravenous ketamine in the emergency department for agitation and pain control


10:00 a.m. ‐ 11:00 a.m.

386916 Brandon Chiu 8‐230 Demonstrate the impact of matrix‐assisted laser desorption ionization time of flight (MALDI‐TOF) on antibiotic stewardship, patient outcomes, and cost


10:00 a.m. ‐ 11:00 a.m.

385148 Katie Chizmadia 9‐186 Exploring medication therapy management (MTM) in an inpatient setting


11:15 a.m. ‐ 12:15 p.m.

387705 Eun Jeong Choi 11‐225 Comparison of time to therapeutic international normalized ratio between vitamin K versus warfarin omission in absence of bleeding


1:45 p.m. ‐ 2:45 p.m.

385890 Miesoo Choi 9‐063 Propofol infusion syndrome (PRIS) safety initiative


11:15 a.m. ‐ 12:15 p.m.

387309 Sebastian Choi 9‐187 Assessing the impact of respiratory viral panel and rapid respiratory panel on antibiotic use and length of stay in an adult inpatient population


11:15 a.m. ‐ 12:15 p.m.


Page | 42

Session ID


Title Date Time

385832 Dimpa Choksi 8‐080 Incidence of acute kidney injury in elderly patients receiving vancomycin with intermittent‐infusion piperacillin‐tazobactam versus extended‐infusion piperacillin‐tazobactam: a retrospective, cohort study


10:00 a.m. ‐ 11:00 a.m.

388390 Vanessa Chong 10‐150 Involvement of a hospital pharmacist in an outpatient physician office setting to perform medication management and review


12:30 p.m. ‐ 1:30 p.m.

387750 Nupur Chopra 10‐064 Effectiveness of a pharmacist implemented drug‐induced QTc‐prolongation protocol for the prevention of torsades de pointes in an inpatient hospital setting


12:30 p.m. ‐ 1:30 p.m.

388765 Fabienne Chou 1‐350 Comparing treatment outcomes in patients with opioid use disorder treated with either extended‐release naltrexone or buprenorphine at Veterans Affairs Western New York (VAWNY) Healthcare System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387250 Parita Chowatia 8‐231 Impact of pharmacists on carbapenem usage and integration of transitions‐of‐care within an antimicrobial stewardship program in a community academic medical center


10:00 a.m. ‐ 11:00 a.m.


Page | 43

Session ID


Title Date Time

389553 Emily Christenberry

8‐003 Implementing a medical billing software to increase uptake of Tdap and herpes zoster vaccinations in Medicare Part D beneficiaries


10:00 a.m. ‐ 11:00 a.m.

389048 Alicia Christensen

1‐138 Proposed methicillin‐resistant staphylococcus aureus treatment pathway: validation according to patient‐specific treatment selections made by infectious disease physicians at Avera McKennan Hospital & University Health Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384759 Bryan Chudnow 8‐232 Effect of a pharmacist led post discharge visit and medication reconciliation on thirty day readmission rates and emergency room visits.


10:00 a.m. ‐ 11:00 a.m.

387711 Taylor Chuich 10‐151 Prospective initiation and implementation of a pharmacist and pharmacy student‐run medication reconciliation clinic for pre‐operative patients


12:30 p.m. ‐ 1:30 p.m.

388495 Pamela Chukwuleta

10‐065 Evaluation of nurse driven teaching during new medication administration: a hospital consumer assessment of providers and systems (HCAHPS) measure


12:30 p.m. ‐ 1:30 p.m.

387824 Catherine Chun 12‐224 Conversion of enoxaparin to a direct oral anticoagulant (DOAC) for the treatment of venous thromboembolism (VTE): a retrospective analysis


3:00 p.m. ‐ 4:00 p.m.


Page | 44

Session ID


Title Date Time

389069 Christopher Chung

10‐311 Development and evaluation of a pharmacist‐led vancomycin monitoring service for high risk patients at a tertiary care teaching hospital with limited clinical pharmacy staff


12:30 p.m. ‐ 1:30 p.m.

388717 Vivian Chyan 1‐140 Comparison of video to face‐to‐face education on patient knowledge in a newly established anticoagulation service in an internal medicine clinic with an underserved population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388858 Jason Ciaramitaro

12‐036 Therapeutic substitution at a pediatric hospital: An evaluation


3:00 p.m. ‐ 4:00 p.m.

387769 Alana Ciolek 11‐037 Cost‐effectiveness of strategies aimed at reducing nitroprusside utilization and waste at an academic medical center


1:45 p.m. ‐ 2:45 p.m.

385797 Nicole Cisler 1‐141 Evaluation of system‐wide use of tranexamic acid and its potential safety concerns

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387536 Francesco Ciummo

8‐110 Multimodal pain management and high‐dose liposomal bupivacaine for the treatment of postoperative pain in total knee replacement


10:00 a.m. ‐ 11:00 a.m.

389141 Alexander Clark 12‐225 Evaluating the performance of the pharmacy departments within three community hospitals.


3:00 p.m. ‐ 4:00 p.m.

388657 Dillon Clark 9‐189 Inhaled insulin and chest pain related to second hand smoke


11:15 a.m. ‐ 12:15 p.m.


Page | 45

Session ID


Title Date Time

389611 Jacqueline Clark 1‐142 Use of Intravenous Methadone in an Academic Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386140 Kyle Clark 1‐143 Impact of a pharmacist‐administered biometric screening on patient outcomes in an independent community pharmacy setting.

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389304 Christie Clauss 1‐144 Development of a pharmacist discharge medication review initiative within a children's hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387332 Brenna Clayton 11‐197 Retrospective review of appropriate stress ulcer prophylaxis discontinuation in the intensive care units and the impact of pharmacist education and interventions


1:45 p.m. ‐ 2:45 p.m.

388659 Christina Clemens

9‐190 Evaluation of thromboprophylactic anti‐Xa levels in morbidly obese patients receiving standard versus weight based doses of enoxaparin


11:15 a.m. ‐ 12:15 p.m.

388726 Jenna Clemons 1‐146 Impact of pharmacist intervention to improve appropriate proton pump inhibitor utilization

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385645 Eduardo Clot 9‐001 Characterization of a Clinical Trials Unit Activity in a University Hospital


11:15 a.m. ‐ 12:15 p.m.

388567 Brandon Clubb 1‐147 Evaluating the effect of a pharmacist counseling service on medication‐related HCAHPS scores and hospital readmission rates

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 46

Session ID


Title Date Time

387500 Cory Coffey 12‐226 Evaluating the effect of a pharmacist‐led patient education program on chronic pain management in an underserved ambulatory care clinic.


3:00 p.m. ‐ 4:00 p.m.

387518 Michael Cohen 9‐106 Drug utilization evaluation of sodium polystyrene sulfonate administered at the University of Rochester Medical Center


11:15 a.m. ‐ 12:15 p.m.

387339 Lauren Coker 9‐064 Evaluation of Asthma Readmission Rates as Compared to the Joint Commission Standard


11:15 a.m. ‐ 12:15 p.m.

386535 Rose Colucci 10‐066 Maintenance of patient international normalized ratio (INR) within therapeutic range at a pharmacist managed anticoagulation clinic


12:30 p.m. ‐ 1:30 p.m.

386257 Brette Conliffe 10‐047 Impact of an advanced pharmacy practice experience (APPE) student‐run 'Meds 2 Beds' and discharge counseling program on quality of care


12:30 p.m. ‐ 1:30 p.m.

385413 Theresa Connelly 10‐152 CMS guideline complicance at Saint Joseph Mercy Oakland for acute venothromboembolism treatment utilizing warfarin and a parenteral anticoagulant and its effect on length of stay


12:30 p.m. ‐ 1:30 p.m.

388963 Savannah Connolly

10‐304 Evaluation of multiple dose dinoprostone for cervical ripening for induction of labor at a high volume community birth center


12:30 p.m. ‐ 1:30 p.m.


Page | 47

Session ID


Title Date Time

387632 Kathryn Conti 8‐233 Analysis of benzodiazepine and opioid co‐prescribing to Veterans at the Providence VA Medical Center: a pilot study


10:00 a.m. ‐ 11:00 a.m.

387254 Maureen Converse

1‐149 Evaluation of dexmedetomidine use for sedation across a state‐wide health system

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385273 Erin Conway 1‐150 A retrospective review of outpatients treated for skin and skin structure infections in a VA hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387787 Monique Conway

9‐037 Evaluation of chromogenic factor X levels in the transition from argatroban to warfarin


11:15 a.m. ‐ 12:15 p.m.

388539 Allene Cook 8‐111 Comparison of acute kidney injury in hospitalized patients with cellulitis when treated with broad‐spectrum antibiotics versus gram positive coverage alone


10:00 a.m. ‐ 11:00 a.m.

385747 Amy Cook 10‐305 Evaluation of current utilization of dornase alfa in the neonatal and pediatric populations in a community hospital


12:30 p.m. ‐ 1:30 p.m.

385551 Elizabeth Cook 10‐260 Unit equivalency of insulin glargine to insulin detemir


12:30 p.m. ‐ 1:30 p.m.

387443 Emily Cooke 10‐226 Evaluation of health literacy and knowledge of febrile neutropenia in parents and caregivers of pediatric hematology and oncology patients


12:30 p.m. ‐ 1:30 p.m.

389047 Brandy Cooper 9‐007 Impact of medication history collection by pharmacy students in the emergency department


11:15 a.m. ‐ 12:15 p.m.


Page | 48

Session ID


Title Date Time

387623 Nathan Cope 9‐038 Evaluating the usage of TPN in adult patients at Carilion Roanoke Memorial Hospital


11:15 a.m. ‐ 12:15 p.m.

387812 Vanessa Copeland

10‐028 Development of a value stream map for producing compounded sterile products using LEAN principles at a large academic medical center


12:30 p.m. ‐ 1:30 p.m.

387731 Alexander Corboy

1‐151 Assessment of safety outcomes with a pharmacist‐managed protocol for dosing and monitoring of vancomycin in a Veterans Affairs hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386283 Ashley Core 8‐112 Timing of anticoagulation therapy in atrial fibrillation status post cardioembolic stroke


10:00 a.m. ‐ 11:00 a.m.

384734 Laura Cotiguala 8‐081 Pharmacist‐led medication education service for cardiac transplant recipients


10:00 a.m. ‐ 11:00 a.m.

385881 Benjamin Cottongim

10‐067 Effects of ketamine on early extubation in postoperative mechanically ventilated coronary artery bypass graft patients


12:30 p.m. ‐ 1:30 p.m.

385833 Stephanie Cotugno

9‐039 Impact of pharmacist intervention on influenza vaccination rates in a psychiatric patient population


11:15 a.m. ‐ 12:15 p.m.

388349 Lindsey Coval 10‐029 Antibiotic consumption after implementation of a neutropenic fever guideline


12:30 p.m. ‐ 1:30 p.m.

389107 Kevin Cowart 10‐068 Evaluation of intravenous acetaminophen usage in bariatric surgery patients


12:30 p.m. ‐ 1:30 p.m.


Page | 49

Session ID


Title Date Time

387521 Ann Cowden 8‐026 Impact of multiplex polymerase chain reaction (PCR) technology and automatic infectious disease consultation on clinical and economic outcomes


10:00 a.m. ‐ 11:00 a.m.

387654 Jacob Cox 11‐060 Analysis of carbapenem utilization at a regional community hospital


1:45 p.m. ‐ 2:45 p.m.

387515 Sarah Cox 8‐113 Factors associated with 30‐day readmission avoidance after pharmacist‐led inpatient diabetes education


10:00 a.m. ‐ 11:00 a.m.

384380 Rachael Craft 9‐263 Impact of proper allergy reporting of antibiotics for inpatients on a routine medical floor


11:15 a.m. ‐ 12:15 p.m.

386538 Andrea Crahan 11‐102 Prescribing cascades: the incidence of anti‐gout medications in patients taking thiazide diuretics


1:45 p.m. ‐ 2:45 p.m.

386427 Adam Craig 9‐107 Mock Signal Evaluation: A longitudinal project designed to enhance student understanding of how a clinical skill set can be transferred to a real pharmaceutical industry activity


11:15 a.m. ‐ 12:15 p.m.

387205 Danielle Craig 11‐143 Evaluation of facility‐specific risk factors for Clostridium difficile infection rates and implementation of strategies for subsequent rate reduction


1:45 p.m. ‐ 2:45 p.m.

389449 William Crall 10‐153 Evaluation of dyskalemia in pentobarbital‐treated patients with refractory status epilepticus or intracranial hypertension


12:30 p.m. ‐ 1:30 p.m.


Page | 50

Session ID


Title Date Time

386516 Lindsay Crawford

11‐300 Evaluation of medication‐related variables in heart failure readmissions at the Boise VA Medical Center


1:45 p.m. ‐ 2:45 p.m.

387318 Nicole Croyden 8‐114 Evaluation of antimicrobial de‐escalation for mechanically ventilated patients in a community teaching hospital intensive care unit


10:00 a.m. ‐ 11:00 a.m.

386657 Emily Crum 10‐154 Antibiotic therapy for the treatment of urinary tract infections in a long term care facility


12:30 p.m. ‐ 1:30 p.m.

388017 Keri Crumby 11‐061 Impact of pharmacist driven, multidisciplinary initiative to reduce antibiotic use for treatment of asymptomatic bacteriuria


1:45 p.m. ‐ 2:45 p.m.

388573 Sara Csont 8‐234 The impact of an inpatient medication therapy management (MTM) service at a community hospital


10:00 a.m. ‐ 11:00 a.m.

385147 Marissa Csovelak 1‐152 Retrospective study to evaluate nausea, vomiting, and hypersensitivity reactions in patients receiving FOLFOX for colorectal cancer at an infusion center not routinely administering prophylactic dexamethasone

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387454 Yan Cui 1‐153 Evaluation of the current monitoring process for patients receiving target specific oral anticoagulants (TSOACs) and its impact at the Cincinnati Veterans Affairs Medical Center (CVAMC)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 51

Session ID


Title Date Time

386110 Marissa Cullen 10‐282 Intravenous infusion administration charge verification in a charge on administration environment


12:30 p.m. ‐ 1:30 p.m.

385638 Melanie Cullen 10‐283 Pharmacist consult for the conversion or initiation of direct acting oral anticoagulants


12:30 p.m. ‐ 1:30 p.m.

387304 Heidi Cung 8‐115 Optimization of medication clinical decision support (mCDS) with focus on improving clinical relevance in drug‐drug interaction (DDI) and duplication therapy


10:00 a.m. ‐ 11:00 a.m.

387925 Jeff Curless 12‐037 Nitazoxanide for the treatment of Clostridium difficile infection in pediatric patients


3:00 p.m. ‐ 4:00 p.m.

389241 Kelly Curran 11‐038 Evaluation of a pharmacist led admission medication reconciliation process with an effort to reduce medication errors in a community hospital setting.


1:45 p.m. ‐ 2:45 p.m.

388678 Brent Curry 10‐209 Assessing prescribing practices of clozapine before and after the implementation of an updated risk evaluation and mitigation strategy (REMS).


12:30 p.m. ‐ 1:30 p.m.

386350 Breanna Curtis 8‐068 Effects of the availability of CYP2C19 genotype on prescribing behavior for clopidogrel in primary care


10:00 a.m. ‐ 11:00 a.m.

388935 Christa Curtis 9‐040 Hypoglycemia and its association with tighter glucose control in type two diabetics in a community hospital


11:15 a.m. ‐ 12:15 p.m.


Page | 52

Session ID


Title Date Time

385666 Jaclyn Cusumano 11‐226 Daptomycin non‐susceptible methicillin resistant Staphylococcus aureus: a case report


1:45 p.m. ‐ 2:45 p.m.

388759 Lindsay Cwynar 8‐082 Evaluating the effect of insulin prescribing practices on blood glucose control in critically ill patients


10:00 a.m. ‐ 11:00 a.m.

386880 Akorede Dada 11‐039 Pharmacist‐led transitional care program on 30‐day readmissions, medication appropriateness, and patient satisfaction within a community hospital


1:45 p.m. ‐ 2:45 p.m.

383201 Matthew Dandino

10‐155 Pediatric antithrombin III medication use evaluation


12:30 p.m. ‐ 1:30 p.m.

387353 Daniel Dang 10‐156 Evaluation of fluconazole prescribing patterns in a non‐teaching community hospital


12:30 p.m. ‐ 1:30 p.m.

387603 Divya Daniel 8‐116 Effect of lactobacillus on duration of ventilator therapy in critically ill patients


10:00 a.m. ‐ 11:00 a.m.

389451 Ryan DasGupta 8‐069 Evaluation of intravenous phenytoin and fosphenytoin loading doses in obese patients


10:00 a.m. ‐ 11:00 a.m.

387702 Aimee Dassner 8‐117 Evaluation of nephrotoxicity before and after implementation of vancomycin per pharmacist protocol


10:00 a.m. ‐ 11:00 a.m.

388385 Nhu Quyen Dau 11‐227 Evaluation of rivaroxaban and apixaban prescribing patterns and associated outcomes in patients with atrial fibrillation at a large academic medical center


1:45 p.m. ‐ 2:45 p.m.


Page | 53

Session ID


Title Date Time

388782 Michelle Davids 9‐008 A retrospective review of intensive versus conventional blood glucose protocols in critically ill patients


11:15 a.m. ‐ 12:15 p.m.

387938 Erin Davidson 1‐155 The role of a pharmacist managed smoking cessation program in a community charity clinic: a retrospective review

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389319 Camellia Davis 10‐157 Utilization of multiplex polymerase chain reaction (PCR) technology and pharmacist involvement in the identification of gram negative blood stream infections


12:30 p.m. ‐ 1:30 p.m.

387961 Joseph Davis 12‐227 Impact of a pharmacist vancomycin dosing guideline on achievement of therapeutic trough levels


3:00 p.m. ‐ 4:00 p.m.

388732 Kevin Davis 12‐193 Medication use evaluation of budesonide/formoterol use in large community hospital system.


3:00 p.m. ‐ 4:00 p.m.

383722 N. Logan Davis 9‐065 Development of a peer‐review quality improvement program for clinical pharmacy services


11:15 a.m. ‐ 12:15 p.m.

384565 Tamara Davis 9‐041 Evaluation of time to first dose of antibiotics and appropriateness of antibiotic choice in PICU patients with suspected severe sepsis and septic shock


11:15 a.m. ‐ 12:15 p.m.

388721 AMAYA DE BASAGOITI GORORDO

8‐118 Standardization of antineoplastic agents dosage in hepatic insufficiency


10:00 a.m. ‐ 11:00 a.m.


Page | 54

Session ID


Title Date Time

388482 Alyssa De Castro 11‐144 Role of lorazepam in treating chemotherapy‐induced nausea and vomiting after unsuccessful ondansetron treatment in pediatric population


1:45 p.m. ‐ 2:45 p.m.

388901 Jaymes Dean 9‐191 Improving the management of drug shortages through the development of a workflow checklist, intranet webpage, and telephone hotline


11:15 a.m. ‐ 12:15 p.m.

386752 Heather DeAtley Ratliff

11‐145 Evaluating the efficacy of morphine protocols to treat neonatal abstinence syndrome for a level two nursery in a rural community hospital.


1:45 p.m. ‐ 2:45 p.m.

387614 Angela DeBerardine

1‐156 Evaluation of the use of rivaroxaban in cancer patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385831 John Dechand 8‐119 Vasoplegic syndrome in patients undergoing coronary artery bypass grafting: an evaluation of pharmacologic management


10:00 a.m. ‐ 11:00 a.m.

388535 Andrew Decker 11‐062 Stability of extemporaneously prepared sodium benzoate oral solution


1:45 p.m. ‐ 2:45 p.m.

387429 Kaitlyn DeHoff 11‐283 The effect of heparinization on outcomes of therapeutic hypothermia


1:45 p.m. ‐ 2:45 p.m.

387946 Sarah Deitering 10‐069 Comparison of iron dextran infusion times on safety, efficacy, and cost for the treatment of iron‐deficiency anemia


12:30 p.m. ‐ 1:30 p.m.


Page | 55

Session ID


Title Date Time

386279 Kelly DeJager 8‐326 Evaluation of rivaroxaban, apixaban, dabigatran, and warfarin on hospital readmission rates following initiation of medication for non‐valvular atrial fibrilation and venous thromboembolism


10:00 a.m. ‐ 11:00 a.m.

389053 Timothy DeJesus 12‐194 Evaluation of intravenous immune globulin utilization and prescribing practices in a community health system


3:00 p.m. ‐ 4:00 p.m.

387293 Annalisa Delagarza

1‐157 Testosterone drug use evaluation with implementation of a medication use evaluation tool in a Veteran Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389061 Daniel Delaney 9‐188 Antimicrobial utilization and the effect of rapid methicillin‐resistant Staphylococcus aureus colonization detection on vancomycin discontinuation in pneumonia: a quality improvement evaluation


11:15 a.m. ‐ 12:15 p.m.

387856 Hanna Delaney 8‐235 Pharmacist impact in a patient‐centered medical home (PCMH): average hemoglobin A1C and co‐morbidity reduction in patients with type 2 diabetes


10:00 a.m. ‐ 11:00 a.m.

388330 Michael Deleener

9‐108 The impact of a points‐based medication screening tool and pharmacist counseling on fall rates in a community hospital


11:15 a.m. ‐ 12:15 p.m.


Page | 56

Session ID


Title Date Time

387891 Christopher DeLeersnyder

8‐236 Impact of transfusion guidelines on the use of erythropoietin stimulating agents and parenteral iron


10:00 a.m. ‐ 11:00 a.m.

382943 Alexander Dellabella

1‐159 Evaluation of ceftaroline and restricted use policy at a large, tertiary care institution

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387640 Bethany Dellay 9‐042 Evaluating the use of intravenous hydralazine at a teaching institution


11:15 a.m. ‐ 12:15 p.m.

387501 Lindsey DeLoach 11‐063 Patient adherence in patient assistance programs


1:45 p.m. ‐ 2:45 p.m.

387616 Paige DeLuca 8‐120 Medication use evaluation of dexmedetomidine in adult intensive care unit (ICU) patients


10:00 a.m. ‐ 11:00 a.m.

388295 Jason Dent 10‐306 Evaluation of comprehensive prospective pharmacist order verification in the emergency room


12:30 p.m. ‐ 1:30 p.m.

388870 Lauren DeRespiris

1‐160 Stewardship evaluation of anti‐infective use errors in hospitalized patients on hemodialysis

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385682 Melissa Derner 1‐161 The prevalence of adults 65 years and older presenting to a US ED with injury who are prescribed a skeletal muscle relaxant

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386522 Kathryn Derrig 10‐284 Impact of pharmacists in adherence to American Heart Association guidelines during advanced cardiac life support


12:30 p.m. ‐ 1:30 p.m.

386426 Charles Gregor Derupe

8‐121 Igniting pharmacy advocacy: increasing Maine pharmacist and pharmacy student engagement in pharmacist provider status advocacy


10:00 a.m. ‐ 11:00 a.m.


Page | 57

Session ID


Title Date Time

388637 Anand Desai 8‐312 Measurement & improvement of intravenous antibiotic administration time in critically‐ill patients


10:00 a.m. ‐ 11:00 a.m.

385529 Bansri Desai 1‐162 Impact of targeted adherence calls among a Marketplace population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386549 Hilary Devine 8‐122 Assessing adverse bleeding events in patients taking rivaroxaban or warfarin


10:00 a.m. ‐ 11:00 a.m.

385807 Lauren Devine 1‐163 Rate of appropriate statin therapy in HIV patients on a protease inhibitor antiretroviral therapy regimen

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386792 Jordan DeWitt 1‐164 Negative predictive value of methicillin‐resistant staphylococcus aureus (MRSA) nasal polymerase chain reaction (PCR) in critical care patients with pneumonia

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387265 Tara Dicker 9‐109 Impact of pharmacist‐driven discharge counseling and medication therapy management (MTM) on 30‐day hospital readmission rates in patients with chronic illnesses


11:15 a.m. ‐ 12:15 p.m.

387510 Sarah Dickey 8‐027 Transitional interventions from the emergency room: impact of clinical pharmacists and telehealth services on acute care utilization (TIER project)


10:00 a.m. ‐ 11:00 a.m.

387286 Sarah DiDominick

8‐004 Retrospective assessment of efficacy, safety, and satisfaction of updated pain management order sets at a community hospital


10:00 a.m. ‐ 11:00 a.m.


Page | 58

Session ID


Title Date Time

385733 Sandy Diec 12‐038 Evaluation of a mobile telehealth support for self‐monitoring of blood glucose in primary care clinic patients with diabetes ‐ a pilot study


3:00 p.m. ‐ 4:00 p.m.

386856 Tyson Dietrich 1‐165 Implications of carrier fluids in critically ill patients with a positive fluid balance

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387477 Girish Dighe 8‐237 Development and implementation of a denials prevention program at two outpatient hospital‐based infusion centers


10:00 a.m. ‐ 11:00 a.m.

388788 Naomi Digiantonio

9‐009 Impact of a pharmacy‐led medication reconciliation program


11:15 a.m. ‐ 12:15 p.m.

387329 Roman Digilio 10‐070 Impact of a hospital pharmacist coordinating transition of care in an assisted living facility


12:30 p.m. ‐ 1:30 p.m.

385953 Sylvia Dikas 1‐166 The Impact of Intravenous Acetaminophen on Opioid Requirements in Postoperative Inpatients in a Veteran Affairs Health System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385567 Heather Dillenbeck

1‐167 Drug‐use evaluation: the treatment of intra‐abdominal infections at Highland Hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387549 Nicholas Dillman 12‐039 Evaluation of the effects of ventricular assist devices on vancomycin serum concentrations in pediatric patients


3:00 p.m. ‐ 4:00 p.m.

385237 Ryan Dillon 8‐123 Evaluation of intravenous chlorothiazide use at a large academic medical center


10:00 a.m. ‐ 11:00 a.m.

387681 Mary Dimaano 10‐071 Evaluation of hepatitis c virus cure rates in those receiving direct acting antiviral therapy


12:30 p.m. ‐ 1:30 p.m.


Page | 59

Session ID


Title Date Time

384755 Erica Dimitropoulos

1‐168 Evaluation of concurrent oral and long‐acting injectable antipsychotic prescribing at the Minneapolis Veterans Affairs Health Care System (MVAHCS)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389348 Pavlin Dimitrov 9‐110 Understanding the impact of delirium on patients admitted to the ICU in a community‐based, level II trauma center: a retrospective analysis


11:15 a.m. ‐ 12:15 p.m.

388202 Catherine Dinkins

11‐146 Designing a comparison of hospital length of stay in patients treated with direct oral anticoagulants or warfarin for venous thromboembolism


1:45 p.m. ‐ 2:45 p.m.

388487 Kyle DiPaola 11‐040 Assessing the impact of a pain and sedation protocol revision on mechanically ventilated pediatric patients in the pediatric intensive care unit


1:45 p.m. ‐ 2:45 p.m.

388336 Caitlin Dirvonas 10‐010 The prevalence and management of vitamin D insufficiency and deficiency in veterans admitted to an acute inpatient psychiatric unit


12:30 p.m. ‐ 1:30 p.m.

385614 Brianne Dixon 8‐238 Bad to the Bone: Ceftolozane/Tazobactam for Osteomyelitis. Two Case Reports


10:00 a.m. ‐ 11:00 a.m.

389593 Tamara Dixon 1‐169 Improving Diabetes Care at a Rural VA Outpatient Clinic

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385272 Brian Do 11‐228 Incidence of venous thromboembolism in oncology patients following major surgery


1:45 p.m. ‐ 2:45 p.m.


Page | 60

Session ID


Title Date Time

388257 Geeyeon Do 1‐170 Pharmacist development and implementation of multidisciplinary hypertonic saline administration policies, procedures, dosing algorithm, and education

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387894 Jennifer Do 11‐301 Effectiveness of a vancomycin dosing regimen utilizing adjusted body weight in obese patients versus non‐obese patients


1:45 p.m. ‐ 2:45 p.m.

389089 Timmy Do 8‐124 Medication use evaluation of intravenous fluids containing vitamins


10:00 a.m. ‐ 11:00 a.m.

387358 Cortney Dodson 8‐028 Accuracy of body weight obtainment in patients who receive alteplase in the emergency department for an acute ischemic stroke


10:00 a.m. ‐ 11:00 a.m.

388646 Nicholas Dodson 12‐040 Evaluation of pharmacist‐led discharge education in the emergency department: impact on 30‐day emergency department revisits and hospital admissions


3:00 p.m. ‐ 4:00 p.m.

384331 Kim Doerhoff 11‐302 Assessment of the continuation of antipsychotics prescribed for ICU delirium


1:45 p.m. ‐ 2:45 p.m.

386349 Philip Dollin 9‐043 Analysis of use of procalcitonin assay in COPD exacerbations at an academic medical center


11:15 a.m. ‐ 12:15 p.m.

386602 Kirsten Donnan 12‐007 Safety and efficacy of direct oral anticoagulant (DOAC) use in patients who completed catheter‐directed thrombolysis with the endowave system


3:00 p.m. ‐ 4:00 p.m.


Page | 61

Session ID


Title Date Time

387276 Kailee Donner 12‐228 Evaluation of meningococcal vaccination rates in adolescents at one urban clinic


3:00 p.m. ‐ 4:00 p.m.

386859 Sasha Dorzin 11‐122 Implementation of a pediatric antimicrobial stewardship program (ASP) targeted to decreasing the use of antibiotics in children during an asthma exacerbation.


1:45 p.m. ‐ 2:45 p.m.

388811 Emily Doss 12‐008 Prescribing patterns and follow‐up practices of target‐specific oral anticoagulants within VA‐Tennessee Valley Healthcare System


3:00 p.m. ‐ 4:00 p.m.

385302 Cassandra Dotson

12‐009 Evaluation of pharmacist views and safety aspects of house bill 2879


3:00 p.m. ‐ 4:00 p.m.

385684 Kierra Dotson 8‐239 Evaluation of real life treatment outcomes among veterans with HCV genotype 1 treated with 12‐week regimens of newer direct‐acting antivirals


10:00 a.m. ‐ 11:00 a.m.

389204 KariLynn Dowling

10‐072 Implementation of a two‐phase intranasal naloxone initiative in a patient‐centered medical home


12:30 p.m. ‐ 1:30 p.m.

388747 April Downey 11‐007 Seizure prophylaxis after traumatic brain injury: a retrospective analysis of antiepileptic use for post‐traumatic seizure prevention


1:45 p.m. ‐ 2:45 p.m.


Page | 62

Session ID


Title Date Time

386647 Lauren Downing 9‐264 An Evaluation of Antimicrobial Exposure and Therapeutic Management in Patients Diagnosed with Clostridium Difficile at an organization with an Antimicrobial Stewardship Program


11:15 a.m. ‐ 12:15 p.m.

386099 Zachary Drabick 8‐029 Evaluation of a noninvasive cardiac output monitoring (NICOM)‐based protocol in patients with septic shock


10:00 a.m. ‐ 11:00 a.m.

385211 Nadine Drago 8‐083 Intravenous acetaminophen use: a retrospective review of adherence to hospital restrictions


10:00 a.m. ‐ 11:00 a.m.

389289 Michael Drake 1‐171 Implementation of a pharmacist‐run outpatient oral chemotherapy clinic at a veterans affairs medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388582 Anna Drapkin 9‐192 Common themes in Clostridium difficile infection at a community teaching hospital


11:15 a.m. ‐ 12:15 p.m.

387478 Zachary Drawe 1‐172 Vancomycin‐associated nephrotoxicity: a retrospective review of the incidence and associated risk factors

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386791 Annette Drobac 9‐018 Optimizing empiric prescribing practices and outcomes in cellulitis patients seen in an urban community hospitals emergency department


11:15 a.m. ‐ 12:15 p.m.

387989 Amy D''Silva 8‐125 Venous thromboembolism prophylaxis point prevalence study


10:00 a.m. ‐ 11:00 a.m.


Page | 63

Session ID


Title Date Time

387053 Le Du 1‐173 Visual assessment tool to evaluate performance and improve pharmacy quality and productivity: clinical and financial measures

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388875 Maria Duarte 8‐126 Evaluating the use of non‐vitamin k antagonist oral anticoagulants in a community hospital


10:00 a.m. ‐ 11:00 a.m.

388523 Kari Duckworth 9‐193 Description of antibiotic therapy in patients with healthcare‐associated pneumonia and a documented beta‐lactam allergy


11:15 a.m. ‐ 12:15 p.m.

385744 Rachel Duffield 1‐174 Expansion of a pharmacist‐managed hypertension clinic within the patient aligned care team (PACT) model in the VA Central Iowa Health Care System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384356 Katerine Dumais 1‐175 Retrospective chart review assessing impact of weekly paclitaxel plus carboplatin and dose‐dense doxorubicin/cyclophosphamide (ddAC) on relative dose intensity (RDI) in breast cancer patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385154 Kellyn Duncan 12‐041 Evaluation of vancomycin dosing in patients receiving high‐flux dialysis


3:00 p.m. ‐ 4:00 p.m.

386129 Samantha Duncan

1‐176 PTSD screening in underserved population in a primary care setting

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389112 Abby Dunker 1‐177 Development of a pharmacy response plan to prepare for a nursing workforce disruption

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 64

Session ID


Title Date Time

385643 Laura Dunlap 10‐261 Evaluation of tranexamic acid utilized in patients undergoing total knee arthroplasty


12:30 p.m. ‐ 1:30 p.m.

383309 Sarah Dunn 11‐123 Anticoagulation therapy in non‐valvular atrial fibrillation upon discharge from UTMC: an analysis of guideline compliance


1:45 p.m. ‐ 2:45 p.m.

386541 Ian Dunne 1‐178 Evaluation of daptomycin dosage on clinical outcomes in vancomycin‐resistant enterococcal infections at a Veterans Affairs academic teaching hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387615 Richard Duong 9‐111 Retrospective evaluation of disease modifying therapy utilization patterns and healthcare resource utilization in multiple sclerosis


11:15 a.m. ‐ 12:15 p.m.

387340 Marianne Dust 10‐011 Implementation of pharmacist directed warfarin dosing in a community hospital


12:30 p.m. ‐ 1:30 p.m.

387291 Elliott Duvall 12‐042 Barcode scanning compliance within the antepartum unit and the impact of educational intervention


3:00 p.m. ‐ 4:00 p.m.

385897 Andrew Dwenger

1‐179 Beta‐blocker review of agents in veterans with reduced ejection fraction (BRAVE)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385432 Stephanie Dwyer 11‐229 Evaluation of digoxin therapy in veterans with atrial fibrillation and time to first hospitalization related to a cardiac event


1:45 p.m. ‐ 2:45 p.m.

386826 Caitlin Early 11‐147 Pegging down risk factors for peg‐asparaginase toxicity in patients with acute lymphoblastic leukemia


1:45 p.m. ‐ 2:45 p.m.


Page | 65

Session ID


Title Date Time

386254 Chelsea Ebert 1‐180 Impact of pharmacist‐run medication management clinic in a patient centered medical home

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385383 John Edelstein 10‐227 Impact of an infectious disease consult on Staphylococcus aureus bacteremia management


12:30 p.m. ‐ 1:30 p.m.

387941 Simone Edgerton 12‐297 Implementation of the lean six sigma methodology to reduce pharmaceutical waste within an urban, government funded, tertiary care hospital


3:00 p.m. ‐ 4:00 p.m.

386319 Lindsay Edmondson

9‐265 Efficacy of 6mg single fixed‐dose rasburicase for prophylaxis and treatment of tumor lysis syndrome in a hospital network of adult and pediatric hematology/oncology patients


11:15 a.m. ‐ 12:15 p.m.

387710 Marc Edmundson

1‐181 Predictors of tobacco cessation success among VA participants

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385775 Ahmed Eid 10‐228 Medication use evaluation: prescribing indications of levetiracetam for adult mixed intensive care unit patients.


12:30 p.m. ‐ 1:30 p.m.

389525 Amber Elam 9‐112 Central Alabama Veterans Healthcare System


11:15 a.m. ‐ 12:15 p.m.

386097 Megan Elavsky 8‐030 Medication use evaluation of argatroban for heparin induced thrombocytopenia at a tertiary care institution


10:00 a.m. ‐ 11:00 a.m.


Page | 66

Session ID


Title Date Time

387746 Yasmine Elbaga 8‐327 Implementation of a pharmacist‐driven antimicrobial stewardship service for general medicine adult inpatients receiving piperacillin/tazobactam or cefepime ‐ a pilot study


10:00 a.m. ‐ 11:00 a.m.

389266 Katie Elder 10‐307 Evaluation of empiric antifungal treatment in patients with thermal or inhalational injury


12:30 p.m. ‐ 1:30 p.m.

385224 Zane Elfessi 11‐230 Impact of push‐dose phenylephrine to prevent hemodynamic instability during rapid sequence intubation


1:45 p.m. ‐ 2:45 p.m.

389093 Emily Elftman 1‐182 Assessment of referrals initiated and facilitated in a pharmacist‐led transition of care outpatient clinic

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386794 Amy Eliason 12‐175 Evaluation of the implementation of a new neonatal gentamicin dosing regimen based on the pharmacokinetic parameters in neonates with early onset sepsis


3:00 p.m. ‐ 4:00 p.m.

385592 Kaitlyn Elliott 1‐183 Evaluation of vancomycin dose calculators in predicting empiric dosing and steady state trough levels in the adult veteran patient population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 67

Session ID


Title Date Time

385587 Amanda Eloma 12‐229 Evaluation of clinical institute withdrawal assessment‐alcohol, revised (CIWA‐Ar): correct initiation in the presence or absence of documented risk factors for alcohol withdrawal


3:00 p.m. ‐ 4:00 p.m.

386200 Sarah El‐rachidi 1‐184 Retrospective review of fosaprepitant for prophylaxis and treatment of nausea and vomiting in patients undergoing autologous stem cell transplant

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388709 Steven Elrod 9‐170 How to Optimize Polypharmacy Services that are Integral to Patient Centered Medical Home (PCMH)


11:15 a.m. ‐ 12:15 p.m.

385376 Eric Elsasser 10‐285 Assessment of patient benefits and follow‐up for commonly approved non‐formulary medications at a single veterans affairs medical center


12:30 p.m. ‐ 1:30 p.m.

384746 Osama Emara 11‐064 Analysis of pharmacist involvement in management of urinary tract infections in a long‐term care facility


1:45 p.m. ‐ 2:45 p.m.

389138 Elizabeth England

8‐127 Dexmedetomine adjunct therapy compared to benzodiazepines alone for the treatment of alcohol withdrawal syndrome in critically ill trauma patients


10:00 a.m. ‐ 11:00 a.m.

386131 Corinne English 10‐229 Dexmedetomidine versus usual care for treatment of severe alcohol withdrawal in the medical intensive care unit


12:30 p.m. ‐ 1:30 p.m.


Page | 68

Session ID


Title Date Time

386273 Erin Eriksson 10‐073 Evaluation of sotalol monitoring at a community teaching hospital


12:30 p.m. ‐ 1:30 p.m.

386896 Aaron Ernstberger

1‐185 Evaluation of a dosing strategy for therapeutic enoxaparin for acute venous thromboembolism at the Cincinnati Veterans Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388555 William Erwin 1‐186 Medication use evaluation (MUE) of apixaban in a Veterans Affairs Medical Center (VAMC)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387204 Belen Escudero 11‐148 Optimization of antiretroviral theraphy in HIV patients


1:45 p.m. ‐ 2:45 p.m.

384756 Vicente Escudero‐Vilaplana

11‐189 Structured guide for pharmacist interviews and onco‐hematologic outpatients education


1:45 p.m. ‐ 2:45 p.m.

387590 Fernando Estrada

8‐328 Implementation of pharmacy‐driven evaluation of intravenous antibiotics before hospital discharge


10:00 a.m. ‐ 11:00 a.m.

388258 Raymond Estrada

9‐194 Reduction of healthcare‐associated Clostridium difficile readmission rates through pharmacist antimicrobial stewardship review of discharge antibiotics


11:15 a.m. ‐ 12:15 p.m.

383587 Ashley Evans 9‐195 Impact of implementation of a layered learning model on pharmacy‐led warfarin patient education


11:15 a.m. ‐ 12:15 p.m.


Page | 69

Session ID


Title Date Time

389475 Kellie Evans 10‐158 Effects of a pharmacy technician‐driven admission medication reconciliation program for psychiatric patients boarding in the Grant Medical Center Emergency Department


12:30 p.m. ‐ 1:30 p.m.

389487 Stacy Evans 8‐313 Implementation of an electronic order template to prevent the spread of fluoroquinolone resistance in an outpatient setting


10:00 a.m. ‐ 11:00 a.m.

388029 Michael Ezebuenyi

12‐298 Evaluation of physician prescribing patterns for antibiotics in the treatment of cellulitis


3:00 p.m. ‐ 4:00 p.m.

384412 Nuha Fairaq 12‐043 Impact of medication reconciliation by pharmacist during transition of care from adult intensive care unit (ICU) to regular hospital wards.


3:00 p.m. ‐ 4:00 p.m.

383481 Savana Fairchild 1‐187 Impact of the implementation of Project Re‐Engineered Discharge (RED) for chronic obstructive pulmonary disease (COPD) patients at a Veterans Affairs hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386586 Nicole Farabaugh

10‐159 Impact of pharmacy intervention on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) medication communication scores


12:30 p.m. ‐ 1:30 p.m.

386464 Nada Farhat 10‐160 Risk factors for pseudomonas aeruginosa in diabetic foot infections


12:30 p.m. ‐ 1:30 p.m.


Page | 70

Session ID


Title Date Time

386867 Nicholas Farina 9‐019 Evaluation of fidaxomicin use for Clostridium difficile infections across a state‐wide health system


11:15 a.m. ‐ 12:15 p.m.

389159 Kevin Farrow 11‐204 Evaluation of a newly implemented diabetic ketoacidosis (DKA) protocol in a community teaching hospital


1:45 p.m. ‐ 2:45 p.m.

386235 Esther Fasanmi 8‐314 Determination of medication possession ratio thresholds for viral suppression in HIV‐infected patients


10:00 a.m. ‐ 11:00 a.m.

388435 Veronica Fassio 1‐188 Trends in non‐steroidal anti‐inflammatory drug prescriptions before and after an opioid safety initiative in the Veterans Health Administration

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387563 Shane Fassnacht 11‐231 Comparing error rates of a newly implemented electronic health record (EHR) to previous paper record orders in an outpatient oncology setting


1:45 p.m. ‐ 2:45 p.m.

387211 Nayyra Fatani 12‐092 Evaluation of the use of non‐vitamin‐K‐antagonist oral anticoagulants (NOACs) in a community teaching hospital and the impact of medication reconciliation on medication discrepancies


3:00 p.m. ‐ 4:00 p.m.

384314 Joseph Faulhaber

1‐190 Evaluation of the treatment of alcohol withdrawal before and after implementation of a new alcohol withdrawal treatment protocol at a community teaching hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 71

Session ID


Title Date Time

385836 Mollie Fearing 9‐113 Evaluation of opioid education in post‐operative orthopedic patients


11:15 a.m. ‐ 12:15 p.m.

387226 Ryan Feeney 9‐114 Evaluation of pharmacologic agents for the management of atrial fibrillation in hemodynamically unstable patients


11:15 a.m. ‐ 12:15 p.m.

389358 Jessica Fennelly 9‐266 Evaluation of a comprehensive medication review service in a patient‐centered medical home


11:15 a.m. ‐ 12:15 p.m.

385206 Amanda Fenstermacher

10‐030 Medication use evaluation of calcitonin injection within the St. Luke's University Health Network


12:30 p.m. ‐ 1:30 p.m.

386524 Kirsten Ferguson 10‐074 Targeted temperature management following cardiac arrest: Outcomes of cooling to 33 degrees celsius versus 36 degrees celsius


12:30 p.m. ‐ 1:30 p.m.

389322 Ryan Ferren 9‐066 Impact of the Verigene Gram‐positive blood culture assay on time to appropriate antibiotic therapy for Staphylococcus aureus bacteremia at an academic medical center


11:15 a.m. ‐ 12:15 p.m.

387273 Kelsey Fink 8‐128 Compliance with oxytocin protocol in laboring patients


10:00 a.m. ‐ 11:00 a.m.

388755 Meggie Finley 11‐149 Evaluating the utilization of tbo‐filgrastim and pegfilgrastim in adult patients with solid tumors and non‐myeloid malignancies


1:45 p.m. ‐ 2:45 p.m.


Page | 72

Session ID


Title Date Time

387969 Danielle Finn 1‐191 Effectiveness of a psychiatric pharmacy resident intervention in reducing benzodiazepine use in elderly veterans

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388433 Michela Fiori 8‐031 Outcomes of a pharmacist‐driven education program for residents discharged from a skilled nursing facility


10:00 a.m. ‐ 11:00 a.m.

384738 Lindsey Firman 12‐195 Development of a pharmacist driven medication review process to address polypharmacy in patients within a neurology clinic


3:00 p.m. ‐ 4:00 p.m.

388558 Daniel Fischer 9‐267 Prothrombin complex concentrate compared to fresh frozen plasma for the emergent reversal of warfarin related intracranial hemorrhage


11:15 a.m. ‐ 12:15 p.m.

388175 Diana Fischer 10‐078 Pharmacist resident implementation of a transitions of care system in a community hospital


12:30 p.m. ‐ 1:30 p.m.

387407 Allison Fisher 8‐240 Assessment of prophylactic antibiotics on surgical site infections in elective colorectal surgeries


10:00 a.m. ‐ 11:00 a.m.

385810 Scott Fitter 10‐075 Comparison of outcomes in patients receiving four factor prothrombin complex concentrate for reversal of warfarin vs. other coagulopathies


12:30 p.m. ‐ 1:30 p.m.


Page | 73

Session ID


Title Date Time

386519 Alyssa Fixl 10‐003 Risk factors for adverse events during hypertension management in the emergency department: a comparison of intravenous antihypertensive therapies


12:30 p.m. ‐ 1:30 p.m.

386276 Meghan Fletcher 11‐150 Effect of education on tetanus vaccinations administered in an emergency department


1:45 p.m. ‐ 2:45 p.m.

388896 Rebecca Fletcher 1‐193 Low‐dose methotrexate induced hematologic toxicity after acute kidney Injury and concomitant diflunisal

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387409 Elizabeth Flippin 1‐194 Characterizing antidiabetic prescribing in hospitalized patients at a Veterans Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384577 Marcus Flores 9‐196 Bariatric surgery in patients receiving oral cancer treatment at MetroHealth Medical Center


11:15 a.m. ‐ 12:15 p.m.

387613 Kelsie Flynn 1‐195 Comparison of venlafaxine and duloxetine: measuring clinical impact of time to therapeutic effect among patients achieving therapeutic dosing for pain.

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387376 Kevin Flynn 1‐196 Effect of decentralization of as needed and one‐time hospital medication dispensing on pharmacy workload and timeliness of medication administration in a Veterans Affairs hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386894 Lauren Flynt 12‐044 To cap or not to cap? The effects of dose‐capping unfractionated heparin for venous thromboembolism.


3:00 p.m. ‐ 4:00 p.m.


Page | 74

Session ID


Title Date Time

389422 Christopher Foley

1‐197 Correlating uncontrolled depression with worsening control of diabetes using HbA1c and PHQ9 scores

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389263 Heather Folz 1‐198 Course redesign of the my first patient program into the clinical assessment course

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386299 Garrett Foo 1‐199 Impact of a clinical pharmacist at reducing anticholinergic medication burden in older, medically complex Veterans

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385144 Farnaz Foolad 11‐151 Impact of a stewardship intervention on duration of therapy and associated Clostridium difficile infection among patients with community acquired pneumonia


1:45 p.m. ‐ 2:45 p.m.

385411 Ashley Ford 8‐241 Evaluation of patient safety when using U‐500 insulin in an acute care setting


10:00 a.m. ‐ 11:00 a.m.

388819 Maria Foreman 9‐268 Implementation and evaluation of a pharmacist‐based vancomycin dosing protocol in a rural, community hospital


11:15 a.m. ‐ 12:15 p.m.

382641 Jeanne Forrester 9‐171 Incidence of hyponatremia and hypovolemia in pediatric patients receiving standard intravenous maintenance fluids


11:15 a.m. ‐ 12:15 p.m.

388865 Emily Foster 9‐115 Time to resolution of SIRS criteria in patients with acute pancreatitis receiving lactated ringer's solution versus normal saline for fluid resuscitation


11:15 a.m. ‐ 12:15 p.m.


Page | 75

Session ID


Title Date Time

386128 Ashley Fox 8‐032 Prescribing patterns at discharge after an acute coronary event in a state with high rates of coronary heart disease mortality


10:00 a.m. ‐ 11:00 a.m.

387697 Jill Frament 8‐129 Medication dosage form adjustment prior to bariatric surgery: partnering with patients and providers before admission


10:00 a.m. ‐ 11:00 a.m.

386489 Jeannie Francis 1‐200 The impact of a clinical oncology pharmacist in the management of oral chemotherapy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387141 Julie Francisco 1‐201 Evaluation of specialty pharmacy services and outcomes for hepatitis C at a large academic medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

383584 Richard Francisconi

10‐076 Overview of antiemetic use in pediatric oncology patients at a children's hospital


12:30 p.m. ‐ 1:30 p.m.

387314 Taylor Franckowiak

10‐077 Derivation and validation of a 30 day hospital readmission risk index


12:30 p.m. ‐ 1:30 p.m.

385856 Elizabeth Franco 10‐308 Duration of mechanical ventilation in patients in the intensive care unit (ICU) treated with benzodiazepine vs nonbenzodiazepine based sedation


12:30 p.m. ‐ 1:30 p.m.

389524 Matthew Franke 11‐232 Implementation of a community‐outreach program to increase usage of intrauterine devices (IUD) in women less than 18 years old


1:45 p.m. ‐ 2:45 p.m.


Page | 76

Session ID


Title Date Time

385168 Andria Frazier‐Brantley

12‐010 Bridging gaps in care through direct pharmacist involvement in admission, discharge, and transitions of care


3:00 p.m. ‐ 4:00 p.m.

385595 Amy Frederick 12‐230 Effect of visit frequency of pharmacist‐led medication management program (MMP) visits on diabetes clinical outcomes


3:00 p.m. ‐ 4:00 p.m.

386433 Anna Claire Freeman

9‐269 Optimization of daptomycin: assessing prescribing habits after criteria‐for‐use implementation


11:15 a.m. ‐ 12:15 p.m.

382939 Mallory Freeman 8‐242 Evaluation of confounding factors prior to hyperglycemic events in adult hospitalized patients


10:00 a.m. ‐ 11:00 a.m.

387600 Caitlin Frohnapple

12‐231 The Use of tPA for Acute Ischemic Stroke in Patients with low NIHSS scores


3:00 p.m. ‐ 4:00 p.m.

389378 Madeline Fry 10‐161 Impact of an innovative patient communication tool on a pharmacists identification of medication related problems and the patient‐pharmacist relationship in a high‐risk Medicaid population


12:30 p.m. ‐ 1:30 p.m.

386592 Vanessa Gaerig 9‐270 Early steroid withdrawal and graft rejection in kidney transplant patients


11:15 a.m. ‐ 12:15 p.m.

388536 Alexis Gaggini 11‐103 Impact of a pharmacist‐directed insulin management collaborative practice agreement on diabetes care in a patient‐centered medical home


1:45 p.m. ‐ 2:45 p.m.


Page | 77

Session ID


Title Date Time

386356 Patrick Galdun 1‐202 Establishment of a pharmacist managed hepatitis c clinic in a rural Indian Health Service hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387650 Stormi Gale 11‐194 New protocol using unfractionated heparin for radial‐access percutaneous coronary intervention in acute coronary syndrome patients


1:45 p.m. ‐ 2:45 p.m.

388460 Joseph Galipean 1‐204 Use of coformulated ledipasvir/sofosbuvir for hepatitis C virus genotype 1 in patients coinfected with HIV‐1 being treated with concomitant boosted HIV protease inhibitors and tenofovir

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387737 Anthony Gall 12‐232 Analyzing the feasibility of a pharmacy managed anemia clinic


3:00 p.m. ‐ 4:00 p.m.

388436 Sara Gallardo Borge

12‐045 Acute intermittent porphyria case report


3:00 p.m. ‐ 4:00 p.m.

387527 Alyssa Gallipani 12‐233 Cost analysis of single, low‐dose rasburicase for the management of tumor lysis syndrome in adult cancer patients


3:00 p.m. ‐ 4:00 p.m.

389659 Jeffery Galyon 11‐104 Title: Effectiveness of adjunct dexmedetomidine therapy on decreasing benzodiazepine administration in the treatment of alcohol withdrawal syndrome (AWS) in the intensive care unit (ICU)


1:45 p.m. ‐ 2:45 p.m.


Page | 78

Session ID


Title Date Time

386343 Angela Gamwell 9‐044 Severe sepsis or septic shock upon arrival to the emergency department (ED)‐ are ED pharmacists improving outcomes?


11:15 a.m. ‐ 12:15 p.m.

386551 Kevin Gan 1‐205 Development of a protocol for the prevention of deep vein thrombosis/pulmonary embolism for patients admitted in an acute care setting

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387505 Geetika Gandhi 12‐234 Evaluation of heparin and enoxaparin monitoring in patients with doses adjusted for obesity


3:00 p.m. ‐ 4:00 p.m.

388456 Erin Gandrud 9‐067 Medication utilization evaluation of imipenem/cilastatin at a northern Colorado community hospital


11:15 a.m. ‐ 12:15 p.m.

385864 Jessica Ganschow

1‐206 Optimization of aldosterone antagonists for heart failure at hospital discharge from the Portland VA Healthcare System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388228 David Garbarz 10‐230 Clinical and financial impact of a pharmacist coordinated penicillin allergy testing program


12:30 p.m. ‐ 1:30 p.m.

387602 Graham Garcia 10‐162 Impact of antibiotic dispensing and counseling by a pharmacist at the time of hospital discharge on readmission rates for patients with pneumonia


12:30 p.m. ‐ 1:30 p.m.


Page | 79

Session ID


Title Date Time

386911 Katelynn Garcia 8‐130 Evaluation of therapeutic enoxaparin dosing and corresponding anti‐Xa levels in obese hospitalized patients: a prospective observational study


10:00 a.m. ‐ 11:00 a.m.

385866 Xandra Garcia‐Gonzalez

10‐309 Adverse events associated with genetic variations in colorectal cancer patients treated with capecitabine


12:30 p.m. ‐ 1:30 p.m.

385232 Jessica Gardea 1‐203 Evaluating glycemic control for patient‐aligned care team Clinical Pharmacy Specialists at the Michael E. DeBakey Veterans Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389380 David Gardner 8‐005 Efficacy of educational videos on health related topics and its correlation with health literacy


10:00 a.m. ‐ 11:00 a.m.

386143 Stephanie Gartrell

11‐152 Implementation of a patient self‐testing program within a pharmacist‐managed anticoagulation clinic


1:45 p.m. ‐ 2:45 p.m.

389083 Mike Gassmann 1‐207 Quality assessment of admission medication reconciliation process at a VA medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386687 Katie Gauen 12‐299 Effect of Advanced Pharmacy Practice Experience (APPE) students on preceptor productivity on general medicine floors in a large, academic medical center


3:00 p.m. ‐ 4:00 p.m.

387564 Elizabeth Gavioli 8‐243 Prevention of granulocyte‐colony stimulating factors(G‐CSF) induced bone pain using a double histamine blockade


10:00 a.m. ‐ 11:00 a.m.


Page | 80

Session ID


Title Date Time

387597 Aubrey Gawron 10‐163 Assessment of vasopressin utilization for distributive shock in the intensive care unit population


12:30 p.m. ‐ 1:30 p.m.

388791 Brian Gawronski 12‐176 Effect of the implementation of a transition of care pharmacy service on readmission rates, emergency department visits, and inpatient care costs


3:00 p.m. ‐ 4:00 p.m.

387596 Elizabeth Gearhart

10‐264 Incorporating matrix‐assisted laser desorption ionization time‐of‐flight (MALDI‐TOF) rapid identification into a pharmacy clinical on‐call program


12:30 p.m. ‐ 1:30 p.m.

385275 Megan Gee 1‐376 Analysis of the Diagnosis and Treatment of Urinary Tract Infections in the Veterans Affairs Western New York Healthcare System Home Based Primary Care Population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387767 Gina Gelonese 8‐244 Impact of pharmacist‐led diabetic ketoacidosis education provided to intensive care unit and emergency department nursing staff on utilization of diabetic ketoacidosis order set


10:00 a.m. ‐ 11:00 a.m.

389556 Steven Geltzer 11‐233 Utilization of a telehealth smartphone application to improve medication adherence and reduce hospital readmission rates in pneumonia patients


1:45 p.m. ‐ 2:45 p.m.

387319 Stefanie George 8‐245 Comparison of phenobarbital and lorazepam treatment for alcohol withdrawal syndrome


10:00 a.m. ‐ 11:00 a.m.


Page | 81

Session ID


Title Date Time

383591 Teresa George 10‐079 Combining pharmacy expertise with asthma educator certification: assessing the impact on inner‐city asthma patients


12:30 p.m. ‐ 1:30 p.m.

388382 Nicole Anne Gerardo

1‐208 Scaling the tissue plasminogen activator (tPA) dose: the effect of weight variance on the tPA dose for acute ischemic stroke patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385156 Alexander German

1‐209 Impact of a Diabetes Shared Medical Appointment in Patients with Poorly Controlled Type 2 Diabetes Mellitus

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385131 Alicia Gesenhues 10‐080 Comparison of fungal prophylaxis strategies in pediatric patients undergoing hematopoietic stem cell transplantation: a retrospective review


12:30 p.m. ‐ 1:30 p.m.

388936 Amina Ghalyoun 1‐210 Evaluation of the veterans health administration (VHA) opioid safety initiative (OSI) daily morphine equivalent dose cutoff in relation to mortality

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386498 Erika Giblin 1‐211 Insulin titration per protocol versus standard care for management of hyperglycemic crises

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389374 Shannon Giddens

1‐212 Evaluation of inpatient narcotic waste at a large pediatric hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

382942 Stacey Giles 11‐008 Retrospective evaluation to determine appropriate use of statins based on current guidelines within a multi‐specialty outpatient practice


1:45 p.m. ‐ 2:45 p.m.


Page | 82

Session ID


Title Date Time

387424 Colin Gillis 12‐196 Risk evaluation and mitigation strategy prevalence among new drug application (NDA) and biologic license application (BLA) submissions and implications for regulatory strategy


3:00 p.m. ‐ 4:00 p.m.

388612 Allison Gilmore 1‐213 Evaluation of overtreatment of diabetes in a veteran population at high risk for hypoglycemia

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386699 Brianna Glynn 1‐214 Development and evaluation of a pharmacist‐managed telehealth GRECC Connect clinic to optimize medication regimens in recently hospitalized rural geriatric Veterans

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388544 Meghan Glynn 10‐012 Impact of medication adherence in underinsured renal transplant recipients assisted by an outpatient pharmacy based medication assistance program


12:30 p.m. ‐ 1:30 p.m.

387289 Charleen Gnisci 9‐272 Evaluating the safety and efficacy of using actual versus ideal body weight for daptomycin dosing


11:15 a.m. ‐ 12:15 p.m.

387176 Wyatt Gold 9‐010 Improving lipid measures at the Boise VA Medical Center through pharmacy interventions


11:15 a.m. ‐ 12:15 p.m.

388398 Erika Goldberg 1‐215 Evaluation of extravasation of peripherally infused vasopressors in the intensive care units of a veterans affairs medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 83

Session ID


Title Date Time

387842 Rebecca Goldsmith

10‐081 Infection‐related readmission rates following traumatic splenic injury at a level‐1 trauma center


12:30 p.m. ‐ 1:30 p.m.

385902 Leigh Gomez 11‐284 Association between the incidence of venous thromboembolism and body mass index classification


1:45 p.m. ‐ 2:45 p.m.

388638 Aurea M Gomez‐Marquez

10‐272 PREVALENCE OF MALNUTRITION IN INSTITUTIONALIZED PATIENTS


12:30 p.m. ‐ 1:30 p.m.

388975 David Gonzalez 9‐197 Impact of a pharmacist‐led discharge education program on reducing medication errors and readmission rates in a 360‐bed acute care community teaching hospital


11:15 a.m. ‐ 12:15 p.m.

387723 Kendra Gonzalez 12‐197 Impact of a pharmacist directed risk assessment discharge tool (RADT) on hospital readmissions


3:00 p.m. ‐ 4:00 p.m.

388956 Loliet Gonzalez Martinez

12‐310 Impact of implementing an antimicrobial stewardship program on the appropriateness of antimicrobial utilization in a 360‐bed community teaching hospital


3:00 p.m. ‐ 4:00 p.m.

384324 Kellie Goodlet 1‐216 Necessity of carbapenem use when prescribed per infectious diseases specialists

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387722 Brittany Gorden 11‐041 Application of the 2013 American College of Cardiology/American Heart Association blood cholesterol guidelines in HIV patients in an ambulatory care setting


1:45 p.m. ‐ 2:45 p.m.


Page | 84

Session ID


Title Date Time

389394 Emma Gorman 1‐217 Antibiotic selection in the treatment of acute bacterial skin and skin structure infections in the emergency department setting

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389587 Jenna Gorrell 8‐329 Evaluation of outcomes in orthopedic surgery patients receiving liposomal bupivacaine with historical patients who have not.


10:00 a.m. ‐ 11:00 a.m.

382716 Ted Grabarczyk 8‐131 Comparison of the effectiveness of FDA approved weight loss medications utilized by the Veterans Affairs population, a retrospective cohort study


10:00 a.m. ‐ 11:00 a.m.

388871 Nista Gracien 9‐116 Design and implement an e‐consultation for medication fall risk evaluation for pharmacists


11:15 a.m. ‐ 12:15 p.m.

385825 Robert Granett 1‐218 Safety and efficacy of the standard intensity heparin dosing nomogram at Mercy Health Saint Mary's

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386025 Kimberly Grant 9‐045 AAT‐Falls: Adherence to antihypertensive therapeutic guidelines and association with falls in a long‐term care facility


11:15 a.m. ‐ 12:15 p.m.

388663 Glenn Grantner 12‐311 Implementation and evaluation of a pharmacist‐led patient‐controlled analgesia rounding service at a community hospital


3:00 p.m. ‐ 4:00 p.m.

385200 Brandon Green 9‐002 Effects of liposomal bupivacaine, for periarticular pain control post total knee arthroplasty, a retrospective cohort study.


11:15 a.m. ‐ 12:15 p.m.


Page | 85

Session ID


Title Date Time

388354 Christopher Green

11‐285 Evaluation of appropriate use of 4‐factor prothrombin complex concentrate at a large tertiary care hospital


1:45 p.m. ‐ 2:45 p.m.

388133 Sarah Green 10‐164 Evaluation of Nephrotoxicity Associated with Intravenous Colistin or Polymyxin B


12:30 p.m. ‐ 1:30 p.m.

387575 Stephanie Gregg 11‐234 Development and implementation of system‐wide staff education modules of medications with risk evaluation and mitigation strategy (REMS) programs


1:45 p.m. ‐ 2:45 p.m.

386767 Amanda Grego 9‐068 Impact of pharmacist‐delivered discharge counseling on heart failure readmissions


11:15 a.m. ‐ 12:15 p.m.

382593 Lindsey Greiner 12‐235 The effects of ranolazine on hemoglobin A1c in a veteran population


3:00 p.m. ‐ 4:00 p.m.

386843 Chelsea Gresham

10‐082 Assessing the impact of pharmacist‐delivered transition of care services at the time of discharge from a community teaching hospital


12:30 p.m. ‐ 1:30 p.m.

387303 Morgan Greutman

8‐070 Implementation of outpatient naloxone pharmacy services to at‐risk patients


10:00 a.m. ‐ 11:00 a.m.

386574 Alexandra Grieco 10‐165 Impact of targeted pharmacist outreach on increasing smoking cessation efforts among Medicaid managed care members


12:30 p.m. ‐ 1:30 p.m.

389311 Emily Griesbach 10‐166 Retrospective chart review of prothrombin complex concentrate utilization


12:30 p.m. ‐ 1:30 p.m.

389016 Reid Griffin 8‐132 Evaluation of Myeloid Growth Factor Use at a Community Hospital


10:00 a.m. ‐ 11:00 a.m.


Page | 86

Session ID


Title Date Time

389530 Sonja Grinfeld 10‐083 Medication use evaluation of ceftaroline at Erie County Medical Center (ECMC) in Buffalo, NY


12:30 p.m. ‐ 1:30 p.m.

389251 Diana Gritsenko 11‐065 Evaluation of the safety and efficacy of catheter directed thrombolysis in a community teaching hospital


1:45 p.m. ‐ 2:45 p.m.

387017 Reid Grobe 1‐219 Evaluation of anti‐xa level use in adult patients on enoxaparin

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387898 Marti Groeneweg

9‐198 Measuring the value of utilization management: a cost analysis of a regional health plan prior authorization program


11:15 a.m. ‐ 12:15 p.m.

386352 Brittany Gross 9‐273 Retrospective review of pediatric hypertension and management in Mississippi medicaid population


11:15 a.m. ‐ 12:15 p.m.

388794 Joel Grussendorf 1‐220 Evaluation of metabolic monitoring in patients with obesity receiving olanzapine at a Veterans Affairs medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388805 Jessica Guastadisegni

8‐006 Incidence of acute kidney injury with vancomycin and beta‐lactam antibiotics in adult hospitalized patients


10:00 a.m. ‐ 11:00 a.m.

385742 Gabriel Guerra 9‐199 Analyzing and universalizing the components of a clinical decision support project prioritization tool


11:15 a.m. ‐ 12:15 p.m.

388849 Valerie Guerrier 10‐084 Evaluation of a pharmacist‐led basal bolus insulin protocol in a community hospital


12:30 p.m. ‐ 1:30 p.m.


Page | 87

Session ID


Title Date Time

387865 Courtney Guinn 9‐020 Evaluation of the appropriateness of use and adverse effects of proton pump inhibitors for stress ulcer prophylaxis


11:15 a.m. ‐ 12:15 p.m.

389277 Adam Gummersheimer

10‐167 Evaluation of a pharmacist‐led thromboembolism prophylaxis protocol on an adult mental health unit in a rural hospital


12:30 p.m. ‐ 1:30 p.m.

386630 Wenting Guo 12‐236 Evaluation of a pharmacist‐managed vancomycin consult service versus standard of care at a large academic medical center


3:00 p.m. ‐ 4:00 p.m.

389540 Natalia Gut 11‐042 Converting twice daily tacrolimus to the once daily extended‐release tacrolimus formulation in renal transplant recipients


1:45 p.m. ‐ 2:45 p.m.

388232 Kristyn Gutowski 8‐246 Pharmacist‐led patient education: the impact of managing chemotherapy‐induced nausea and vomiting in ambulatory oncology patients in a prospective study


10:00 a.m. ‐ 11:00 a.m.

385634 Michael Ha 10‐085 Evaluation of an electrolyte repletion protocol in patients receiving therapeutic hypothermia for sudden cardiac death


12:30 p.m. ‐ 1:30 p.m.

389180 Katie Haas 8‐315 Evaluation of sedation practices in mechanically ventilated intensive care unit (ICU) patients across metro hospitals of a health system


10:00 a.m. ‐ 11:00 a.m.


Page | 88

Session ID


Title Date Time

386593 Jamie Haase 1‐221 Evaluation of the appropriateness and tolerability of formulary second‐generation, long‐acting injectable antipsychotics at the James J. Peters VA Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386261 Anthony Haberstroh

10‐168 Advancement of pharmacy services for pediatric and neonatal patients at two acute care regional community hospitals


12:30 p.m. ‐ 1:30 p.m.

388658 Melanie Hackney 11‐066 Utilization of a procalcitonin level to identify and appropriately treat critically ill sepsis patients


1:45 p.m. ‐ 2:45 p.m.

386207 Kyra Hagan 9‐200 Cost evaluation of physician‐selected versus pre‐defined intravenous electrolyte fluid replacement for the treatment of diabetic ketoacidosis


11:15 a.m. ‐ 12:15 p.m.

387568 Maureen Hagedorn

10‐169 Impact of health‐system pharmacist‐driven interventions on the care of patients followed by hospitalist teams at a community teaching hospital


12:30 p.m. ‐ 1:30 p.m.

388328 Kyle Hagen 1‐222 Characteristics of patients prescribed naloxone kits in a Veterans Affairs medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386176 Emily Haggard 11‐286 Retrospective analysis of risk factors associated with linezolid‐induced thrombocytopenia


1:45 p.m. ‐ 2:45 p.m.

385722 Aya Haghamad 12‐011 Quality improvement project to improve pain relief in pediatric patients


3:00 p.m. ‐ 4:00 p.m.


Page | 89

Session ID


Title Date Time

385562 Jenelle Hall 9‐274 Impact of provider education on high risk patient utilization of outpatient pharmacy services within a community teaching hospital


11:15 a.m. ‐ 12:15 p.m.

386196 Joshua Hall 1‐400 Impact of enhanced external counterpulsation on VO2MAX: an update

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387986 Lela Hall 9‐172 Retrospective evaluation of immune thrombocytopenia treatment in an adult population


11:15 a.m. ‐ 12:15 p.m.

388723 Brandi Hamilton 10‐170 Evaluation of the impact of a new patient‐centered pharmacist staffing model at a large academic medical center


12:30 p.m. ‐ 1:30 p.m.

388681 Lakisha Hamilton 10‐310 Evaluation of a pharmacy antibiotic streamlining program in a community hospital


12:30 p.m. ‐ 1:30 p.m.

389695 Walid Hammoud 12‐237 Evaluation of pharmacist‐prescriber communication preferences at a community teaching hospital


3:00 p.m. ‐ 4:00 p.m.

388237 Joseph Han 11‐105 Comparing high‐dose dexmedetomidine (HD) versus standard‐dose dexmedetomidine (SD) for sedation of adult patients in the intensive care unit (ICU)


1:45 p.m. ‐ 2:45 p.m.

388962 Sarah Hand 1‐223 Retrospective evaluation of the impact of selective serotonin reuptake inhibitors on the incidence of bleeding events in Veterans receiving new oral anticoagulants

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 90

Session ID


Title Date Time

387330 Paul Hanley 8‐247 Comparison of the incidence of nephrotoxicity with vancomycin plus piperacillin‐tazobactam versus an alternative beta‐lactam: A retrospective, non‐inferiority, cohort study


10:00 a.m. ‐ 11:00 a.m.

385164 Rashad Hanna 11‐153 Impact of a Pharmacist‐Led Transition of Care Telephone Service on 30‐day Hospital Readmissions and ED Visits in Patients with Recent Discharge


1:45 p.m. ‐ 2:45 p.m.

389126 Jessica Hanson 8‐133 Molecular epidemiology of carbapenem resistant Enterobacter cloacea isolates from a Mississippi hospital


10:00 a.m. ‐ 11:00 a.m.

387768 Joshua Hapney 11‐303 Retrospective analysis of patients with reported penicillin allergy


1:45 p.m. ‐ 2:45 p.m.

389046 Allison Hardy 10‐171 Evaluation of fluconazole prophylaxis for invasive candidiasis in a neonatal intensive care unit: developing a successful standardized protocol


12:30 p.m. ‐ 1:30 p.m.

386557 David Harriman II

1‐224 Examining the Clinical and Economic Impact of a Hyperglycemia Management Protocol Implemented at the VA of Southern Nevada Healthcare System: A Three Month Observational Study.

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388724 Amanda Harrington

8‐134 Development of a direct oral anticoagulant guideline for pharmacist‐led patient education


10:00 a.m. ‐ 11:00 a.m.


Page | 91

Session ID


Title Date Time

388158 Kiydra Harris 9‐069 Experience with IBRANCE (palbociblib) at the UT Health Memorial Hermann Cancer Center


11:15 a.m. ‐ 12:15 p.m.

388381 Kiya Harrison 1‐225 Impact of a pharmacist‐led vancomycin dosing and monitoring service at an academic medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389692 Stephanie Hart 11‐009 Implementation of a pharmacist‐driven, transition‐of‐care program to reduce readmission rates for certain CMS diagnosis‐related groups at an Indian Health Services hospital


1:45 p.m. ‐ 2:45 p.m.

384416 Somer Harvey 8‐248 Evaluation of antibiotic use in uncomplicated appendectomies


10:00 a.m. ‐ 11:00 a.m.

389634 Alycia Hatashima 1‐226 Clinical and Pharmacoeconomic Impact of Extended Infusion Cefepime and Meropenem

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385229 Jessica Hatton 1‐227 Patient Satisfaction with Clinical Video Teleconferencing versus Conventional Care

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389518 Kathryn Hauenstein

1‐228 Impact of a pharmacist‐run telehealth anticoagulation service in a rural hospital setting

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384642 Tara Haworth 10‐231 Prevalence of fractures in pediatric patients on an antiepileptic drug


12:30 p.m. ‐ 1:30 p.m.

389544 Alastair Hay 12‐238 The evaluation of pharmacy technician readiness to engage in and discuss medication therapy management services with patients


3:00 p.m. ‐ 4:00 p.m.


Page | 92

Session ID


Title Date Time

385153 Cara Hay 12‐046 Alteplase for catheter clearance: a retrospective review on utilization


3:00 p.m. ‐ 4:00 p.m.

382969 Michelle Hayes 9‐070 Comparison of time to achieve rate‐control in atrial fibrillation between esmolol and diltiazem


11:15 a.m. ‐ 12:15 p.m.

389491 Sarah Hayes 12‐177 Inpatient use of intravenous immune globulin for the treatment of hematologic and neurologic disorders in a tertiary care hospital


3:00 p.m. ‐ 4:00 p.m.

387770 Jay Hazelcorn 8‐316 Evaluation of daptomycin prescribing patterns in a large tertiary care, teaching hospital


10:00 a.m. ‐ 11:00 a.m.

387821 Dana He 8‐135 Impact of a pharmacy resident on inappropriate treatment of asymptomatic bacteriuria in a community teaching hospital


10:00 a.m. ‐ 11:00 a.m.

385289 Ann Heble 9‐021 Characterization of rituximab use at a pediatric hospital


11:15 a.m. ‐ 12:15 p.m.

386148 Cory Hedin 1‐229 Prevalence of spurious systolic hypertension in an active young adult population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388430 Jessica Hedvat 11‐287 Evaluation of new oral anticoagulants for the treatment of venous thromboembolism in the oncology population


1:45 p.m. ‐ 2:45 p.m.

385681 Alyssa Heiden 10‐232 Lung cancer disparities in rural United States


12:30 p.m. ‐ 1:30 p.m.

386135 Krista Heinrich 11‐010 Impact of telehealth on warfarin education on patient retention: a quality improvement study


1:45 p.m. ‐ 2:45 p.m.


Page | 93

Session ID


Title Date Time

387621 Matthew Heinsen

9‐201 Evaluation of adjunctive tigecycline use for clostridium difficile


11:15 a.m. ‐ 12:15 p.m.

386990 Ronald Heisel 11‐235 Impact of vancomycin utilization on VRE colonization among acute myeloid leukemia patients undergoing intensive induction chemotherapy


1:45 p.m. ‐ 2:45 p.m.

389203 Lauren Held 9‐275 Incidence of Invasive Fungal Infections in Newly Diagnosed AML Patients Based on TRM score and Choice of Prophylactic Antifungal Regimen


11:15 a.m. ‐ 12:15 p.m.

383485 Lindsey Helm 9‐202 Reconciling common medication reconciliation discrepancies in a community hospital setting: what are the most common mistakes made and how can we improve upon accuracy?


11:15 a.m. ‐ 12:15 p.m.

387275 Olivia Henderson 11‐304 Evaluation of the appropriate use of rabies immunoglobulin and the rabies vaccine for post exposure prophylaxis in the emergency department


1:45 p.m. ‐ 2:45 p.m.

388921 Nicole Henige 9‐046 Evaluation of 4‐factor prothrombin complex concentrate (4F‐PCC) use in a community teaching hospital


11:15 a.m. ‐ 12:15 p.m.

387772 Kevin Henke 10‐273 Impact of clinical pharmacy services through collaborative drug therapy management in diabetes patients receiving subcutaneous insulin


12:30 p.m. ‐ 1:30 p.m.


Page | 94

Session ID


Title Date Time

384503 Christina Henkel 10‐265 Evaluate the use of 23.4% vs. 7.5% hypertonic saline in patients in the ICU setting: a systematic chart review


12:30 p.m. ‐ 1:30 p.m.

388320 Sarah Hennemann

10‐032 Evaluation of system‐wide use of cefazolin for surgical prophylaxis


12:30 p.m. ‐ 1:30 p.m.

387247 Stacy Henthorne 8‐136 Impact of frequency of psychiatric medication administration on time to psychiatric readmission and adherence in patients with schizophrenia and schizoaffective disorder


10:00 a.m. ‐ 11:00 a.m.

388113 Zachay Henz 1‐230 Assessing the impact of an internal "Pharmacist Intervention Tool" in a tertiary academic medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386801 Ashley Herlihy 12‐198 Evaluation of stimulant use in the treatment of Attention‐Deficit and Attention‐Deficit Hyperactivity disorders at a Veterans Affairs Medical Center: Utilization of diagnostic criteria, appropriate monitoring and follow‐up.


3:00 p.m. ‐ 4:00 p.m.

387269 Luis Hernandez 9‐117 Developing a hazardous drugs training module to educate pharmacy personnel and assess their competency throughout a health system


11:15 a.m. ‐ 12:15 p.m.

387341 Vata Hernandez 1‐231 Medication Use Evaluation of Posaconazole

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384789 Omaida Hernandez‐Ray

9‐276 The effect of personalized letters on pneumococcal‐ 13 valent vaccination rates in community pharmacies


11:15 a.m. ‐ 12:15 p.m.


Page | 95

Session ID


Title Date Time

386741 Brooke Herndon 1‐232 Evaluating differences in mortality within the susceptible minimum inhibitory range: comparison of patients with positive Pseudomonas aeruginosa cultures who are treated with piperacillin/tazobactam or cefepime

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389607 Andrew Hibbard 10‐172 The upstream solution to the prior authorization process: observations from a pharmacist led innovation team


12:30 p.m. ‐ 1:30 p.m.

386406 Lauren Hickman 12‐178 Standardization of intervention documentation for pharmacists in the outpatient setting


3:00 p.m. ‐ 4:00 p.m.

386810 Joshua Hille 1‐233 Evaluation of the appropriate and safe use of parenteral nutrition in an institutional setting

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388376 Andrew Himsel 11‐154 Effect of the history of ethanol or cannabinoid use on sustained virologic response rates following direct‐acting anti‐viral treatment in hepatitis C virus infected veterans.


1:45 p.m. ‐ 2:45 p.m.

384627 Abigail Hines 10‐233 Comparison of two anti‐emetic regimens and their effectiveness in patients treated with highly and moderately emetogenic chemotherapy


12:30 p.m. ‐ 1:30 p.m.

385719 Randall Hinojosa 8‐137 Pharmacy role in the primary management of total parenteral nutrition in a single institution


10:00 a.m. ‐ 11:00 a.m.


Page | 96

Session ID


Title Date Time

388532 Charles Hinton 8‐249 Outcomes of pharmacist led medication management in care transitions pilot program on resolution of drug therapy problems for heart failure patients


10:00 a.m. ‐ 11:00 a.m.

385915 RaeAnn Hirschy 9‐118 Venous thromboembolism prophylaxis in obese patients


11:15 a.m. ‐ 12:15 p.m.

388156 LETIANA HITOALIAJ

1‐234 Evaluation of cannabis use in veterans with posttraumatic stress disorder at VA Connecticut Healthcare System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388254 Christina Ho 8‐250 Evaluation of antibiotic administration for early sepsis management in the emergency department


10:00 a.m. ‐ 11:00 a.m.

389072 Courtnee Ho 12‐199 Benefits of implementing a pharmacy education referral service


3:00 p.m. ‐ 4:00 p.m.

387557 Quynh Ho 12‐239 Evaluation of compliance and safety of standardized heparin protocol


3:00 p.m. ‐ 4:00 p.m.

388125 Brenda Hoang 9‐071 Comparing the effectiveness of apixaban and rivaroxaban educational videos through tablet to written education


11:15 a.m. ‐ 12:15 p.m.

387047 Hoan Hoang 11‐067 Evaluation of low‐dose hydrocortisone continuous infusion versus intermittent boluses in septic shock


1:45 p.m. ‐ 2:45 p.m.

388365 Caitlin Hoar 11‐106 Long‐term outcomes of weight and metabolic outcomes after gastric bypass in a large patient‐centered medical home


1:45 p.m. ‐ 2:45 p.m.

387763 Jessica Hochstetler

9‐277 Impact of electronic pop‐up alerts on antibiotic therapy duration


11:15 a.m. ‐ 12:15 p.m.


Page | 97

Session ID


Title Date Time

387127 Jennifer Hockings

11‐155 Evaluation of a three‐tier sliding scale insulin protocol based on insulin sensitivity


1:45 p.m. ‐ 2:45 p.m.

384476 Sarah Hoerner 12‐240 Evaluation of caffeine citrate usage in the neonatal intensive care unit during a medication shortage


3:00 p.m. ‐ 4:00 p.m.

388882 Marissa Hoffman 1‐235 Pediatric safety and formulary compliance with parenteral hydantoin anticonvulsant agents

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387175 Brendon Hogan 1‐236 Adherence rates of target specific oral anticoagulants (TSOACs): comparison of once daily versus twice daily dosing among Central Texas Veterans Healthcare System patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385198 Mary Caroline Hogue

11‐236 Impact of pharmacist involvement in admission medication reconciliation in a long‐term acute care hospital


1:45 p.m. ‐ 2:45 p.m.

384326 Kylie Holland 1‐237 Maintenance of glycemic control in Veterans discharged from pharmacy medication management clinics

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386247 Adam Hollingsworth

1‐389 The effectiveness of using a case‐based card game verses traditional study methods to learn pharmacological treatment guidelines

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387263 Amanda Holyk 11‐043 Evaluating outcomes of poractant alfa versus calfactant in neonates


1:45 p.m. ‐ 2:45 p.m.

385865 Kristin Hong 11‐190 Evaluation of national sepsis protocol driven antibiotic initiation in the emergency department


1:45 p.m. ‐ 2:45 p.m.


Page | 98

Session ID


Title Date Time

386723 Katelyn Hood 10‐312 Retrospective review of prazosin use for the treatment of post‐traumatic stress disorder (PTSD)‐related nightmares in pediatric and adolescent patients


12:30 p.m. ‐ 1:30 p.m.

385766 Jessica Hoover 8‐138 Risk factors for respiratory syncytial virus‐associated lower respiratory illnesses in the pediatric population


10:00 a.m. ‐ 11:00 a.m.

387864 Teri Hopkins 8‐251 Cefazolin plus metronidazole versus cefoxitin for the prevention of surgical site infections in elective colorectal surgery


10:00 a.m. ‐ 11:00 a.m.

385777 Caleb Hopkinson 11‐124 Length of hospital stay and outcomes in patients with venous thromboembolism: comparison of different anticoagulant regimens


1:45 p.m. ‐ 2:45 p.m.

389099 Liane Horiuchi 10‐086 Evaluation of patient outcomes after implementation of an enhanced recovery after surgery (ERAS) protocol for laparoscopic gynecologic procedures


12:30 p.m. ‐ 1:30 p.m.

388596 Justin Horowitz 11‐237 Nephrotoxicity associated with concomitant vancomycin and standard versus extended infusion piperacillin‐tazobactam


1:45 p.m. ‐ 2:45 p.m.

388708 Spencer Horst 1‐238 Evaluation of subcutaneous versus intravenous erythropoietin administration in hemodialysis patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 99

Session ID


Title Date Time

384497 Sherry Hou 11‐068 Impact of pharmacy students in the utilization of patient assistance programs (PAP) for qualified patients: a rural hospitals experience


1:45 p.m. ‐ 2:45 p.m.

386678 Andrew Houck 9‐119 Dexmedetomidine medication use evaluation in a community pediatric hospital


11:15 a.m. ‐ 12:15 p.m.

387523 Alison Houng 12‐012 Optimization of antimicrobials to promote antimicrobial stewardship in a childrens hospital


3:00 p.m. ‐ 4:00 p.m.

385713 Anna Howard 11‐156 Carboplatin dosing strategies in patients with obesity


1:45 p.m. ‐ 2:45 p.m.

389640 Kristin Howard 12‐047 Ketamine versus propofol or benzodiazepines for continuous sedation in critically ill patients


3:00 p.m. ‐ 4:00 p.m.

384400 Kimberly Howe 1‐239 Comparison of the effectiveness of FDA approved weight loss medications utilized by the Veterans Affairs population, a retrospective cohort study

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388112 Adam Howell 10‐087 : Empiric Dose‐Reduction Strategy for Tacrolimus After Initiation of IV and Oral‐tablet Formulations of Posaconazole


12:30 p.m. ‐ 1:30 p.m.

386309 Emalee Hribick 1‐240 Implementation of a pharmacist‐managed telehealth anticoagulation clinic

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387889 Tiffany Hsu 9‐203 Identifying high risk hypertension patients using a population health strategy


11:15 a.m. ‐ 12:15 p.m.


Page | 100

Session ID


Title Date Time

388287 Tracy Hsu 1‐192 Predictors of direct antiviral agent treatment failure in a Veteran population with hepatitis C infection

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388096 Huiyuan Hu 9‐120 Assessment of fructosamine and glycated albumin tests as an alternative to hemoglobin A1C test in managing diabetes for HIV and hepatitis C patients on antiviral therapy


11:15 a.m. ‐ 12:15 p.m.

386999 Linda Huang 11‐011 Value and design of pharmacy residency research programs


1:45 p.m. ‐ 2:45 p.m.

387324 Samuel Huber 9‐121 Retrospective evaluation of pharmacist interventions on optimal use of antimicrobials using a clinical decision support tool


11:15 a.m. ‐ 12:15 p.m.

385835 Kayla Hubrich 8‐330 Evaluation of quality and cost‐related outcomes from implementing prior authorization criteria for specialty medications


10:00 a.m. ‐ 11:00 a.m.

385999 Chelsea Hudak 11‐205 Overcoming barriers of medication adherence to antihypertensive therapy through pharmacist intervention in an employer sponsored healthcare clinic


1:45 p.m. ‐ 2:45 p.m.

388874 Joel Huffman 12‐200 Retrospective review of surgical intervention versus medical management for the treatment of infective endocarditis in injection drug users


3:00 p.m. ‐ 4:00 p.m.


Page | 101

Session ID


Title Date Time

387882 Adrian Hughes 1‐241 Development and evaluation of a transitions‐of‐care referral process from inpatient clinical pharmacists to outpatient clinical pharmacists for heart failure patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388492 April Hughes 11‐206 Impact of community pharmacist education through the use of a patient friendly handout on statin adherence


1:45 p.m. ‐ 2:45 p.m.

389402 Jonathan Hughes 1‐242 Effect of the 2012 American College of Rheumatology Management of Gout Guidelines on Monitoring of and Adherence to Urate Lowering Therapy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389065 Mitchell Hughes 9‐072 Association between tacrolimus concentrations and hypertension in allogeneic hematopoietic stem cell transplant recipients


11:15 a.m. ‐ 12:15 p.m.

387105 Lauren Hundley 1‐319 Assessment of outcomes with bisphosphonates as secondary prevention for recurrent osteoporotic fractures in a veterans affairs community

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386509 Allyson Hunt 9‐279 Impact of auto‐verification of high‐risk medications in an emergency department


11:15 a.m. ‐ 12:15 p.m.

385903 Hannah Hutchinson

11‐107 Evaluating extended sterility of single dose vials attached to an automated IV compounding device


1:45 p.m. ‐ 2:45 p.m.

388608 Carolkim Huynh 8‐317 Enhancing the delivery of clinical services to specialty patients in the community pharmacy setting


10:00 a.m. ‐ 11:00 a.m.


Page | 102

Session ID


Title Date Time

388977 Hoang Huynh 9‐280 Assessment of antimicrobial use in the infant special care unit utilizing the Centers for Disease Control and Prevention 12 step campaign


11:15 a.m. ‐ 12:15 p.m.

389160 Yuna Huynh 10‐088 Evaluation of the utilization of a clinical decision support system to expand antimicrobial stewardship interventions by pharmacists in the hospital setting


12:30 p.m. ‐ 1:30 p.m.

386087 Cara Iacobellis 8‐139 Evaluating the efficacy of fecal microbiota transplantation in patients with recurrent clostridium difficile infection


10:00 a.m. ‐ 11:00 a.m.

387896 Carlo Iasella 12‐242 Clinical factors predicting variability in drug response with the target‐specific oral anticoagulants


3:00 p.m. ‐ 4:00 p.m.

386674 Christine Ibarra 10‐089 Quality of elder care: a study to determine possible treatment related sleep interruptions


12:30 p.m. ‐ 1:30 p.m.

388337 marisol ibarra 12‐048 Clinical outcomes of the new Hepatitis C drugs in the veteran population at VACHS


3:00 p.m. ‐ 4:00 p.m.

386624 Christine Ibrahim 12‐179 Development of a primary care pharmacist practice model in the patient centered medical home (PCMH)


3:00 p.m. ‐ 4:00 p.m.

388686 Tamara Idlibi 12‐243 Impact of pharmacist counseling and discharge clopidogrel on acute coronary syndrome 30 day readmission rate


3:00 p.m. ‐ 4:00 p.m.

388822 April Ingason 11‐012 Evaluation of vecuronium dosing and subsequent neostigmine utilization in surgical patients


1:45 p.m. ‐ 2:45 p.m.


Page | 103

Session ID


Title Date Time

386903 Kelly Ishizuka 8‐252 Association between procalcitonin levels and clostridium difficile infection


10:00 a.m. ‐ 11:00 a.m.

387334 Daniel Israel 12‐180 A prospective, observational study of novel oral anticoagulant prescribing: A pharmacy resident review


3:00 p.m. ‐ 4:00 p.m.

387752 Marissa Israel 1‐244 Pharmacist‐led inquiry during an outpatient counseling session to increase influenza vaccination rates in a veteran population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389144 erika issler 10‐090 Evaluation of bolus versus continuous infusion neuromuscular blocker administration in the management of therapeutic hypothermia


12:30 p.m. ‐ 1:30 p.m.

385384 Nicholas Jackson 10‐173 Assessment of current VA practices regarding chronic heart failure patient management to analyze role and implementation of a pharmacist‐managed clinical service


12:30 p.m. ‐ 1:30 p.m.

387706 Jeena Jacob 8‐331 Incidence and analysis of infectious complications in patients with left ventricular assist devices


10:00 a.m. ‐ 11:00 a.m.

386679 Carissa Jacobs 9‐204 Evaluation of a multimodal approach to education provided to pediatric pharmacists on resuscitation events


11:15 a.m. ‐ 12:15 p.m.

386800 Jaleena Jacobs 11‐238 Implementation of inhaled epoprostenol in neonatal and pediatric intensive care units (NICU/PICU)


1:45 p.m. ‐ 2:45 p.m.


Page | 104

Session ID


Title Date Time

387101 Sonja Jacobsen 10‐174 Improving oral chemotherapy fulfillment processes and implementation of a pharmacist‐managed oral chemotherapy follow‐up program


12:30 p.m. ‐ 1:30 p.m.

387473 Brandon Jacoby 11‐288 Efficacy of topical versus oral tranexamic acid in total knee arthroplasty: a retrospective chart review


1:45 p.m. ‐ 2:45 p.m.

385689 Nilofar Jafari 9‐122 Evaluation of duplicate medication orders at a tertiary care hospital


11:15 a.m. ‐ 12:15 p.m.

387112 Katherine Jahng 8‐033 Identification of an optimal steroid tapering schedule for treatment of acute graft‐versus‐host‐disease following allogeneic hematopoietic stem cell transplantation


10:00 a.m. ‐ 11:00 a.m.

387438 Joy Jakubek 8‐253 Relapse rate of complicated urinary tract infections in inpatient rehabilitation patients treated with cefuroxime at a tertiary teaching hospital


10:00 a.m. ‐ 11:00 a.m.

385710 Jennifer James 10‐175 Developing a shortage and recalls program


12:30 p.m. ‐ 1:30 p.m.

388346 Amna Jamil 11‐055 Clinical impact of pharmacist intervention in the maintenance of glycemic control at a community teaching hospital


1:45 p.m. ‐ 2:45 p.m.

387584 Whitney Jandreau

1‐245 Expanding access to hepatitis C care for rural Maine veterans using pharmacist‐driven education

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 105

Session ID


Title Date Time

389050 Stephen Jankovic 8‐140 Evaluation of Post Intubation Analgesia and Sedation in the Emergency Department


10:00 a.m. ‐ 11:00 a.m.

386195 Jennifer Jankovsky

8‐254 Evaluation of atropine efficacy for symptomatic bradycardia in the emergency department


10:00 a.m. ‐ 11:00 a.m.

387755 Adrienne Jantzi 12‐201 The Impact of a Multidisciplinary Pain Group on Disease Understanding and Quality of Life in Chronic Pain Patients


3:00 p.m. ‐ 4:00 p.m.

388451 Kristin Janzen 8‐034 Implementation of continuous quality improvement program for assessing success of residency program graduates.


10:00 a.m. ‐ 11:00 a.m.

385978 Elizabeth Jasper 11‐305 Physical compatibility and chemical stability of the combination of ziprasidone mesylate 20mg/mL with lorazepam 2mg/mL


1:45 p.m. ‐ 2:45 p.m.

388609 Gurbinder Jassar 10‐013 Evaluating the impact of the implementation of an operational dashboard on inpatient pharmacy productivity in a veterans affairs medical center


12:30 p.m. ‐ 1:30 p.m.

387928 Gregory Jaszczur 9‐281 Optimizing electronic health record patient lists to improve pharmacist efficiency: a time motion study


11:15 a.m. ‐ 12:15 p.m.

386234 Tara Jawaro 10‐234 Evaluation of the propensity and prevalence of drug‐drug interactions in patients discharged from an academic emergency department


12:30 p.m. ‐ 1:30 p.m.


Page | 106

Session ID


Title Date Time

384486 Bryan Jennings 1‐246 Risk of proton‐pump inhibitors and clostridium difficile in the veteran population: a retrospective review

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386844 Poonam Jewani 10‐176 Incidence of venous thromboembolism (VTE) in hospitalized medically ill patients receiving fixed‐dose unfractionated heparin prophylaxis in three weight cohorts


12:30 p.m. ‐ 1:30 p.m.

387668 Christine Ji 9‐011 Evaluating the effectiveness of intravenous acetaminophen for pain relief


11:15 a.m. ‐ 12:15 p.m.

389086 Jennifer Jiang 12‐244 Evaluating the effectiveness of a national hypoglycemia safety initiative at a Veterans Affairs health care system


3:00 p.m. ‐ 4:00 p.m.

384494 Lauren Jindracek 1‐247 Identifying missed opportunities for the pneumococcal conjugate vaccine (PCV13) in outpatient veterans 65 years and older

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385906 Juliana Jing 8‐141 Sirolimus use in heart transplant patients


10:00 a.m. ‐ 11:00 a.m.

385593 Matthew Jirasek 11‐157 Evaluation of an institutionally‐approved guideline for the management of anticoagulants in the perioperative setting at an academic medical center


1:45 p.m. ‐ 2:45 p.m.

384710 Janet Job 10‐014 Predicting tolerability of leucovorin, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) in the treatment of pancreatic cancer


12:30 p.m. ‐ 1:30 p.m.


Page | 107

Session ID


Title Date Time

387062 Hala Joharji 9‐047 Use of rituximab in the management of antibody mediated rejection (AMR) post heart transplant: A 9‐years single center experience


11:15 a.m. ‐ 12:15 p.m.

386913 Billee John 1‐248 Evaluating the impact of implementing a penicillin skin testing protocol to guide antimicrobial therapy selection

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384766 Natalie John 1‐249 Evaluation of antimicrobial surveillance software on systemic antibiotic use in a community teaching hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387985 Amanda Johnson 8‐142 Association of cumulative epinephrine dose and mortality in patients with in‐hospital cardiac arrest


10:00 a.m. ‐ 11:00 a.m.

386463 Bess Johnson 11‐158 Impact of dispensing no cost discharge antibiotics on pneumonia readmission rates


1:45 p.m. ‐ 2:45 p.m.

386632 Christopher Johnson

12‐245 Evaluation of physician responsiveness to procalcitonin results and compliance with evidence based recommendations


3:00 p.m. ‐ 4:00 p.m.

388815 Edwin Johnson 12‐202 Daptomycin usage at an academic medical center: patterns in indication for use and prescribing tendencies


3:00 p.m. ‐ 4:00 p.m.

385691 Heather Johnson 8‐255 Impact of pharmacist involvement during inpatient hospitalization: interventions required for discharge medication reconciliation on patients with congestive heart failure for teaching services versus hospitalist services


10:00 a.m. ‐ 11:00 a.m.


Page | 108

Session ID


Title Date Time

386666 Jessica Johnson 1‐250 Implementation of alert tool for antibiotic initiation in veterans on warfarin therapy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388310 Kelley Johnson 9‐003 Management of acute pain in sickle cell patients experiencing a vaso‐occlusive crisis: comparing the safety and efficacy of patient‐controlled analgesia versus intermittent intravenous push


11:15 a.m. ‐ 12:15 p.m.

386646 Laura Johnson 8‐035 Impact of a pharmacist‐driven culture follow‐up program in the emergency department


10:00 a.m. ‐ 11:00 a.m.

387698 Laura Johnson 12‐246 Patient knowledge and utilization of medicare assignment of benefits for diabetic testing supplies in a community pharmacy


3:00 p.m. ‐ 4:00 p.m.

385860 Nancy Johnson 8‐256 Evaluation of pain management post‐tonsillectomy


10:00 a.m. ‐ 11:00 a.m.

388426 Tonya Johnson 10‐091 Potential Benefits of Developing a Collaborative Practice Agreement to Establish a Pharmacist‐Run Outpatient Clinic for Monitoring, Evaluating, and Treating Unipolar Depression


12:30 p.m. ‐ 1:30 p.m.

387244 William Johnson 1‐251 Association of outpatient inhaled corticosteroid use in hospitalized pneumonia patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387751 Jackie Johnston 11‐069 The Evaluation of Nystatin Compared to Low‐Dose Fluconazole on Tacrolimus Levels in Renal Transplant Patients


1:45 p.m. ‐ 2:45 p.m.


Page | 109

Session ID


Title Date Time

386387 Whitney Johnston

8‐084 Impact of missed prophylaxis doses on the incidence of venous thromboembolism (VTE) in hospitalized surgical patients: a case‐control study


10:00 a.m. ‐ 11:00 a.m.

386669 Dylan Jones 12‐049 Treatment Outcomes among Patients with Methicillin‐Susceptible Staphylococcus aureus Bloodstream Isolates Possessing mecA by Commercial PCR compared to Patients with Methicillin‐Resistant S. aureus (MRSA) Bloodstream Isolates.


3:00 p.m. ‐ 4:00 p.m.

385162 Gerrick Jones 1‐252 Improving hypertension control: Million Hearts campaign at Gallup Service Unit

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388054 Gina Jones 9‐205 Evaluating the effect of a pharmacist‐run post myocardial infarction program on 30 day readmission rates


11:15 a.m. ‐ 12:15 p.m.

388588 Hillary Jones 1‐253 Impact of various interventions on medication therapeutic duplication orders

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386244 Katharine Jones 11‐239 Evaluation of a nurse‐driven protocol using early dose escalation of benzodiazepines in the treatment of alcohol withdrawal syndrome


1:45 p.m. ‐ 2:45 p.m.

387667 Kyle Jones 9‐073 Evaluation of sliding scale insulin for glycemic control in medical intensive care patients


11:15 a.m. ‐ 12:15 p.m.

387122 Laney Jones 8‐143 The role of continuous subcutaneous insulin infusions for uncontrolled type 2 diabetes mellitus (T2D) with or without clinical pharmacy management


10:00 a.m. ‐ 11:00 a.m.


Page | 110

Session ID


Title Date Time

388353 Aaron Joseph 9‐206 Utilization of albumin solutions in hospitalized patients


11:15 a.m. ‐ 12:15 p.m.

386652 Roy Joseph 11‐125 Evaluation of pharmacist impact on standardized extended‐interval aminoglycoside dosing strategy


1:45 p.m. ‐ 2:45 p.m.

388647 Karin Josephson 1‐254 Transitions of care discharge follow‐up: effect on readmissions and emergency department visits

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387807 Malena Jost 1‐294 Retrospective study comparing combat related post‐traumatic stress disorder treated with a selective serotonin reuptake inhibitor/serotonin‐norepinephrine reuptake inhibitor (SSRI/SNRI) with or without prazosin

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389691 Mishna Joy 8‐060 Evaluation of dexmedetomidine‐based sedation compared to non‐dexmedetomidine‐based sedation following cardiac surgery


10:00 a.m. ‐ 11:00 a.m.

384749 Kayla Joyner 8‐036 Comparison of Bleeding and Thrombosis between Dual and Triple Antithrombotic Therapy in Post‐Stent Patients with an Indication for Anticoagulation Therapy


10:00 a.m. ‐ 11:00 a.m.

386724 Ellen Jung 1‐255 Community pharmacy utilization of evidence‐based interventions for increasing medication adherence: a survey study

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 111

Session ID


Title Date Time

388069 Hemi Jung 8‐145 Tigecycline as adjunctive treatment for Clostridum difficile infections


10:00 a.m. ‐ 11:00 a.m.

385419 Sarah Jung 8‐318 Evaluation of dexmedetomidine in the intensive care unit for development of a new protocol addressing pain, agitation, and delirium in critically ill patients


10:00 a.m. ‐ 11:00 a.m.

389465 Amber Kabrick 9‐282 Pharmacy evaluation of inhaler education to reduce chronic obstructive pulmonary disease readmission rates


11:15 a.m. ‐ 12:15 p.m.

385179 Ekaterina Kachur 9‐283 Evaluation of the efficacy and safety of high dose tigecycline in 3 critically ill patients


11:15 a.m. ‐ 12:15 p.m.

387846 Onchuma Tanya Kaenkumchorn

10‐092 Retrospective review of alvimopan usage at a community health system


12:30 p.m. ‐ 1:30 p.m.

387351 Cristina Kaifer 12‐247 Antibiotic management in patients with severe sepsis and septic shock


3:00 p.m. ‐ 4:00 p.m.

388092 Cindy Kaing 1‐256 Retrospective review of prescribing and monitoring practices of antiarrhythmics using a pharmacy‐driven protocol at a veterans affairs medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389413 Babafunlola Kalejaiye

1‐257 Evaluation of adherence to medications for the management of chronic cardiovascular conditions in HIV positive patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 112

Session ID


Title Date Time

386327 Brittany Kalemkarian

10‐235 Impact of antibiotic stewardship program driven antibiotic timeouts on non‐intensive care unit patients with sepsis


12:30 p.m. ‐ 1:30 p.m.

385259 Charissa Kam 12‐181 Mycophenolic acid levels and rejection rates one year post‐lung transplant in pediatric patients


3:00 p.m. ‐ 4:00 p.m.

388048 Linda Kamakuru 11‐044 Oral midodrine to wean off intravenous vasopressors in the intensive care unit


1:45 p.m. ‐ 2:45 p.m.

385811 Bonnie Kaminsky 12‐248 Evaluation of an ongoing medication use evaluation of four‐factor prothrombin complex concentrate


3:00 p.m. ‐ 4:00 p.m.

386136 cibi ann kandammalil

1‐258 Measuring the reversals of opioid overdose achieved by prescribing and dispensing naloxone rescue kits

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386488 Rebecca Kandilian

1‐259 Evaluating the impact of implementing decision support tools on the clinical outcomes of patients at high risk for hypoglycemia

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385843 Clare Kane 9‐123 Outcomes in obese versus non‐obese kidney transplant recipients that receive basiliximab induction immunosuppression


11:15 a.m. ‐ 12:15 p.m.

387744 Hyeon Hye Kang 1‐260 Managing peri‐procedural bridging during warfarin interruptions in a veteran population prescribed chronic warfarin therapy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 113

Session ID


Title Date Time

387599 Kristen Kannel 1‐261 Effect of pharmacist and nurse practitioner diabetes focused clinic visits on diabetic outcomes and statin use within an internal medicine department

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389597 Daisy Kannukkaden

1‐262 Impact of a pharmacist discharge service on hospital readmission rates

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387742 Daniel Kapp 12‐249 Non benzodiazepine hypnotic use in older adults: evaluation of adherence to the 2012 Beers Criteria and the impact of a collaborative medication safety intervention program


3:00 p.m. ‐ 4:00 p.m.

386035 Masa Karanovic 11‐240 Emergent uridine triacetate for fluorouracil overdose


1:45 p.m. ‐ 2:45 p.m.

385789 Katie Karkowski 8‐257 Risk factors for the development of new‐onset congestive heart failure with gemcitabine


10:00 a.m. ‐ 11:00 a.m.

385381 Celeste Karpow 10‐266 Evaluation of intravenous prostacyclin initiation for patients with pulmonary arterial hypertension in an intensive care unit


12:30 p.m. ‐ 1:30 p.m.

389312 Madison Karr 11‐126 Retrospective analysis of outcomes associated with labeled versus off‐label use of a four‐factor prothrombin complex concentrate within a three‐hospital system


1:45 p.m. ‐ 2:45 p.m.

387403 Joanna Kasper 8‐085 Empiric antibiotic use in oncology patients with febrile neutropenia


10:00 a.m. ‐ 11:00 a.m.

389505 Stephanie Kasten

1‐263 Use and safety of metformin in veterans with renal dysfunction

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 114

Session ID


Title Date Time

385223 Lauren Kato 11‐045 Effectiveness of stochastically controlled versus standard vancomycin dosing in adults.


1:45 p.m. ‐ 2:45 p.m.

389038 Daniel Katzenberger

1‐264 Reduction of niacin and gemfibrozil therapy for hyperlipidemia and optimization of HMG‐CoA reductase inhibitors (statins) at a Veterans Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

383188 Brianne Kaufman 9‐207 Tranexamic acid use in the total hip and total knee arthroplasty population at an academic medical center: a retrospective review of postoperative outcomes


11:15 a.m. ‐ 12:15 p.m.

387490 Harpreet Kaur 10‐177 Evaluation of Pediatric Medication Safety Initiatives in the Emergency Department of a Community Hospital


12:30 p.m. ‐ 1:30 p.m.

385215 Haley Kavelak 10‐093 Retrospective evaluation of patients with primary diagnosis DVT for earlier discharge or outpatient treatment eligibility


12:30 p.m. ‐ 1:30 p.m.

388828 Chance Keddington

10‐094 Implementation and evaluation of a community pharmacist led diabetes education program.


12:30 p.m. ‐ 1:30 p.m.

388934 Peter Keddis 8‐061 Retrospective review of the combination of mannitol and hypertonic saline for the treatment of cerebral edema


10:00 a.m. ‐ 11:00 a.m.

388036 James Keeler 9‐284 Evaluation of two prandial insulin dosing strategies in hospitalized patients with diabetes mellitus


11:15 a.m. ‐ 12:15 p.m.


Page | 115

Session ID


Title Date Time

389075 Kaylen Keen 9‐208 Evaluation of patient characteristics as predictors of drug‐related problems in a community pharmacy


11:15 a.m. ‐ 12:15 p.m.

388652 Rebecca Keeton 10‐015 Evaluation of low molecular weight heparin (LMWH) use for bridge therapy in a Veterans Affairs population


12:30 p.m. ‐ 1:30 p.m.

388878 Jessica Kehm 9‐285 Evaluating the efficacy and tolerability of ledipasvir and sofosbuvir at 8, 12, and 24 weeks in hepatitis c virus infected genotype 1 veterans


11:15 a.m. ‐ 12:15 p.m.

388351 Katrina Lee Keith 11‐013 Determination of susceptibility of Pseudomonas aeruginosa and extended spectrum beta‐lactamase Enterobactericeae bacterial isolates to ceftazidime/avibactam as compared to ceftazidime: an internal MIC distribution study


1:45 p.m. ‐ 2:45 p.m.

382597 Jennifer Kelleher 8‐037 Effect of a vancomycin dosing protocol for obese patients with renal impairment on goal trough levels in a community hospital setting


10:00 a.m. ‐ 11:00 a.m.

387508 Sara Keller 11‐241 Impact of pharmacist‐driven baseline metabolic monitoring of antipsychotic medications in an inpatient behavioral health unit


1:45 p.m. ‐ 2:45 p.m.

387008 Sean Kelly 12‐250 Association between home anticholinergic medications and delirium onset in trauma patients


3:00 p.m. ‐ 4:00 p.m.


Page | 116

Session ID


Title Date Time

388976 Shannon Kelly 10‐313 Implementation of depression screening into the clinical pharmacy services workflow at a federally qualified health center


12:30 p.m. ‐ 1:30 p.m.

386641 Alyssa Kelsch 12‐050 Selective serotonin reuptake inhibitor (SSRI) use in pregnancy and neonatal withdrawal


3:00 p.m. ‐ 4:00 p.m.

388630 Madeline Kelzenberg

1‐265 Developing a protocol for pharmacist intervention during transitions of care in high risk patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389041 Benjamin Kematick

9‐124 Changes in chronic pain management therapy after sleeve gastrectomy


11:15 a.m. ‐ 12:15 p.m.

389134 Alexander Keppel

9‐125 Lean evaluation of first dose preparation from pharmacy automation within an inpatient central pharmacy at an academic medical center


11:15 a.m. ‐ 12:15 p.m.

388922 Daniel Kerner 1‐266 Implementing interventions to improve patient primary non‐adherence

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387197 Amanda Kernodle

8‐007 Implementation of persuasive messages to increase participation in comprehensive medication reviews in a community pharmacy setting


10:00 a.m. ‐ 11:00 a.m.

386218 Jacob Kesner 1‐267 Outcomes of Enterobacteriaceae urinary tract infections treated with cephalosporins based on new susceptibility breakpoints

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384559 Ryan Keul 9‐286 Dipping into the Clostridium difficile pool


11:15 a.m. ‐ 12:15 p.m.


Page | 117

Session ID


Title Date Time

388722 Emily Kilber 10‐095 Hypoglycemia incidence following insulin administration for the treatment of hyperkalemia


12:30 p.m. ‐ 1:30 p.m.

388575 Megan Kildea 9‐287 Evaluation of the use of bupivacaine elastomeric infusion technology in post‐operative adults for inpatient pain management


11:15 a.m. ‐ 12:15 p.m.

383583 Daniel Kim 8‐146 Identifying the Key Features of a Pharmaceutical Industry Postdoctoral Fellowship that Impact Career Paths


10:00 a.m. ‐ 11:00 a.m.

386546 David Kim 1‐268 A retrospective review of an increased risk of hemorrhage and elevated INR during the initiation of duloxetine in patients taking warfarin therapy in a veteran population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386769 James Kim 11‐159 Establishing and Expanding Pharmacy Clinical Services in the Acute Care Setting


1:45 p.m. ‐ 2:45 p.m.

388741 Janet Kim 10‐096 SVR12 rates in genotype 1 hepatitis C patients treated with ledipasvir/sofosbuvir: the experience of a regional HMO


12:30 p.m. ‐ 1:30 p.m.

387582 Maryanne Kim 9‐074 Evaluation of the incidence of pre‐defined morbidity and mortality outcomes in post‐orthotopic heart transplant patients after implementation of the tacrolimus monotherapy protocol


11:15 a.m. ‐ 12:15 p.m.


Page | 118

Session ID


Title Date Time

388650 Priscilla Kim 8‐258 Evaluation of chronic musculoskeletal and joint pain management for geriatric patients in the emergency department


10:00 a.m. ‐ 11:00 a.m.

389302 Soyoung Kim 1‐269 Use of antipsychotics for the management of delirium in the intensive care unit

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384754 Susan Kim 1‐270 Evaluation of the institutional economic impact of a pharmacy implemented protocol for stress ulcer prophylaxis (SUP) discontinuation

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386163 Heather Kindermann

1‐271 Appropriateness of procalcitonin guided antimicrobial therapy utilization in hospitalized veteran patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389071 Alexandra King 11‐160 Evaluating the appropriate use and tolerability associated with plerixafor in autologous hematopoietic stem cell transplant patients.


1:45 p.m. ‐ 2:45 p.m.

387440 Ashley King 12‐251 Implementation and outcome of a person‐centered medication pass schedule in a long term care facility


3:00 p.m. ‐ 4:00 p.m.

388837 Jacqueline King 1‐272 Medication utilization evaluation of recombinant factor VIIa in a large community hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386660 Jaimie King 12‐051 Retrospective review of the prescribing and management of gene‐targeted oral chemotherapeutics in non‐small cell lung cancer (NSCLC)


3:00 p.m. ‐ 4:00 p.m.


Page | 119

Session ID


Title Date Time

388445 Morgan King 8‐259 Comparison of the incidence of side effects of high‐dose vs. low‐dose dexmedetomidine in the intensive care unit of a community hospital


10:00 a.m. ‐ 11:00 a.m.

385589 Jessica Kinstler 9‐126 Reduction of chronic obstructive pulmonary disease (COPD) exacerbations and 30 day readmission rates via implementation of a pharmacist‐led COPD clinic.


11:15 a.m. ‐ 12:15 p.m.

389296 Justin Kirby 1‐273 Effect on therapeutic values for previously non‐adherent patients with diabetes enrolled in a medication synchronization and education program at a community pharmacy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387161 Cain Eric Kirk 12‐203 Medication use evaluation of citalopram prescribing and monitoring practices at a Veterans Affairs health care center


3:00 p.m. ‐ 4:00 p.m.

388208 Vanessa Kirkwood

1‐274 Assessing the number and types of close calls at the VISN 11 pharmacy call center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389117 Michele Kislan 9‐209 Establishment Of Pain Clinic Pharmacy Improves Patient Care


11:15 a.m. ‐ 12:15 p.m.

386653 Ashraf Kittaneh 11‐070 Clinical pharmacist impact on antibiotic treatment for sepsis in the Emergency Department


1:45 p.m. ‐ 2:45 p.m.

389338 Sarah Klembith 12‐052 Evaluation of the impact of a national opioid safety initiative on suicide rates among Central Texas Veterans Healthcare System patients on concurrent opioids and benzodiazepines


3:00 p.m. ‐ 4:00 p.m.


Page | 120

Session ID


Title Date Time

388570 Andrew Klick 11‐161 A retrospective analysis of fixed versus weight‐based dosing of four‐factor prothrombin complex concentrate.


1:45 p.m. ‐ 2:45 p.m.

385675 Zachary Klick 1‐275 Evaluation of factor product use perioperatively in cardiovascular surgery in non‐hemophiliac patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387162 Katy Klinefelter 12‐252 Adherence to guideline based treatment for patients admitted to the hospital with community acquired pneumonia; focus on duration and transition to oral therapy


3:00 p.m. ‐ 4:00 p.m.

387458 Chantal Kneifel 1‐276 Effects on antibiotic prescribing rates after physician and nurse education on upper respiratory infections

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387543 Sara Knoll 11‐028 Impact of a standardized intravenous vancomycin loading dose protocol on therapeutic outcomes


1:45 p.m. ‐ 2:45 p.m.

388924 Emir Kobic 10‐097 Leveraging a community level one trauma hospital's electronic health record for antimicrobial stewardship by pharmacists


12:30 p.m. ‐ 1:30 p.m.

389257 Gerard Kokett 10‐178 Implementation and assessment of an opioid withdrawal protocol in an adult inpatient behavioral health setting


12:30 p.m. ‐ 1:30 p.m.


Page | 121

Session ID


Title Date Time

386240 Chelsea Konopka 1‐277 Evaluation of management of acute bacterial skin and skin structure infections prior to the implementation of an Antimicrobial Stewardship Program initiative

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387073 Laura Koppen 9‐288 Conservative management of pediatric appendicitis in a community hospital setting


11:15 a.m. ‐ 12:15 p.m.

384399 Bianca Korkis 12‐253 Periprocedural bridging in patients with atrial fibrillation: practice patterns and outcomes from an urban pharmacist‐run anticoagulation clinic


3:00 p.m. ‐ 4:00 p.m.

387082 Benjamin Korman

9‐127 Reduction of near miss occurrence through process improvement


11:15 a.m. ‐ 12:15 p.m.

387555 Karin Koseck 9‐289 Fluoroquinolone use and development of Clostridium difficile infection post autologous hematopoietic stem cell transplantation


11:15 a.m. ‐ 12:15 p.m.

389467 Jaclyn Kotula 1‐278 Impact on blood glucose readings after implementation of electronic health record clinical decision support tools for basal bolus insulin dosing

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388749 Megan Koyle 9‐210 Improving medication reconciliation through implementation of a technician‐centered medication reconciliation program in the primary care setting at the Boise VA Medical Center


11:15 a.m. ‐ 12:15 p.m.


Page | 122

Session ID


Title Date Time

387677 Sarah Kraus 1‐279 Impact of a melphalan dose rounding protocol on efficacy and cost in patients with multiple myeloma undergoing autologous stem cell transplantation

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384318 Megan Kroll 10‐179 Evaluation of the incidence of post‐operative wound infection in neonates and infants receiving stress dose hydrocortisone prior to gastrointestinal surgery


12:30 p.m. ‐ 1:30 p.m.

386594 Laura Kroon 12‐053 Pharmacist review of medication reconciliation completed by physicians and nursing staff at hospital discharge


3:00 p.m. ‐ 4:00 p.m.

386220 Tiffani Krzywda 1‐280 Review of pharmacist intervention in reducing cardiovascular risk in women Veterans

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387775 Jenna Ksiazkiewicz

10‐180 Total versus adjusted body weight dosing of vancomycin in obese patients: a retrospective review of safety and efficacy


12:30 p.m. ‐ 1:30 p.m.

387921 William Kuan 11‐306 Evaluation of treating elevated pulmonary arterial pressures with phosphodiesterase‐5 inhibitors in patients with left ventricular assist device


1:45 p.m. ‐ 2:45 p.m.

386536 Kara Kubli 9‐290 Compliance of darbepoetin use in hospitalized patients


11:15 a.m. ‐ 12:15 p.m.

385696 Ashlie Kucera 12‐054 Patient satisfaction with an appointment‐based medication synchronization program in community pharmacy


3:00 p.m. ‐ 4:00 p.m.


Page | 123

Session ID


Title Date Time

385278 Wesley Kufel 12‐254 Impact of Pre‐mix Antibiotic Formulations and Time to Administration in Sepsis Patients


3:00 p.m. ‐ 4:00 p.m.

385748 Stephanie Kuhl 9‐291 Incidence of adverse events with full dose enoxaparin in moderate renal impairment


11:15 a.m. ‐ 12:15 p.m.

388222 Ivie Kumura 8‐147 Digoxin Dose (>0.125mg Daily) Reduction in Patients Age 64 with Chronic Atrial Fibrillation (Beers Criteria 2013 and CMS High Risk Medication in the Elderly)


10:00 a.m. ‐ 11:00 a.m.

388604 Binni Kunvarjee 8‐038 Efficacy and safety of tbo‐filgrastim versus filgrastim in patients with acute myeloid leukemia and patients post hematopoietic transplant with melphalan conditioning


10:00 a.m. ‐ 11:00 a.m.

388933 Julia Kuroski 8‐039 Utilization of eculizumab for atypical hemolytic‐uremic syndrome within a large, academic health center


10:00 a.m. ‐ 11:00 a.m.

385586 Kari Kurtzhalts 1‐120 Optimum duration of antibiotic therapy for males admitted with urinary tract infections

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386421 Eliana Kurzum 8‐148 Evaluation of the use of new oral anticoagulants for the treatment of venous thromboembolism in patients with active malignancy


10:00 a.m. ‐ 11:00 a.m.

388552 Amy Kyle 1‐281 Effect of the cumulative dose of testosterone on adverse cardiovascular events in a Veteran population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385741 Kelly Kyrouac 1‐282 Description of a newly instituted teaching certificate program

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 124

Session ID


Title Date Time

385393 Yvonne Labram 12‐255 Medication Use Evaluation of Phytonadione within the St. Lukes University Health Network


3:00 p.m. ‐ 4:00 p.m.

384639 Cameron LaChappelle

1‐283 Efficacy and patient satisfaction of medication synchronization at Crownpoint Healthcare Facility

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389210 Emily Lachiewicz 10‐098 Medication use evaluation of denosumab for the management of bone metastases in an outpatient oncology clinic


12:30 p.m. ‐ 1:30 p.m.

385290 Joseph Ladd 12‐256 Use of Low‐Dose Ketamine for Pain Management in an Emergency Department


3:00 p.m. ‐ 4:00 p.m.

387280 Margaret Ladlie 8‐040 Insulin therapy in type 2 diabetes mellitus: standard management versus pharmacy titration protocol


10:00 a.m. ‐ 11:00 a.m.

389477 Jenni‐lyn Ladutko

1‐284 Redefining peri‐procedural bridging during warfarin interruptions: a quality improvement project at the Salt Lake City Veterans Administration Health Care System (VASLCHCS)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388192 Joshua Ladwig 8‐149 Incorporating home clinical video telehealth into a pharmacy medication therapy management clinic at a rural Veterans Affairs healthcare system.


10:00 a.m. ‐ 11:00 a.m.

387095 Samuel LaFollette

11‐127 Comparison of timely oseltamivir therapy to delayed therapy in hospitalized patients


1:45 p.m. ‐ 2:45 p.m.


Page | 125

Session ID


Title Date Time

388740 Marie Lafosse 9‐075 Medication use evaluation of calcitonin injection for the treatment of hypercalcemia


11:15 a.m. ‐ 12:15 p.m.

385172 Sophia Lai 1‐285 Value of a rounding pharmacist on an internal medicine team

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389271 Christina Laird 1‐286 Canagliflozin as adjunct therapy in type 1 diabetic patients receiving continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) in an outpatient setting

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

382599 Benjamin Laliberte

8‐150 Pilot observation of the intended discharge diuretic regimen in patients with acute decompensated heart failure at risk for rehospitalization


10:00 a.m. ‐ 11:00 a.m.

387085 ELENA LALLANA 9‐292 Staff of the Hospital Pharmacy Service: key point of success towards Excellence


11:15 a.m. ‐ 12:15 p.m.

385930 Megan Lam 12‐257 Retrospective analysis of vitamin K usage for reversal of anticoagulation in a quaternary care teaching hospital


3:00 p.m. ‐ 4:00 p.m.

385178 Mindy Lam 1‐287 Evaluating change in hemoglobin A1C after addition of a TZD, DPP4‐inhibitor, or GLP‐1 agonist to metformin and sulfonylurea therapy in patients with type 2 diabetes

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386963 Thomas Lancaster

9‐076 Transitions of care team in a primary care clinic: a unique answer to a common problem


11:15 a.m. ‐ 12:15 p.m.

386255 Macayla Landi 1‐288 Evaluation and standardization of current practices for reinitiation of warfarin therapy post‐procedurally at a VA healthcare facility

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 126

Session ID


Title Date Time

387126 Susan Lane 8‐151 Impact of pharmacy‐driven interventions on time to antibiotic administration in febrile neutropenia patients


10:00 a.m. ‐ 11:00 a.m.

386291 Shelby Lang 1‐289 Implementation of a Pharmacist‐Run, Multidisciplinary Tobacco Cessation Shared Medical Appointment for Veterans

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385829 Nicholas Lange 8‐260 Prescribing practices of peripherally administered vasoactive medications


10:00 a.m. ‐ 11:00 a.m.

386229 Katie Langley 9‐293 Hemodynamic effects of propofol versus dexmedetomidine for sedation during mechanical ventilation in adult medical and surgical intensive care units


11:15 a.m. ‐ 12:15 p.m.

389309 Julie Large 11‐162 Evaluating the impact of pharmacist intervention on pneumococcal vaccination rates in a community pharmacy setting


1:45 p.m. ‐ 2:45 p.m.

386018 Ashley Larson 11‐163 Development and implementation of a risk assessment tool for patients receiving oral chemotherapy to continually offer enrollment in a specialty pharmacy therapy management program


1:45 p.m. ‐ 2:45 p.m.

386275 Andrew Lau 1‐290 Evaluating implementation of VA opioid overdose education and naloxone distribution (OEND) program within a primary care clinic at San Francisco Veterans Affairs Health Care System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 127

Session ID


Title Date Time

389456 Gary Lau 12‐182 Evaluation of a pharmacy technician as a process navigator in obtaining oral anticancer agents in an outpatient oncology clinic


3:00 p.m. ‐ 4:00 p.m.

386533 Brian Lauer 9‐128 Clinical outcomes in Human Immunodeficiency Virus (HIV) positive individuals using an on‐site outpatient pharmacy compared to off‐site pharmacy options


11:15 a.m. ‐ 12:15 p.m.

388814 Alyssa Laurich 8‐041 Pharmacist impact on high risk medication use and adherence in a senior health center


10:00 a.m. ‐ 11:00 a.m.

386622 Alexandra Lavoie 9‐077 Evaluation of adherence to the dofetilide Risk Evaluation and Mitigation Strategy (REMS) program: a pre‐ and post‐implementation analysis of quality improvement initiatives


11:15 a.m. ‐ 12:15 p.m.

387492 Fern Lawson 10‐181 Implementation of a discharge medication reconciliation review protocol in a non‐teaching community hospital


12:30 p.m. ‐ 1:30 p.m.

388774 Nicholeah Lay 8‐152 Assessment of pharmacists' knowledge of oral chemotherapy agents before and after completion of a continuing education (CE) program


10:00 a.m. ‐ 11:00 a.m.

385569 Brian Le 10‐236 Risk factors for Clostridium difficile‐associated diarrhea in adult cancer patients without recent antibiotic exposure


12:30 p.m. ‐ 1:30 p.m.


Page | 128

Session ID


Title Date Time

385920 Elizabeth Le 9‐294 Evaluation of the current management of chronic obstructive pulmonary disease (COPD) at a federally qualified health center


11:15 a.m. ‐ 12:15 p.m.

385641 Giang Le 1‐291 Innovative pharmacy practice model: development and implementation of pharmacy‐initiatives into measurable performance metrics

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388205 Huong Le 11‐289 Assessment of appropriate use of anti‐methicillin resistant Staphylococcus aureus (MRSA) agents in patients with pneumonia


1:45 p.m. ‐ 2:45 p.m.

388944 Jennifer Le 10‐237 Implementation of a pharmacy‐driven pediatric vancomycin safety monitoring service.


12:30 p.m. ‐ 1:30 p.m.

389612 Jennifer Le 11‐128 Appropriateness of empiric antibiotic therapy for the treatment of severe sepsis and septic shock in the emergency department


1:45 p.m. ‐ 2:45 p.m.

389423 Phuong Le 10‐182 Pharmacy residents role as a liaison in hospital practice settings: an evaluation of associated outcomes from clinical pharmacy interventions


12:30 p.m. ‐ 1:30 p.m.

385926 Rachael Le 9‐129 Wholesale acquisition cost‐containment strategies for inpatient drug purchasing at a county hospital


11:15 a.m. ‐ 12:15 p.m.

388590 Thang Le 8‐153 Evaluating the risk of arthralgia in United States Veterans on dipeptidyl peptidase‐4 (DPP‐4) inhibitors


10:00 a.m. ‐ 11:00 a.m.


Page | 129

Session ID


Title Date Time

384656 Tiffany Le 8‐319 Single center evaluation of three antifungal strategies in post lung transplant recipients and their efficacy in reducing the occurrence of invasive fungal infections


10:00 a.m. ‐ 11:00 a.m.

386221 Lisa LeCleir 11‐071 Optimizing automated dose‐rounding and dose range checking protocols for acetaminophen and hydrocodone‐acetaminophen in a pediatric population


1:45 p.m. ‐ 2:45 p.m.

387887 Sheena LeClerc 1‐292 Impact of achieving virologic response from hepatitis c direct‐acting antivirals on diabetes control

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388694 David Lee 8‐154 Comparison of safety outcome between iron sucrose and ferumoxytol in iron deficiency anemia


10:00 a.m. ‐ 11:00 a.m.

386703 DongOuk Lee 9‐023 Comparison of pharmacist‐managed versus physician‐managed vancomycin dosing in a large academic medical center


11:15 a.m. ‐ 12:15 p.m.

389415 Joshua Lee 9‐211 Evaluation of safety and efficacy outcomes in warfarin reversal using 3 versus 4‐factor prothrombin complex concentrate in a hospital system


11:15 a.m. ‐ 12:15 p.m.

387949 Jung Sun Lee 9‐130 Study on the Demand of Investigators and Clinical Trial Subjects Regarding Medication Counseling Categories for Drugs Used in Clinical Trials


11:15 a.m. ‐ 12:15 p.m.


Page | 130

Session ID


Title Date Time

384621 Monica Lee 9‐078 Detecting the frequency and severity of paroxysmal sympathetic hyperactivity in traumatic brain injury patients using assessment measurement tools


11:15 a.m. ‐ 12:15 p.m.

385247 Orlaine Lee 8‐062 Measuring the impact of a transitional care pharmacist on reducing readmission rates and increasing cost savings for Medicare patients


10:00 a.m. ‐ 11:00 a.m.

383204 Phyllis Lee 8‐155 Evaluating regulatory timelines of companion diagnostics and oncology therapies


10:00 a.m. ‐ 11:00 a.m.

386898 Sarah Lee 12‐258 Community‐acquired pneumonia (CAP) and the effect of a transitional care program on 30‐day readmission rates


3:00 p.m. ‐ 4:00 p.m.

387692 Sharon Lee 10‐183 Evaluation of the relationship between proton pump inhibitor use and Clostridium difficile infection in a community hospital


12:30 p.m. ‐ 1:30 p.m.

384724 Stephanie Lee 8‐332 Hospitalization risk with concomitant benzodiazepine or opioid use in veterans with posttraumatic stress disorder


10:00 a.m. ‐ 11:00 a.m.

388206 Steven Lee 11‐290 Multidisciplinary approach to improve vancomycin dosing and monitoring practices


1:45 p.m. ‐ 2:45 p.m.

386288 Susan Lee 1‐293 Evaluating adherence to a probiotic drug use criteria to reduce hospital‐acquired Clostridium difficile infections at the San Francisco Veterans Affairs Health Care System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 131

Session ID


Title Date Time

385600 Yeun‐Ju Lee 8‐091 Evaluation of 4T's scoring system in the identification of heparin‐induced thrombocytopenia in patients with mechanical circulatory support


10:00 a.m. ‐ 11:00 a.m.

386228 Michaela Leffler 10‐099 Total benzodiazepine dosage in alcohol withdrawal patients treated with scheduled dosing versus symptom triggered dosing


12:30 p.m. ‐ 1:30 p.m.

387653 Elizabeth Legros 12‐259 Patient characteristics associated with avoidance of hospital admission in adults receiving intravenous magnesium sulfate for an asthma exacerbation in the emergency department


3:00 p.m. ‐ 4:00 p.m.

387786 Matthew Lei 11‐014 Evaluation of the initiation of rapid infusion rituximab at an academic medical center


1:45 p.m. ‐ 2:45 p.m.

388605 Brittany Leiba 12‐300 Use of omalizumab in patients with allergic asthma at the Bay Pines Veterans Affairs Healthcare System


3:00 p.m. ‐ 4:00 p.m.

388538 DeAnna Leiba 11‐108 Use of direct‐acting antiviral agents (DAA) for the treatment of hepatitis C virus (HCV) in a veterans population: a medication use evaluation


1:45 p.m. ‐ 2:45 p.m.

386605 Carrie Leichtweis 12‐055 Evaluation of empiric antibiotic therapy and resistance of catheter‐associated urinary tract infections (CAUTI) versus non‐catheter‐associated urinary tract infections (non‐CAUTI) in a level II trauma center


3:00 p.m. ‐ 4:00 p.m.


Page | 132

Session ID


Title Date Time

387123 Caitlin Lemmer 10‐262 Medication management by a pharmacist for patients with diabetes in a patient‐centered medical home


12:30 p.m. ‐ 1:30 p.m.

386011 Janelle Lenz 8‐008 Development of a risk score for major bleeding associated with novel oral anticoagulants


10:00 a.m. ‐ 11:00 a.m.

387506 Chelsea Leonard 12‐093 Impact of an automated outbound call system on influenza vaccine administration in a community pharmacy


3:00 p.m. ‐ 4:00 p.m.

386782 Sean Leonard 11‐291 Proactive prevention of hypoglycemia in ICU and CICU patients


1:45 p.m. ‐ 2:45 p.m.

386003 Philip Leong 8‐063 Use of quantitative bronchoalveolar lavage and procalcitonin to decrease antimicrobial use in patients suspected to have ventilator‐associated pneumonia (VAP).


10:00 a.m. ‐ 11:00 a.m.

387104 Julie Lernihan 1‐295 Dual antithrombotic therapy in non‐valvular atrial fibrillation patients at the VA Maine Healthcare System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389174 Elizabeth Lessmann

9‐131 Assessment of cytomegalovirus prophylaxis in a liver transplant population at a large academic medical center


11:15 a.m. ‐ 12:15 p.m.

388760 Daniel Leszczynski

10‐184 Procalcitonin as a Biomarker in Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Lower Respiratory Tract Infection


12:30 p.m. ‐ 1:30 p.m.


Page | 133

Session ID


Title Date Time

388848 Stephanie Lewis 8‐009 Implications of pharmacist‐initiated medication therapy management and a medication synchronization program upon medication adherence outcomes


10:00 a.m. ‐ 11:00 a.m.

387712 Temeka Lewis 10‐238 Retrospective review of crotalidae polyvalent immune fab (Crofab) use at a tertiary care hospital prior to implementation of a protocol


12:30 p.m. ‐ 1:30 p.m.

388383 David Li 12‐260 Streamlining pharmacy tray preparation with radio frequency identification technology


3:00 p.m. ‐ 4:00 p.m.

386820 Jueli Li 9‐212 Assessment of outpatient rituximab use post‐implementation of cost‐savings guideline


11:15 a.m. ‐ 12:15 p.m.

384349 Kenric Li 11‐109 Comparison of oral aspirin to other chemoprophylaxis agents for venous thromboembolism prophylaxis in hospitalized patients status post total knee arthroplasty


1:45 p.m. ‐ 2:45 p.m.

384531 Rosanna Li 10‐314 Post‐Cardiothoracic Surgery Atrial Fibrillation Rates After Implementing Perioperative Prophylaxis Guideline


12:30 p.m. ‐ 1:30 p.m.

389566 Siyue Li 1‐296 Identification and reduction of concomitant therapy of benzodiazepine and opioid through implementation of an opioid surveillance program within a rural VA Health Care System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 134

Session ID


Title Date Time

388907 Tracey Li 9‐213 Evaluation of fentanyl transdermal patch prescribing practices before and after pain management education by a pharmacist


11:15 a.m. ‐ 12:15 p.m.

388388 Michael Licari 10‐004 Prescribing trends of antibiotics in patients with documented beta‐lactam allergy or intolerance


12:30 p.m. ‐ 1:30 p.m.

388139 Christina Lichtinger

8‐156 Evaluate the effect of structured orientation sessions on fourth year pharmacy students on rotation in an ambulatory care clinic


10:00 a.m. ‐ 11:00 a.m.

386501 Michael Light 11‐015 Evaluation of Epoetin Use in Chronic Kidney Disease Patients


1:45 p.m. ‐ 2:45 p.m.

382596 Eric Likar 9‐295 Management of a positive Candida urinary culture in hospitalized patient


11:15 a.m. ‐ 12:15 p.m.

387620 Rachel Lim 11‐072 Efficacy of single dose vancomycin for treating cellulitis in the emergency department


1:45 p.m. ‐ 2:45 p.m.

384982 Shannon Lim 1‐297 Medication de‐escalation in Veteran cancer patients within the last 90 days of life

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

383486 Ken Lin 1‐298 Impact of penicillin allergy on appropriateness of treatment in veterans

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389539 Lauren Linder 12‐261 Impact of implementing a parenteral nutrition algorithm on prescribing patterns


3:00 p.m. ‐ 4:00 p.m.


Page | 135

Session ID


Title Date Time

387703 Marley Linder 9‐214 Evaluation of clinical outcomes for multiple myeloma patients treated with lenalidomide and managed via an integrated health‐system specialty pharmacy


11:15 a.m. ‐ 12:15 p.m.

385125 Desirae Lindquist 1‐299 Comparison of post‐operative bleeding events in patients undergoing total hip or total knee arthroplasty and receiving enoxaparin, rivaroxaban, or aspirin for thromboprophylaxis

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388400 Dylan Lindsay 12‐013 Increasing Mississippi pharmacist awareness about cessation (IMPAC): a statewide needs assessment for community pharmacist tobacco cessation services


3:00 p.m. ‐ 4:00 p.m.

383946 Sara Lindsay 1‐300 Assessing safety, efficacy and tolerability of novel, direct‐acting antivirals in treatment of Veterans with chronic Hepatitis C

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386841 Savannah Lindsey

10‐274 Implications of the presence of an emergency medicine pharmacist during critical care patient resuscitation


12:30 p.m. ‐ 1:30 p.m.

387365 Ashley Lindstrom 9‐048 Naloxone for management of pediatric clonidine ingestions


11:15 a.m. ‐ 12:15 p.m.

385279 Courtney Linhart 9‐049 Prevalence of inappropriate prescribing of non‐benzodiazepine hypnotics for patients 65 years and older in the United States


11:15 a.m. ‐ 12:15 p.m.


Page | 136

Session ID


Title Date Time

385132 Juliana Lipetzky 1‐301 Cefazolin versus nafcillin for the treatment of complicated methicillin‐sensitive staphylococcus aureus (MSSA) bacteremia in a veteran patient population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388368 David Liu 1‐302 Evaluation of Compliance to Beta‐Blocker Therapy for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387550 Derek Liu 1‐303 Implementation of redesigned non‐formulary drug request adjudication process and evaluation of pharmacist workload and decision making at VA Puget Sound

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386417 Roger Liu 1‐304 Estimating return on investment of a mobile application providing supplementary, audio medication counseling in a rural, Native American healthcare setting: a pilot survey study.

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385834 Shimeng Liu 10‐033 Clinical and economic evaluation of oritavancin use in the emergency department at a community hospital


12:30 p.m. ‐ 1:30 p.m.

387442 Sonia Liu 10‐315 Target serum magnesium concentration for asthma exacerbation in pediatric patients


12:30 p.m. ‐ 1:30 p.m.


Page | 137

Session ID


Title Date Time

387592 Nicholas Lockhart

10‐267 Implementation of an automatic pharmacy stop for granulocyte colony stimulating factors: a retrospective chart review


12:30 p.m. ‐ 1:30 p.m.

389154 Kashelle Lockman

11‐110 Knowledge, skills, and attitudes of pain management among first‐year pharmacy students


1:45 p.m. ‐ 2:45 p.m.

388358 Drew Lockstein 10‐100 Utilization of ertapenem for surgical prophylaxis in a tertiary care institution


12:30 p.m. ‐ 1:30 p.m.

388766 Emily Lodwick 10‐016 Evaluation of intravenous acetaminophen and its effects on opioid use following surgery


12:30 p.m. ‐ 1:30 p.m.

386719 Leah Loeffler 12‐056 Developing a pharmacist‐driven transitions of care program for nursing facility patients within the continuum of care


3:00 p.m. ‐ 4:00 p.m.

389399 Tawny Loera 8‐333 Review of inhaler use in hospitalized patients to implement a cost‐effective inhaler‐to‐nebulizer conversion protocol and discharge plan for patients with chronic obstructive pulmonary disease


10:00 a.m. ‐ 11:00 a.m.

385205 Katherine Loiacono

1‐305 A prospective evaluation of compliance to a newly implemental VA hospital policy regarding dual PRN pain medication orders

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 138

Session ID


Title Date Time

386294 Mary Lomberk 8‐064 Impact of pharmacist‐driven employer‐sponsored diabetes management initiative on medication adherence for patients with uncontrolled diabetes


10:00 a.m. ‐ 11:00 a.m.

386677 Brittany Long 10‐185 Effectiveness of a university on‐campus pharmacist directed tobacco cessation program


12:30 p.m. ‐ 1:30 p.m.

385564 Holly Long 1‐306 Review of potentially inappropriate benzodiazepine use in elderly Veterans at a Veterans Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385394 Danielle Longo 8‐157 Assessment of inpatient granulocyte‐colony stimulating factor (G‐CSF) utilization at a tertiary care academic medical center


10:00 a.m. ‐ 11:00 a.m.

386969 Samantha Loutzenheiser

11‐016 Retrospective cohort analysis comparing proportions of patients prescribed statin therapy with or without diagnosis of hepatitis C after myocardial infarction, stroke, or transient ischemic attack


1:45 p.m. ‐ 2:45 p.m.

385274 Amanda Lovell 9‐296 Evaluation of QTc interval prolongation among hospitalized cancer pain patients on oral methadone


11:15 a.m. ‐ 12:15 p.m.

386425 Brittany Loy 11‐207 Description of pharmacist recommendations in the caring for older adults and caregivers at Home (COACH) program and impact on potentially inappropriate medication prescribing


1:45 p.m. ‐ 2:45 p.m.


Page | 139

Session ID


Title Date Time

386518 Caitlin Lozorak 9‐215 Evaluation of an evidence‐based pediatric acute hematogenous osteomyelitis treatment protocol


11:15 a.m. ‐ 12:15 p.m.

388928 Carmen Lu 10‐316 Comparison of Intravenous (IV) Vancomycin Therapy Management Before and After Pharmacy Protocol Implementation at a Large Academic Medical Center


12:30 p.m. ‐ 1:30 p.m.

389215 Crystal Lu 12‐057 Evaluating prescribing habits for non‐formulary psychiatry‐related medications in inpatient psychiatry units


3:00 p.m. ‐ 4:00 p.m.

389409 Kylie Lucas 8‐334 Evaluation of effect of chemical restraint with ziprasidone compared to physical restraint on patient ambulation


10:00 a.m. ‐ 11:00 a.m.

383184 Caitlyn Luecke 1‐307 Acetaminophen for PDA Closure: Does It Work?

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384404 Courtney Lujan 8‐261 Standardization of initial emergency department management and inpatient pediatric community‐acquired pneumonia antibiotic prescribing practices in order to align with current national guidelines


10:00 a.m. ‐ 11:00 a.m.

386315 Laura Lum 8‐262 Decreasing the use of chronic Zolpidem in our High Risk Elderly


10:00 a.m. ‐ 11:00 a.m.

388553 Liliana Lunares 1‐308 Medication use evaluation of warfarin management by usual medical care at Virginia Garcia Memorial Health Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 140

Session ID


Title Date Time

388713 Tim Lundberg 9‐132 Effect of probiotic bundle and education to reduce proton pump inhibitor use on Clostridium difficile infection


11:15 a.m. ‐ 12:15 p.m.

389232 Christer Lundblad

9‐173 Pharmacist‐initiated discontinuation of empiric vancomycin therapy in patients with pneumonia


11:15 a.m. ‐ 12:15 p.m.

388852 Traci Lundeen 11‐164 Evaluating the efficacy of kefir in preventing antibiotic‐associated diarrhea and Clostridium difficile infection in hospitalized patients receiving systemic antibiotic therapy


1:45 p.m. ‐ 2:45 p.m.

385277 Kristina Luo 8‐158 Evaluating the impact of a multidisciplinary team approach to caring for patients with type 2 diabetes


10:00 a.m. ‐ 11:00 a.m.

387040 Alexander Luong 1‐309 Comparison of Daily 2 GM and 1 GM Ceftriaxone for the Treatment of Methicillin‐Sensitive Staphylococcus Aureus Bloodstream Infections vs. Standard of Care

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386382 Kristie Luu 1‐310 Evaluating the impact of clinical pharmacists on oncology performance measures at the San Francisco Veterans Affairs Health Care System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388214 Thanh Ly 10‐034 Medication delivery service to Emergency Department patients: a pilot study to reduce wait time from discharge to medication dispense


12:30 p.m. ‐ 1:30 p.m.


Page | 141

Session ID


Title Date Time

387343 Alessandra Lyman

9‐133 A comparative evaluation of the incidence of aspiration pneumonia requiring hospitalization between clozapine and risperidone: A Pilot Study


11:15 a.m. ‐ 12:15 p.m.

385221 Katherine Lyndaker

1‐065 Single‐center retrospective cohort study on the treatment of asymptomatic bacteriuria and urinary tract infection, the impact on subsequent urinary tract infection outcomes

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387869 John Lyons 1‐311 An evaluation of the incidence and management of BK virus within an academic medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386590 Adrienne Ma 9‐297 Retrospective Review of Sustained Virologic Response Rate with Hepatitis C Medications in the Era of Direct Acting Antivirals Approval


11:15 a.m. ‐ 12:15 p.m.

385976 Laura MacCall 1‐312 Impact of a care process model on antibiotic prescribing for urinary tract infection in an emergency department

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388075 Sandy Mach 8‐159 Evaluation of a pharmacokinetic‐driven vancomycin dosing protocol to achieve therapeutic vancomycin trough concentrations


10:00 a.m. ‐ 11:00 a.m.

385397 Lauren Machell 10‐101 Evaluation of acute hyperkalemia treatment at a tertiary care academic medical center


12:30 p.m. ‐ 1:30 p.m.


Page | 142

Session ID


Title Date Time

385048 Jade Machin 10‐035 Surviving sepsis campaign bundles of care: implementation and effect on mortality rate


12:30 p.m. ‐ 1:30 p.m.

387998 Molly Mack‐Mortenson

8‐263 Evaluation of time to therapeutic anticoagulation before and after implementation of a modified heparin drip protocol


10:00 a.m. ‐ 11:00 a.m.

386259 Eric MacPherson 8‐160 Comparing the effectiveness of single fixed‐dose versus weight‐based dosing of rasburicase in patients with tumor lysis syndrome


10:00 a.m. ‐ 11:00 a.m.

388988 Ashley MacWhinnie

10‐102 Evaluation of the prescribing patterns of quetiapine for delirium in the intensive care unit


12:30 p.m. ‐ 1:30 p.m.

389212 Melanie Madorsky

8‐161 Impact of a pharmacy‐managed anticoagulation consult service in a community hospital setting


10:00 a.m. ‐ 11:00 a.m.

387982 Uchechukwu Maduako

9‐134 Safety and efficacy of target specific oral anticoagulants (TSOACs) versus long‐term enoxaparin use for prophylaxis and treatment of cancer‐related venous thromboembolism


11:15 a.m. ‐ 12:15 p.m.

386336 Tristan Maiers 10‐017 Evaluation of vancomycin‐induced renal toxicity in hematology and oncology patients


12:30 p.m. ‐ 1:30 p.m.

388692 Trisha Major 1‐313 Effects of a pharmacist managed online warfarin dosing algorithm on time to reach therapeutic anticoagulation

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 143

Session ID


Title Date Time

389397 Anne Louise Male Ervik

1‐314 Pharmacist Competency in Total Parenteral Nutrition

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386150 Jody Mallicoat 8‐162 Evaluation of provider prescribing practices related to patient‐controlled analgesia in adult surgical/trauma patients at a large academic medical center


10:00 a.m. ‐ 11:00 a.m.

385820 Kendra Malone 9‐050 Development of an ambulatory care pharmacist‐managed transitions of care service within a Veterans Affairs Medical Center


11:15 a.m. ‐ 12:15 p.m.

385672 Liana Mandel 1‐315 Evaluation of daptomycin use in a 445‐bed community hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386010 Lauren Manganiello

1‐316 Evaluation of patient vaccination rates in a veteran population enrolled in a home‐based primary care program

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387579 Nicholas Manion 12‐058 Quality improvement project: development and pilot of a clinical pharmacy productivity model


3:00 p.m. ‐ 4:00 p.m.

385249 Francis Manuel 8‐010 Evaluation of a low‐dose 4F‐PCC dosing strategy for acute warfarin reversal


10:00 a.m. ‐ 11:00 a.m.

385998 Kristin Mapes 11‐073 Evaluation of an Emergency Department Sepsis Screening Tool and Code Sepsis Protocol in the Treatment of Sepsis Patients


1:45 p.m. ‐ 2:45 p.m.

386580 Katherine March 9‐024 Management of Amiodarone‐Induced Thyrotoxicosis in a Patient with Underlying Cardiac Abnormalities: A Challenging Therapeutic Endeavor


11:15 a.m. ‐ 12:15 p.m.


Page | 144

Session ID


Title Date Time

388423 Pablo March Lopez

1‐317 Medication review in a spanish primary care center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384661 AMA MARFO 8‐042 Computerized physician order entry implementation in a hematology and oncology outpatient clinic: effect on the quality and safety of chemotherapy orders


10:00 a.m. ‐ 11:00 a.m.

385219 Carrie Margeson 11‐307 Impact of pharmacist led interdisciplinary review using pre‐determined criteria on parenteral nutrition practices


1:45 p.m. ‐ 2:45 p.m.

387132 Lindsay Mark 1‐318 Evaluating the impact of a pharmacist‐managed anticoagulation clinic versus physician‐managed warfarin therapy in a rural outpatient healthcare system

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386937 Marija Markovic 11‐165 Evaluating the potential cost‐savings associated with implementing an intravenous immune globulin dose rounding and body weight adjustment policy


1:45 p.m. ‐ 2:45 p.m.

389115 Megan Marsh 11‐046 Impact of post graduate year‐1 (PGY‐1) pharmacy residents on attending pharmacists productivity


1:45 p.m. ‐ 2:45 p.m.

388634 Jennifer Marshall 11‐242 Expansion of a pharmacist‐driven protocol in the emergency department to optimize treatment of urinary tract infections


1:45 p.m. ‐ 2:45 p.m.

385260 Jennifer Marshall 12‐094 Evaluation of a transitional care pharmacist pilot program; assessing quality, feasibility, and outcomes on high risk patient populations


3:00 p.m. ‐ 4:00 p.m.


Page | 145

Session ID


Title Date Time

385204 Lindsay Martin 11‐292 Evaluation of melatonin use for sleep management and delirium prevention in the critical care setting


1:45 p.m. ‐ 2:45 p.m.

384555 Corinn Martineau

10‐268 Risk factors for emergency department visits amongst diabetes patients from a family medicine clinic


12:30 p.m. ‐ 1:30 p.m.

386542 Tiffany Martinez 10‐317 Evaluation of the Appropriateness of Antibiotic Prescribing at the Time of Hospital Discharge


12:30 p.m. ‐ 1:30 p.m.

389191 Matthew Martin‐Souza

8‐335 Evaluation of prescribing practices of inhaled dornase alfa in non‐cystic patients


10:00 a.m. ‐ 11:00 a.m.

388835 Casey Mashl 1‐320 Survey of 2015 postgraduate year one (PGY1) residents concerning the North American Pharmacist Licensure Examination (NAPLEX) and the Multistate Pharmacy Jurisprudence Examination (MPJE) licensing process

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388203 Jocelyn Mason 11‐308 Impact of an infectious disease physician‐led cellulitis treatment pathway on hospital length of stay


1:45 p.m. ‐ 2:45 p.m.

389298 Erin Massarello 12‐205 Evaluation of sedation in mechanically ventilated patients after implementation of a pain, agitation and delirium protocol in the intensive care unit


3:00 p.m. ‐ 4:00 p.m.

385984 Michael Massmann

12‐301 Evaluation of aprepitant use in the prevention of post‐operative nausea and vomiting (PONV)


3:00 p.m. ‐ 4:00 p.m.


Page | 146

Session ID


Title Date Time

388651 Cathleen Mathew

8‐163 Assessment of pain management through opioid use at an urban community teaching hospital


10:00 a.m. ‐ 11:00 a.m.

383723 Emily Mattson 1‐321 Non‐steroidal anti‐inflammatory drug deprescribing after hospitalization in patients with ischemic heart disease: a Minneapolis Veterans Affairs Health Care System (MVAHCS) medication use evaluation

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388684 Revika Matuknauth

8‐264 Sliding scale insulin use in the long term care (LTC)/community living center (CLC)


10:00 a.m. ‐ 11:00 a.m.

386402 Scott May 1‐322 Evaluation of intravenous potassium replacement in the critically ill patient

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388859 Katelynn Mayberry

9‐079 Mental health of pharmacy and medical residents: incidence of clinical depression


11:15 a.m. ‐ 12:15 p.m.

386702 Katrina Mayr 10‐286 Use of telavancin for the treatment of methicillin‐resistant Staphylococcus aureus‐associated pulmonary exacerbations in patients with cystic fibrosis: a retrospective case series


12:30 p.m. ‐ 1:30 p.m.

387498 Brittany Mazur 12‐262 Impact of centralized pharmacist‐assisted medication reconciliation during transition of care between facilities within a multi‐site health system


3:00 p.m. ‐ 4:00 p.m.


Page | 147

Session ID


Title Date Time

389142 Renee McAlister 1‐323 Retrospective chart review of urinary tract infection management for positive urine cultures in a Veterans Affairs population after discharge from an emergency department

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387493 Claire McClain 11‐111 Pharmacogenomic association with neurotoxicity in Hispanic children with acute lymphoblastic leukemia (ALL)


1:45 p.m. ‐ 2:45 p.m.

383185 Seth McCleary 1‐324 Discontinuation of Delirium Medications in the Intensive Care Units

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388416 Christine McCluskey

8‐265 Beyond surgery: post‐surgical impact of intra‐operative liposomal bupivacaine use in a community hospital setting


10:00 a.m. ‐ 11:00 a.m.

388831 Michael McCormick

8‐164 Patient risk stratification in an outpatient primary care clinic: a medication use evaluation


10:00 a.m. ‐ 11:00 a.m.

386545 Shae McCowan 11‐129 Impact of benzodiazepine use on length of intensive care unit stay and time on the ventilator in patients with delirium


1:45 p.m. ‐ 2:45 p.m.

388319 Grace McCoy 1‐325 Analysis of clinical pharmacy specialist integration within patient‐aligned care teams to provide diabetes management services to Veterans

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387320 Jenna McCoy 8‐266 Optimizing the automated dispensing cabinet refill process at a large community hospital


10:00 a.m. ‐ 11:00 a.m.

387594 Shelbie McCoy 12‐059 Assessment of the use of Dual Antiplatelet Therapy in Acute Ischemic Stroke or TIA


3:00 p.m. ‐ 4:00 p.m.


Page | 148

Session ID


Title Date Time

385736 Kathryn McDaniel

12‐263 Effect of conversion to a qualified health plan on antiretroviral medication adherence in a HIV population


3:00 p.m. ‐ 4:00 p.m.

388210 Kyle McDaniel 8‐165 Introduction of a Pharmacy Driven Culture Review for Outpatient Treatment of Urinary Tract Infections in the Emergency Department


10:00 a.m. ‐ 11:00 a.m.

385959 Kaitlyn McDonald

1‐326 Development of an antimicrobial formulary review process

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386819 Marc McDowell 9‐298 Thromboelastography utility in the management of traumatic hemorrhage within the setting of direct oral anticoagulants


11:15 a.m. ‐ 12:15 p.m.

386527 Mary Martin McGill

1‐327 Comparative evaluation of a vancomycin dosing nomogram versus manual dose calculation in a veteran population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386979 Julie McGinley 11‐191 Initiation of a pharmacist‐managed venous thromboembolism prevention service and the impact on adherence and appropriateness of therapy


1:45 p.m. ‐ 2:45 p.m.

386751 Kayla McGrath 8‐336 Implementation and assessment of drug‐specific chemotherapy preparation checklists


10:00 a.m. ‐ 11:00 a.m.

388772 Cathryn McIntosh

8‐267 Assessing the impact of pharmacy resident‐guided medication reconciliation on medication therapy appropriateness at an urban teaching institution


10:00 a.m. ‐ 11:00 a.m.


Page | 149

Session ID


Title Date Time

387529 Lindsey McIver 1‐328 Evaluation of dextrose utilization as a surrogate for insulin‐induced hypoglycemic events among hospitalized patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388872 Albert McKee 1‐329 Retrospective quality assurance review of patient outcomes post gemfibrozil discontinuation in simvastatin treated patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386668 Kristen McLain 10‐018 Clinical pharmacist impact on sepsis core measure bundle compliance and clinical outcomes in the emergency department.


12:30 p.m. ‐ 1:30 p.m.

385991 Mary McMillan 8‐043 Evaluation of enoxaparin anti‐xa levels in obese vs. morbidly obese patients


10:00 a.m. ‐ 11:00 a.m.

385283 Kathleen McNamara

10‐103 Testing the ability of warfarin treated patients to predict their INR


12:30 p.m. ‐ 1:30 p.m.

389609 Molly McNaull 11‐166 Postoperative abscess rates in children with perforated appendicitis: a direct comparison of piperacillin/tazobactam and ceftriaxone plus metronidazole


1:45 p.m. ‐ 2:45 p.m.

385818 Chelsey McPheeters

9‐216 Implications of statin use on vasopressor therapy in the setting of septic shock


11:15 a.m. ‐ 12:15 p.m.

387252 Michael McQuade

1‐330 Evaluation of enoxaparin based venous thromboembolism prophylaxis in critically ill, obese patients at an academic medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 150

Session ID


Title Date Time

385308 Shannon McVeigh

1‐331 Impact of a polypharmacy initiative: reduction in unnecessary and inappropriate medications in an elderly veteran population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386012 Jeffrey Meadows 8‐011 Oritavancin versus vancomycin in ABSSI: clinical and economic outcomes


10:00 a.m. ‐ 11:00 a.m.

388983 Angela Mechelay 12‐014 Assessment of an outpatient hyperglycemia protocol in an academic primary care clinic


3:00 p.m. ‐ 4:00 p.m.

387883 Katherine Mechtel

8‐166 Evaluation of the incidence of acute kidney injury with extended‐infusion piperacillin‐tazobactam and vancomycin compared to standard infusion piperacillin‐tazobactam and vancomycin.


10:00 a.m. ‐ 11:00 a.m.

386204 Jacqueline Medina

8‐012 Development and implementation of heparin‐induced thrombocytopenia protocol and impact on patient care and cost


10:00 a.m. ‐ 11:00 a.m.

388802 Meera Mehta 1‐332 Survey of residency program directors (RPD) attitudes and perceptions of non‐traditional pharmacy residency applicants

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389280 Selam Melka 10‐104 Evaluation of alteplase utilization at two community hospitals


12:30 p.m. ‐ 1:30 p.m.

385395 Lindsay Menard 11‐293 Therapeutic drug monitoring and dose adjustments of calcineurin inhibitors in pediatric patients for hematopoietic stem cell transplant


1:45 p.m. ‐ 2:45 p.m.


Page | 151

Session ID


Title Date Time

383289 Angela Mensah 1‐333 Development, implementation and evaluation of the effectiveness of computer‐based core critical care competencies for pharmacists

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384645 Darren Mensch 12‐060 Short‐term effect of pharmacist's education on insulin administration technique


3:00 p.m. ‐ 4:00 p.m.

388857 Michael Menzel 8‐268 Assessment of meropenem utilization at SSM Health St. Mary's Hospital ‐ St. Louis.


10:00 a.m. ‐ 11:00 a.m.

386186 Alison Merkel 9‐299 Continuous versus intermittent pantoprazole infusion therapy for nonvariceal gastrointestinal bleed: a retrospective study of an institutional drug shortage management plan


11:15 a.m. ‐ 12:15 p.m.

387782 Jason Mersek 1‐411 Comparison of efficacy and safety outcomes between warfarin and target specific oral anticoagulants (TSOACs) in patients on concomitant amiodarone

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384358 Melodie Merzier‐Michel

11‐309 Assessing the impact of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the development of proteinuria in patients receiving vascular endothelial growth factor inhibitors


1:45 p.m. ‐ 2:45 p.m.

387336 Rachel Meyer 1‐334 Rivaroxaban utilization at a Western Michigan community teaching hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 152

Session ID


Title Date Time

387064 Nightingale Meyou

10‐019 Reducing chronic pain symptoms in clinically depressed patients with first time use of serotonin norepinephrine reuptake inhibitors (SNRI): venlafaxine and duloxetine


12:30 p.m. ‐ 1:30 p.m.

387462 Derek Michalski 9‐012 Assessing the impact of propofol duration, rate, and cumulative dose on the incidence of hypertriglyceridemia in intensive care unit patients


11:15 a.m. ‐ 12:15 p.m.

386597 Christina Miele 12‐061 Assessment of direct oral anticoagulant dosing and monitoring pre‐ and post‐ implementation of a per‐pharmacy protocol at a community teaching hospital


3:00 p.m. ‐ 4:00 p.m.

388186 Sarah Mike 8‐167 Evaluating effects of newly implemented emergency department pharmacist on patient safety, quality improvement, and cost avoidance


10:00 a.m. ‐ 11:00 a.m.

389019 Katie Miklavcic 10‐105 Impact of mobile medication reminder applications for medication adherence on 30‐day hospital readmission rates


12:30 p.m. ‐ 1:30 p.m.

387655 Lena Mikolas 1‐335 Implementing a pharmacist‐managed medication monitoring clinic for hepatitis C treatment

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386742 Sarah Milkovich 1‐336 Serious mental illness and its impact on diabetes care in a nurse/pharmacist managed population within a veterans affairs primary care clinic

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 153

Session ID


Title Date Time

385599 Deven Millay 11‐167 Appropriate Use of Intravenous Antihypertensive Medication During Hypertensive Crises in a Community Teaching Hospital


1:45 p.m. ‐ 2:45 p.m.

387083 Andrea Miller 11‐074 Medication use evaluation of analgesic use with intubation in the emergency department


1:45 p.m. ‐ 2:45 p.m.

387469 Annilee Miller 11‐243 Impact of a pain, agitation, and delirium protocol in mechanically ventilated patients within a community hospital


1:45 p.m. ‐ 2:45 p.m.

385739 Bethany Miller 10‐187 Treatment of community acquired pneumonia (CAP) in pediatric patients at a level I trauma center


12:30 p.m. ‐ 1:30 p.m.

388982 Gerald Miller 12‐264 Efficacy of current hyperkalemia management strategies at a community teaching hospital


3:00 p.m. ‐ 4:00 p.m.

385996 Maelee Miller 9‐300 Efficacy and safety of 3‐factor prothrombin complex concentrate versus fresh frozen plasma in a major or life threatening bleed on warfarin, apixaban, and rivaroxaban


11:15 a.m. ‐ 12:15 p.m.

386725 Micah Miller 8‐065 A didactic curriculum analysis of informatics subjects in the University of Montana Skaggs School of Pharmacy program in preparation for ACPE's


10:00 a.m. ‐ 11:00 a.m.

387685 Rachel Miller 11‐244 Evaluation of a protocolized algorithm for resistant alcohol withdrawal in the medically critically ill


1:45 p.m. ‐ 2:45 p.m.

383166 Susan Miller 1‐337 Evaluating chronic obstructive pulmonary disease (COPD) readmission rates

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 154

Session ID


Title Date Time

387942 Lindsey Minnick 11‐168 Customized versus standardized commercial parenteral nutrition: a community hospital perspective


1:45 p.m. ‐ 2:45 p.m.

388513 Nalisha Minors 9‐301 Evaluating the appropriate use of meropenem in adult patients in a community health system


11:15 a.m. ‐ 12:15 p.m.

385727 Kendall Mintus 8‐168 Evaluation of blood factor product utilization and policy adherence in a tertiary care hospital


10:00 a.m. ‐ 11:00 a.m.

388714 Arya Mishra 9‐135 Analysis of protocol‐based enoxaparin dosing at a tertiary care teaching institution


11:15 a.m. ‐ 12:15 p.m.

389125 Andrea Miskimins

12‐265 Naloxone Kit Distribution from the ED of a Community Hospital: Identifying Patients at Risk for Opioid Overdose


3:00 p.m. ‐ 4:00 p.m.

384880 Jagoda Misniakiewicz

9‐302 Effect of dose‐reduced paclitaxel pre‐medication regimen on rates of hypersensitivity and corticosteroid‐related adverse reactions


11:15 a.m. ‐ 12:15 p.m.

387109 Ardath Mitchell 1‐338 Impact of dolutegravir use in a veteran population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

382554 Kayla Mitchell 11‐310 Evaluation of tobramycin use in cystic fibrosis patients


1:45 p.m. ‐ 2:45 p.m.

387577 Sarah Mitchell 1‐339 Comparison of time to first dose of oral morphine in the treatment of neonatal abstinence syndrome

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388379 Priyam Mithawala

12‐062 Appropriateness of tirofiban use in accordance to current ACC/AHA guidelines


3:00 p.m. ‐ 4:00 p.m.


Page | 155

Session ID


Title Date Time

388656 Shogo Miyagi 11‐192 Impact of re‐warming after therapeutic hypothermia on gentamicin pharmacokinetics in neonates with hypoxic‐ischemic encephalopathy


1:45 p.m. ‐ 2:45 p.m.

388174 Nicole Moersch 12‐015 Compliance of dosing insulin based on internal guidelines at a community health system


3:00 p.m. ‐ 4:00 p.m.

385929 Bella Mogaka 8‐270 Medication reconciliation in the emergency department performed by pharmacy personnel: a prospective cohort comparison study.


10:00 a.m. ‐ 11:00 a.m.

388278 Sara Mohamed 9‐136 Development of a pharmacist driven intravenous to oral medication conversion protocol at a childrens hospital


11:15 a.m. ‐ 12:15 p.m.

386639 Insaf Mohammad

10‐239 Evaluation of a venous thromboembolism (VTE) transitions of care process involving the direct oral anticoagulants (DOAC) in the emergency department and observation unit (EVACUATE)


12:30 p.m. ‐ 1:30 p.m.

384741 Kyle Mohler 1‐340 Exacerbation rates of veterans diagnosed with chronic obstructive pulmonary disease (COPD) in the primary care setting

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386210 Alika Moitra 8‐271 Patient characteristics impacting understanding, retention and demonstration of inhaler technique in an underserved population


10:00 a.m. ‐ 11:00 a.m.

389176 Laura Molander 1‐341 Impact of treatment guidelines on antibiotic use for urinary tract infections (UTIs) in the emergency department (ED)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 156

Session ID


Title Date Time

386587 Juan Molina 9‐303 Medication utilization evaluation (MUE) on patients receiving chronic opioid medication therapy at Veterans Affairs Caribbean Healthcare System in 2015


11:15 a.m. ‐ 12:15 p.m.

389468 Suzanne Molino 1‐342 Implementation and evaluation of a pharmacist managed transitions of care service within a Veterans Affairs Healthcare System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387526 John Mondin 10‐240 Outcomes associated with perioperative management of oral antithrombotic therapies following cardiac surgical intervention


12:30 p.m. ‐ 1:30 p.m.

389085 Jessica Monitz 10‐287 Review of protocol adherence for opioid usage in critical care delirium at a community hospital


12:30 p.m. ‐ 1:30 p.m.

387195 Beatriz Monje 9‐137 Effectiveness and safety of belimumab in the treatment of Systemic Lupus Erythematosus


11:15 a.m. ‐ 12:15 p.m.

389647 Megan Monteen 9‐004 Impact of an Inpatient Medication Therapy Management (MTM) Billing Process on Patient Satisfaction Through HCAHPS Scores in a Rural Community Hospital


11:15 a.m. ‐ 12:15 p.m.

386241 Courtney Montepara

8‐169 Evaluation of the appropriate use of stress ulcer prophylaxis during admission and upon discharge at a community teaching hospital


10:00 a.m. ‐ 11:00 a.m.


Page | 157

Session ID


Title Date Time

386790 Robyn Moodt 10‐036 Determining the appropriateness and safety of discontinuing metformin upon admission in the inpatient non‐critically ill setting: a retrospective study


12:30 p.m. ‐ 1:30 p.m.

386658 Michael Moody 8‐337 The use of ketamine in the peri‐intubation period to facilitate rapid post‐intubation sedation and analgesia in the Emergency Department


10:00 a.m. ‐ 11:00 a.m.

389152 Kyle Moomey 11‐245 Retrospective chart review of the effect of amantadine on cognitive outcomes in the acute treatment of traumatic brain injury patients


1:45 p.m. ‐ 2:45 p.m.

386146 Danielle Moore 9‐138 Evaluation of protocol compliance and patient outcomes in mild traumatic brain injury on antiplatelet or anticoagulant therapy


11:15 a.m. ‐ 12:15 p.m.

387699 Heidi Moore 10‐020 Retrospective evaluation of sirolimus in allogeneic stem cell transplant patients with steroid‐refractory graft‐versus‐host‐disease at a large regional transplant center.


12:30 p.m. ‐ 1:30 p.m.

386329 Jordan Moore 10‐106 Efficacy and safety analysis of P2Y12 antagonists in patients with acute coronary syndrome


12:30 p.m. ‐ 1:30 p.m.

386734 Elisa Morgan 12‐016 Frequency of Pseudomonas aeruginosa (P. aeruginosa) in cultures obtained from patients admitted with diabetic foot infection (DFI)


3:00 p.m. ‐ 4:00 p.m.


Page | 158

Session ID


Title Date Time

388923 Rachel Morgans 8‐066 Impact of pharmacy participation on number of discrepancies identified during admission medication reconciliation process: a pilot study


10:00 a.m. ‐ 11:00 a.m.

384730 Brooke Morris 1‐343 The MOBS Trial: A Retrospective Study on Medication Optimization after Bariatric Surgery at the Huntington Veterans Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385940 Courtney Morse 1‐344 Impact of pharmacist discharge prescription delivery and medication counseling on 30‐day hospital readmission rate

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388452 Whitney Mortensen

10‐037 Implementation and evaluation of an academic detailing pilot program in a large, integrated health system


12:30 p.m. ‐ 1:30 p.m.

388589 Timothy Morton 8‐338 Investigation of factors influencing rates of hypoglycemia among inpatients receiving insulin


10:00 a.m. ‐ 11:00 a.m.

386853 Benjamin Moskoff

10‐188 Confirmation of the equianalgesic conversion of methadone to oral morphine equivalents


12:30 p.m. ‐ 1:30 p.m.

389658 Chandana Mulamalla

10‐107 Root Cause Analysis of glycemic events and pharmacist role in the management of glycemia in hospitalized patients at a teaching community medical center


12:30 p.m. ‐ 1:30 p.m.

383159 Allison Mulberry 1‐345 Evaluation of Progressive Tinnitus Management: An Interdisciplinary Study

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 159

Session ID


Title Date Time

386507 Kimberly Mulcahy

1‐346 Antibiotic Use and Implications of Drug Therapy in Psychiatric Inpatients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386211 Mallory Muller 9‐139 Evaluation of rifaximin utilization in hospitalized patients


11:15 a.m. ‐ 12:15 p.m.

387581 Ashley Mulvey 8‐067 Prevalence of methicillin‐resistant Staphylococcus aureus nasal carriage among long‐term care facility residents directly admitted to the intensive care unit at an urban, non‐teaching community hospital


10:00 a.m. ‐ 11:00 a.m.

384785 Arlette Munoz 8‐044 Evaluation of disease state management and impact of incorporating a chronic illness management (CIM) diabetes clinic to the Veterans Affairs patient aligned care team (PACT)


10:00 a.m. ‐ 11:00 a.m.

384489 Lindsey Munsch 11‐047 Creation of a pharmacy rotation to improve patient satisfaction, understanding of high risk medications, and Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores


1:45 p.m. ‐ 2:45 p.m.

384638 Maida Muratagic 8‐170 Impact of pharmacist‐led physician education on adherence to methylprednisolone dosing for pediatric patients with asthma exacerbations.


10:00 a.m. ‐ 11:00 a.m.

386358 Matthew Murphy

1‐347 A Safety Profile of Allopurinol Use in Chronic Kidney Disease: A Veterans Affairs Perspective

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 160

Session ID


Title Date Time

388601 Ryan Murphy 10‐189 Implementation and assessment of an antimicrobial stewardship program in a centralized pharmacy servicing multiple facilities within a health system


12:30 p.m. ‐ 1:30 p.m.

387734 Joshua Musch 1‐348 Effect of implementing a stress ulcer prophylaxis clinical tool on prescribing habits and associated institutional drug acquisition cost

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387714 Maureen Muthoni

8‐171 Impact of pharmacists counseling oncology patients on oral chemotherapy agents


10:00 a.m. ‐ 11:00 a.m.

388578 Erika Myers 12‐017 Characterization of the use of prophylactic antiepileptics for post traumatic brain injury at an academic medical center


3:00 p.m. ‐ 4:00 p.m.

382714 Doaa naeem 11‐311 Empiric Antibiotic Prescribing Practice in Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines


1:45 p.m. ‐ 2:45 p.m.

389262 Mary Naeger 11‐294 Treatment of Staphylococcus aureus bacteremia pre‐ and post‐implementation of rapid diagnostic testing


1:45 p.m. ‐ 2:45 p.m.

386865 Athar Naif 9‐140 Predicting citrate accumulation during continuous renal replacement therapy using a calcium total to calcium ionized ratio


11:15 a.m. ‐ 12:15 p.m.

387689 Agnieszka Najger 1‐349 Evaluation of an antimicrobial stewardship program at a community hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 161

Session ID


Title Date Time

385299 Halee Namanny 10‐031 Incidence of methicillin‐resistant Staphylococcus aureus (MRSA) and nephrotoxicity in patients empirically treated with vancomycin


12:30 p.m. ‐ 1:30 p.m.

386618 Erin Napier 9‐304 Potential risk factors for the development of clostridium difficile infection at a community hospital


11:15 a.m. ‐ 12:15 p.m.

386310 Michael Napoleon

1‐351 Pump up the hospital: implementation of inpatient continuous subcutaneous insulin infusion

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385823 Sylvia Narciso 11‐075 Evaluating the appropriateness of double gram‐negative coverage in severe septic patients


1:45 p.m. ‐ 2:45 p.m.

388144 Whitney Narramore

11‐076 Implementation and evaluation of annual wellness visits (AWV) and chronic care management (CCM) conducted by a pharmacist in a primary care clinic


1:45 p.m. ‐ 2:45 p.m.

389161 Clara Nassif 9‐217 Impact of standardized transitions of care medication education material on pharmacist‐initiated patient education


11:15 a.m. ‐ 12:15 p.m.

388450 Sean Navin 1‐352 Bubble packaging medications and adherence outcomes in American Indian patients at Albuquerque service unit

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 162

Session ID


Title Date Time

384505 Hilary Navy 11‐312 Evaluating the Impact of Mandatory Prescription Drug Monitoring Program Requirements on Opioid Prescribing Patterns


1:45 p.m. ‐ 2:45 p.m.

385679 Vijay Nayar 11‐169 Assessing the risk of failure with oral antibiotics for the treatment of urinary tract infections after discharge in children less than 24 months of age.


1:45 p.m. ‐ 2:45 p.m.

387486 Pierre Ndje 1‐353 Sofosbuvir/Ledipasvir Efficacy in Patients with genotype 1 at the Washington DC. Veterans Affairs Medical Center (DCVAMC)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389080 Jessica Neal 8‐272 Improving adherence to a severe alcohol withdrawal protocol through targeted order‐set interventions


10:00 a.m. ‐ 11:00 a.m.

386930 Joslyn Neal 10‐108 Retrospective evaluation of renal risk index and acute kidney injury in liver transplant patients


12:30 p.m. ‐ 1:30 p.m.

386667 Breaer Neff 8‐172 Use of procalcitonin as a biomarker of bacterial infections in neuro‐insult patients


10:00 a.m. ‐ 11:00 a.m.

389364 Luke Neff 9‐051 Levetiracetam versus (fos)phenytoin for early onset post‐traumatic seizure prophylaxis in pediatric patients


11:15 a.m. ‐ 12:15 p.m.

389001 Joseph Nekola 12‐302 Containment assessment by opening the Closed‐System Transfer Devices utilized for hazardous drug preparation


3:00 p.m. ‐ 4:00 p.m.


Page | 163

Session ID


Title Date Time

386744 Keyvan Nekouei 8‐013 Implementation of a full‐time perioperative pharmacist in a level 1 trauma center


10:00 a.m. ‐ 11:00 a.m.

389442 Zachary Nelson 11‐017 Successful Treatment of an Intentional Overdose of Capecitabine with Uridine Triacetate


1:45 p.m. ‐ 2:45 p.m.

387189 Kristen Neumeister

1‐354 Evaluation of concomitant benzodiazepine and opioid prescribing at the Minneapolis Veterans Affairs Health Care System (MVAHCS)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387001 Deidra Newbrough

9‐141 Evaluation of smart pump technology implementation at an academic medical center


11:15 a.m. ‐ 12:15 p.m.

384478 Sarah Newman 10‐109 Retrospective review of auto‐verified orders in a pediatric emergency department before and after pharmacist‐driven provider education


12:30 p.m. ‐ 1:30 p.m.

388546 Kristie Newsom 12‐089 Development of criteria for ertapenem use in the emergency department based on a retrospective evaluation in a level one trauma center


3:00 p.m. ‐ 4:00 p.m.

387649 Cheyenne Newsome

9‐080 Evaluation of association between health literacy and diabetes control in a pharmacist‐run medication management clinic


11:15 a.m. ‐ 12:15 p.m.

384714 Michelle Newton 1‐355 Evaluation of pregabalin usage in veterans with painful diabetic peripheral neuropathy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389452 Jennifer Ngan 10‐190 Impact of pharmacy transitions of care services on key patient outcomes


12:30 p.m. ‐ 1:30 p.m.


Page | 164

Session ID


Title Date Time

387419 Marie Ngan 9‐142 Effects of paroxetine on mortality, hospital admissions, and emergency room visits in heart failure patients


11:15 a.m. ‐ 12:15 p.m.

382600 Ijang Ngando 1‐356 Evaluating serum sodium levels in intensive care unit patients requiring 3% hypertonic saline therapy for the management of elevated intracranial pressures at a large rural medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389129 Ai Thi Nguyen 8‐273 Appropriate usage and dosage of vancomycin in neutropenia


10:00 a.m. ‐ 11:00 a.m.

387059 Annie Nguyen 8‐045 Pharmacist impact on appropriateness of insulin infusion and effective transitioning for patients presenting with diabetic ketoacidosis in the acute care setting


10:00 a.m. ‐ 11:00 a.m.

386951 Darlene Nguyen 11‐130 Community pharmacists' role in care transitions for transplant patients


1:45 p.m. ‐ 2:45 p.m.

386986 Duy Nguyen 1‐357 Impact of a pharmacy‐driven venous thromboembolism (VTE) prophylaxis program on post‐operative and 30‐day VTE events

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387471 Lynh Nguyen 8‐274 Impact of transition of care visits on thirty‐day hospital readmission rates


10:00 a.m. ‐ 11:00 a.m.

387957 Michelle Nguyen 10‐038 Adherence to antiemetic guidelines with associated outcomes in patients receiving chemotherapy at an outpatient cancer center


12:30 p.m. ‐ 1:30 p.m.


Page | 165

Session ID


Title Date Time

387962 Paul Nguyen 10‐191 Evaluation of intraoperative redosing of antibiotics in Whipple and neurosurgical procedures


12:30 p.m. ‐ 1:30 p.m.

387402 Quyen Nguyen 10‐192 Evaluating the impact of empiric antimicrobial treatment on hospital length of stay in patients admitted for acute bacterial skin and skin structure infection (ABSSSI)


12:30 p.m. ‐ 1:30 p.m.

386980 Sarah Nguyen 1‐358 Evaluating the impact of beta‐agonist use in patients with heart failure with or without pulmonary dysfunction

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386290 Stephanie Nguyen

12‐063 Anticholinergic medication use and the risk of community‐acquired pneumonia in an older veteran population


3:00 p.m. ‐ 4:00 p.m.

387791 Thanh Nguyen 1‐359 Evaluation of pharmacist intervention in diabetes patients identified from an electronic diabetes registry at a Veterans Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386093 Thomas Nguyen 11‐018 Comparison of annualized relapse rates between oral and self‐injectable disease modifying therapies for the treatment of multiple sclerosis: a historical claims analysis


1:45 p.m. ‐ 2:45 p.m.

387072 WENDY UYEN NGUYEN

9‐305 Enhancing practice through the use of a clinical skills assessment program


11:15 a.m. ‐ 12:15 p.m.


Page | 166

Session ID


Title Date Time

388279 Stephanie Nguyen‐Vuong

9‐143 Evaluating appropriateness of granulocyte colony‐stimulating factors (G‐CSF) for febrile neutropenia (FN) primary prophylaxis (PP) prescribing practice in high and intermediate risk patients receiving chemotherapy


11:15 a.m. ‐ 12:15 p.m.

384807 Megan Nicklaus 10‐039 Evaluation of pantoprazole prescribed for stress ulcer prophylaxis


12:30 p.m. ‐ 1:30 p.m.

388074 Kirk Nielsen 8‐173 Low‐dose tissue plasminogen activator (tPA) for the treatment of submassive pulmonary embolism (PE): an assessment of clinical outcomes at a community hospital


10:00 a.m. ‐ 11:00 a.m.

388925 Shelby Nielsen 11‐208 Procalcitonin guidance document utilization review in an academic medical center


1:45 p.m. ‐ 2:45 p.m.

386700 Sarah Niemi 1‐360 Creation and utilization of a relative value unit system in an outpatient infusion center pharmacy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386188 Lauren Nienas 1‐361 Safety and efficacy of bivalirudin monotherapy versus unfractionated heparin (UFH) monotherapy for percutaneous coronary intervention (PCI)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389466 Stephanie Nieves 9‐218 Evaluation of oral iron replacement therapy in geriatric patients


11:15 a.m. ‐ 12:15 p.m.

388856 Kimberly Niver 11‐077 Description of neonatal enoxaparin dosing and attainment of desired anti‐Xa concentrations


1:45 p.m. ‐ 2:45 p.m.


Page | 167

Session ID


Title Date Time

388306 Ruby Nkwenti 10‐318 Evaluation of a pharmacy driven central line tube priming protocol to reduce central venous catheter (CVC) infections in the neonatal intensive care unit (NICU)


12:30 p.m. ‐ 1:30 p.m.

388018 Meira Nocella 8‐275 Description of the prevalence of risk factors for hospital‐onset, healthcare facility associated Clostridium difficile infection cases at a rural community hospital


10:00 a.m. ‐ 11:00 a.m.

387018 Linda Nong 12‐206 Risk factors associated with immunization‐related adverse events in premature infants in a neonatal intensive care unit


3:00 p.m. ‐ 4:00 p.m.

389055 Kayla Nordhus 9‐306 Implementation of a customized electronic alert for QTc prolonging medications: an evaluation of prescribing habits in the inpatient environment


11:15 a.m. ‐ 12:15 p.m.

387367 Andrew Norman 1‐362 Follow‐up of emergency department microbiological cultures in the event of organism‐antibiotic mismatch

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387909 Nikki Noroian 10‐193 Determining the impact of a piperacillin‐tazobactam shortage on broad‐spectrum antimicrobial prescribing in hospitalized adult patients


12:30 p.m. ‐ 1:30 p.m.

389332 Brandon Nuziale 12‐266 Impact of language preference on diabetes outcomes for patients referred to clinical pharmacy services


3:00 p.m. ‐ 4:00 p.m.


Page | 168

Session ID


Title Date Time

389632 Ucheoma Nwizu 12‐267 Medication discrepancies in frequent users of the healthcare system: the impact and significance of frequent healthcare utilization


3:00 p.m. ‐ 4:00 p.m.

386814 Azuka Nwude 9‐081 Implementation of a discharge medication bedside delivery service


11:15 a.m. ‐ 12:15 p.m.

385767 Ruth Nyakundi 9‐219 Survey of West Virginia Hospital Discharge Practices for Heart Failure Patients


11:15 a.m. ‐ 12:15 p.m.

387385 Amber Oakes 11‐313 Assessing the impact of order set utilization on clinical outcomes in patients with confirmed Clostridium difficile infection


1:45 p.m. ‐ 2:45 p.m.

386645 Eric Ocheretyaner

1‐363 Evaluation of antibiotic prescribing practices in hospitalized pediatric patients for the development of a guided pediatric antimicrobial stewardship program

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388959 Kate O'Connor 12‐064 Evaluation of saxagliptin prescribing practices at six Veterans Affairs community‐based outpatient clinics


3:00 p.m. ‐ 4:00 p.m.

388699 Kiernan O'Connor

1‐364 Evaluation of renal dose checking in commercial clinical decision support (CDS) software

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388259 Morgan Odom 9‐307 Evaluating the efficacy and safety of probiotics for primary prevention of nosocomial Clostridium difficile infection (CDI).


11:15 a.m. ‐ 12:15 p.m.


Page | 169

Session ID


Title Date Time

388830 Guin Ogburn 12‐065 Protocolized versus nonprotocolized management of alcohol withdrawal syndrome utilizing lorazepam and haloperidol in critically ill trauma patients


3:00 p.m. ‐ 4:00 p.m.

389225 Jin Oh 10‐194 Improving patient outcomes by implementing a pharmacy driven vancomycin protocol


12:30 p.m. ‐ 1:30 p.m.

386564 Janine Ohler 8‐339 Daptomycin usage review and potential cost savings of ideal weight‐based dosing at a community hospital


10:00 a.m. ‐ 11:00 a.m.

386971 Alecia Oliver 1‐365 Assessment of antibiotic prescribing practices for acute respiratory infections in the primary care setting within the Atlanta VA Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385382 Ashley Oliver 8‐276 Medication related hospital admissions at a Veterans Affairs Healthcare System


10:00 a.m. ‐ 11:00 a.m.

389193 Katelyn Olsen 10‐110 Effects of initiating long‐acting injectable antipsychotics on hospitalization rates


12:30 p.m. ‐ 1:30 p.m.

386946 Melissa Olsommer

1‐366 Retrospective review in detection of error rates in admission medication reconciliation for patients at high risk of readmission to the hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387164 Kevin Omerza 10‐269 Effectiveness of three‐factor prothrombin complex concentrate to reverse anticoagulation: clinical experience at a level I trauma center


12:30 p.m. ‐ 1:30 p.m.


Page | 170

Session ID


Title Date Time

388076 Albina Ongari 10‐241 Lorazepam versus diazepam for the treatment of alcohol withdrawal syndrome in intensive care unit patients


12:30 p.m. ‐ 1:30 p.m.

388803 Chisom Onyilofor

1‐367 Impact of a pharmacy resident led education on 30‐day hospital readmissions in chronic obstructive pulmonary disease patients at an urban teaching hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385623 Lilian Ooi 10‐319 Diagnostic performance of the methicillin‐resistant Staphylococcus aureus (MRSA) nasal swab PCR for MRSA pneumonia


12:30 p.m. ‐ 1:30 p.m.

387313 Kelsie Ophus 8‐046 Growth changes in premature neonates: a retrospective analysis of human versus bovine milk fortifiers


10:00 a.m. ‐ 11:00 a.m.

388405 Steven Orlando 1‐368 Evaluation of post‐procedural bridging practices at a Veterans Affairs anticoagulation clinic

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385683 Julia O'Rourke 11‐246 Implementation of an oritavancin protocol for patients presenting to the emergency department with acute skin and skin structure infections


1:45 p.m. ‐ 2:45 p.m.

387630 Hillary Orr 11‐295 Assessment of initial vancomycin dosing in a pediatric oncology patient population


1:45 p.m. ‐ 2:45 p.m.

388697 Cristina Ortega Navarro

1‐369 Intradialytic parenteral nutrition in hemodialysis patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 171

Session ID


Title Date Time

388704 Sharmon Osae 1‐370 Evaluation of adverse outcomes and appropriate use of target specific oral anticoagulants (TSOACs) in patients discharged from pharmacist monitoring at a Veterans Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388729 Theodore Osborn

1‐371 Evaluation of empirical treatment for outpatient community acquired pneumonia at a Veterans Affairs healthcare system: a resident‐driven quality improvement project

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388463 Maggie Oser 9‐144 Impact of pharmacy services in a transitions of care clinic


11:15 a.m. ‐ 12:15 p.m.

386021 Jamie Ostrem 9‐082 Preemptive therapy versus universal prophylaxis with valganciclovir for the prevention of cytomegalovirus (CMV) disease in liver transplant recipients


11:15 a.m. ‐ 12:15 p.m.

388343 Alysia Osugi 11‐078 Vancomycin dosing in pediatric patients to achieve a trough of 15 to 20 mg/L


1:45 p.m. ‐ 2:45 p.m.

386006 Anchieh Ouyang 1‐372 Evaluating the efficacy and safety of pharmacologic therapies for obesity in patients managed by clinical pharmacists at the San Francisco Veterans Affairs Health Care System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389379 Ryan Owens 10‐195 Implementation of a new critical heparin lab alert value to enhance heparin drip protocol adherence


12:30 p.m. ‐ 1:30 p.m.


Page | 172

Session ID


Title Date Time

387693 Yashira Pabon‐Padin

9‐145 Evaluating the need of a percutaneous coronary intervention (PCI) bleed risk stratification tool to facilitate appropriate antithrombotic selection


11:15 a.m. ‐ 12:15 p.m.

388705 Puja Padalia 12‐269 Application of best practice strategies in the inpatient management of warfarin


3:00 p.m. ‐ 4:00 p.m.

384207 Daniel Padgett 10‐111 Evaluating the impact of clinical pharmacy services on The Joint Commission hospital based inpatient psychiatric services (HBIPS) core measures


12:30 p.m. ‐ 1:30 p.m.

386928 Danielle Padgett 10‐112 Medication use evaluation of vaccination after non‐elective splenectomy or splenic embolization in trauma patients


12:30 p.m. ‐ 1:30 p.m.

387556 Jinsun Paek 11‐029 Outcomes in utilizing consolidated mail outpatient pharmacy (CMOP) for medical supplies


1:45 p.m. ‐ 2:45 p.m.

382550 Brittany Palasik 8‐277 Evaluation of antipsychotic use in elderly dementia patients


10:00 a.m. ‐ 11:00 a.m.

389459 Megan Paleno 1‐373 Safety and efficacy of antipsychotic medications for the treatment of delirium in the intensive care unit (ICU) within a Veterans Affairs Healthcare System

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389386 Daniel Paley 9‐052 Medication reconciliation: quantifying contribution to patient safety, cost avoidance, and pharmacist workload


11:15 a.m. ‐ 12:15 p.m.


Page | 173

Session ID


Title Date Time

389162 Valerie Palmer 12‐270 Defining and evaluating the impact of clinical pharmacy services in an ambulatory psychiatric clinic


3:00 p.m. ‐ 4:00 p.m.

389391 Micaela Pamplin 12‐183 Evaluation of the appropriateness of reflex indwelling urinary catheter urine studies ordered in a community hospital


3:00 p.m. ‐ 4:00 p.m.

385136 Eva Pan 11‐131 Evaluation of carboplatin dosing using actual body weight compared to adjusted body weight


1:45 p.m. ‐ 2:45 p.m.

384560 Bhumi Pandhi 8‐014 Effect of pharmacist‐driven corticosteroid conversion in patients with COPD in a community hospital setting


10:00 a.m. ‐ 11:00 a.m.

387337 Elizabeth Papa 1‐374 Interprofessional approach to safe medication injection practice changes

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389150 Jeremy Pappacena

8‐174 Cost analysis, development, and implementation of a rituximab rapid infusion protocol in an academic oncology clinic


10:00 a.m. ‐ 11:00 a.m.

388597 Julia Pardo Pastor

10‐196 Review of the use of abiraterone, enzalutamide and ketoconazole for castration resistant prostate cancer


12:30 p.m. ‐ 1:30 p.m.

382620 Ae‐ryoung Park 10‐320 Improvement effect in patients nutrition state according to the adaptation of nutrition support teams consultation


12:30 p.m. ‐ 1:30 p.m.

388540 Eun Park 12‐207 Utilizing pharmacy technicians to obtain home medication history in the emergency department


3:00 p.m. ‐ 4:00 p.m.


Page | 174

Session ID


Title Date Time

388252 Gabriel Park 12‐066 Anticoagulation therapy considerations in factor VII deficiency: a case report


3:00 p.m. ‐ 4:00 p.m.

385793 Hanna Park 8‐340 Capturing the value of clinical pharmacy services


10:00 a.m. ‐ 11:00 a.m.

387116 Jenny Park 9‐083 Effectiveness of a new delirium education and treatment protocol in improving clinicians perceptions and knowledge of delirium in the intensive care unit: survey study.


11:15 a.m. ‐ 12:15 p.m.

388592 Sarah Park 9‐308 Comparison of unfractionated heparin dosage requirements during percutaneous coronary intervention over time


11:15 a.m. ‐ 12:15 p.m.

384315 Haley Parker 1‐375 Assessing A1c goal maintenance following clinical pharmacist management of veterans with type 2 diabetes

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388854 Michael Parks 9‐025 Comparative nephrotoxicity of vancomycin plus cefepime versus vancomycin plus piperacillin‐tazobactam in hospitalized patients


11:15 a.m. ‐ 12:15 p.m.

389305 Brittany Parmentier

8‐086 Medication regimens of patients with schizophrenia and related disorders with 30 day inpatient readmissions compared to patients without 30 day inpatient readmissions


10:00 a.m. ‐ 11:00 a.m.

387838 Katelyn Parrish 9‐084 Impact of pharmacist led education on nurse/pharmacist recognition and management of delirium outside of the intensive care unit


11:15 a.m. ‐ 12:15 p.m.


Page | 175

Session ID


Title Date Time

385257 Michelle Pasciolla

8‐175 Intravenous versus oral posaconazole and adherence to hospital guidelines


10:00 a.m. ‐ 11:00 a.m.

386503 Amy Pasternak 9‐220 Impact of initial intravenous tacrolimus dosage on the first tacrolimus concentration in a pediatric hematopoietic stem cell transplant population


11:15 a.m. ‐ 12:15 p.m.

387411 Abhay Patel 12‐095 Evaluating cost savings and patient benefit from the 340B Drug Pricing Program through expansion of pediatric outpatient pharmacy services


3:00 p.m. ‐ 4:00 p.m.

389541 Amar Patel 10‐197 Evaluating the Reduction in View Alerts Seen By A Patient Aligned Care Team Pharmacist In Improving Veteran Access to Primary Care Services


12:30 p.m. ‐ 1:30 p.m.

386671 Deep Patel 9‐146 Evaluation of maintenance Warfarin dose recommendations using Standing Stone verses Conventional dosing


11:15 a.m. ‐ 12:15 p.m.

386182 Dipale Patel 1‐377 Evaluation of the cost associated with redispensed medications upon patient transfers

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388359 Krishna Patel 1‐378 Development of an online anesthesia drug reference guide

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386620 Kunal Patel 11‐209 Implementation of sedation vacation and titration protocols for mechanically‐ventilated intensive care unit (ICU) patients


1:45 p.m. ‐ 2:45 p.m.


Page | 176

Session ID


Title Date Time

387457 Nilam Patel 9‐309 Evaluation of initial vancomycin dosing strategies and serum trough concentrations in a pediatric setting


11:15 a.m. ‐ 12:15 p.m.

386418 Nilamben Patel 10‐288 Utilization of aldosterone antagonists in veterans with heart failure on optimal therapy with reduced ejection fraction of less than 35%


12:30 p.m. ‐ 1:30 p.m.

389353 Pooja Patel 1‐379 Triple antithrombotic therapy with target specific oral anticoagulants (TSOACs) and the risk of bleeding.

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387056 Pritesh Patel 1‐380 Enhancement of antimicrobial practices at Sells Indian Hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387965 Puja Patel 10‐113 Medication use evaluation of a three factor prothrombin complex concentrate in an academic medical center


12:30 p.m. ‐ 1:30 p.m.

384981 Radha Patel 10‐321 Evaluation of a hospital wide dosing guideline in adult patients initiated on vancomycin


12:30 p.m. ‐ 1:30 p.m.

386531 Ravi Patel 10‐114 Evaluation of clinical outcomes in patients with healthcare‐associated pneumonia (HCAP) treated with community‐acquired pneumonia (CAP) regimens using a pneumonia risk scoring system


12:30 p.m. ‐ 1:30 p.m.

389482 Roshni Patel 9‐147 Evaluation of a pharmacy‐designed order set for use of blood factors to reverse oral anticoagulants


11:15 a.m. ‐ 12:15 p.m.

388787 Ruben Patel 12‐303 Glycemic Management in the Medical Intensive Care Unit


3:00 p.m. ‐ 4:00 p.m.


Page | 177

Session ID


Title Date Time

388044 Shefali Patel 9‐221 Evaluating relationship between the use of proton‐pump inhibitors and Clostridium difficile infection (CDI) and determining efficacy of probiotics in such patients.


11:15 a.m. ‐ 12:15 p.m.

386654 Udeshi Patel 11‐132 Medication history pharmacy technician pilot program for penicillin allergy assessment and documentation


1:45 p.m. ‐ 2:45 p.m.

389056 Clayton Patros 1‐381 Implementation and evaluation of an algorithm‐based order set for the outpatient treatment of urinary tract infections in the spinal cord injury population in a Veteran Affairs Medical Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387157 Stephanie Paul 12‐018 Integration of pharmacy services into an outpatient specialty clinic


3:00 p.m. ‐ 4:00 p.m.

389155 Kathleen Paulson

1‐382 Retrospective study comparing the morphine equivalents in chronic pain patients that are using marijuana compared to those that are not using marijuana

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388333 Julienne Pauly 1‐383 Development and implementation of an opioid overdose education and naloxone distribution (OEND) program

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387605 Chelsey Payne 12‐271 Evaluation of laboratory monitoring in multiple sclerosis patients treated with fingolimod


3:00 p.m. ‐ 4:00 p.m.


Page | 178

Session ID


Title Date Time

389227 Kelly Peddy 10‐198 Implementation and analysis of a patient‐centered educational program: a comparison of traditional warfarin counseling versus a designed, educational audiovisual series


12:30 p.m. ‐ 1:30 p.m.

389350 Betsy Pederson 10‐199 Evaluation of the dosing strategy of enoxaparin for the prevention of venous thromboembolism in morbidly obese patients


12:30 p.m. ‐ 1:30 p.m.

385128 LeeAnna Pederson

12‐272 Differences in US rural versus non‐rural population pharmacotherapy treatment for adults with depression


3:00 p.m. ‐ 4:00 p.m.

385908 Kayla Peeler 1‐384 Mississippi Kidney Foundations renal evaluation and assessment program (REAP): assessment of resource management and targeted participant follow up

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388314 Anita Pena 1‐385 Overcoming barriers to accessing a pharmacist‐run metabolic syndrome monitoring clinic

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384322 Johanna Peragine

1‐386 Identifying risk factors among patients who discontinued hepatitis C treatment to develop a treatment‐readiness assessment tool

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385692 Mariel Pereda 8‐176 Creating a quiet, healing environment: the impact of pharmacist interventions on nighttime medication administration and patient satisfaction


10:00 a.m. ‐ 11:00 a.m.


Page | 179

Session ID


Title Date Time

388773 Luis Pereira 8‐341 Monitoring metabolic adverse effects associated with atypical antipsychotic use in an outpatient psychiatric clinic


10:00 a.m. ‐ 11:00 a.m.

386174 Angela Perhac 11‐170 Recurrent clostridium difficile infection in patients with continued proton pump inhibitor therapy


1:45 p.m. ‐ 2:45 p.m.

386190 Dayna Perkins 12‐208 Clinical and financial outcomes associated with an inpatient therapeutic interchange of insulin detemir to glargine


3:00 p.m. ‐ 4:00 p.m.

388218 Erika Perpich 12‐273 Effectiveness of multidisciplinary post‐transplant endocrine clinic


3:00 p.m. ‐ 4:00 p.m.

384484 Emily Perriello 11‐048 Improper continuation of atypical antipsychotics after treatment and resolution of acute delirium in the intensive care unit


1:45 p.m. ‐ 2:45 p.m.

386664 Rosemary Persaud

10‐115 Correlation of blood pressure reduction in acute intracerebral hemorrhage (COBRA‐ICH)


12:30 p.m. ‐ 1:30 p.m.

387468 Morgan Peterman

1‐387 Assessment of outcomes from a pharmacist‐run tobacco cessation clinic

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389094 Haley Peters 11‐079 Impact of health‐system specialty pharmacy use on hepatitis c treatment


1:45 p.m. ‐ 2:45 p.m.

385130 Silvia Petkova 1‐388 Assessment of initial antimicrobial prescribing in a community hospital emergency department

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 180

Session ID


Title Date Time

388311 Katie Petrone 10‐242 Improving student leadership skills through a structured advisory program in an accelerated three year college of pharmacy program


12:30 p.m. ‐ 1:30 p.m.

387298 Brittany Petrosky 8‐278 Weight Based Dosing of Vancomycin in the Emergency Department


10:00 a.m. ‐ 11:00 a.m.

384877 Kriss Petrovskis 11‐080 Evaluation of the safety of enoxaparin at a pediatric institution.


1:45 p.m. ‐ 2:45 p.m.

386193 Stephen Petry 12‐274 Stress ulcer prophylaxis: assessment of appropriate prescribing in critically ill patients, followed with piloting of pharmacist intervention at transitions of care


3:00 p.m. ‐ 4:00 p.m.

386096 Shelly Pezzella 10‐116 Impact of a care transitions team on HCAHPS survey results and readmission rates within a community health‐system.


12:30 p.m. ‐ 1:30 p.m.

388056 Amy Pham 9‐085 Using gap analysis and lean principles to prepare a community hospital for the arrival of USP 800


11:15 a.m. ‐ 12:15 p.m.

388268 Mai‐An Pham 12‐090 Impact of a pharmacy‐driven education program on HCAHPS scores at an academically affiliated comprehensive cancer center


3:00 p.m. ‐ 4:00 p.m.

389020 Michelle Pham 9‐026 Implementation of a resident facilitated observational skills‐based competency in a hospital pharmacy


11:15 a.m. ‐ 12:15 p.m.


Page | 181

Session ID


Title Date Time

388957 Trang Phan 10‐117 Assessing the appropriateness of current monitoring practices for everolimus, sorafenib, and imatinib at Harris Health System


12:30 p.m. ‐ 1:30 p.m.

388998 John Phillips 9‐013 Evaluating the effectiveness of treatments for patients with NAP1/027 Clostridium difficile


11:15 a.m. ‐ 12:15 p.m.

388389 Nicholas Phillips 10‐040 Evaluation of emergency department empiric antibiotic selection for admitted patients


12:30 p.m. ‐ 1:30 p.m.

387450 Amanda Phoenix 11‐247 Heparin infusion dosing: does one size fit all?


1:45 p.m. ‐ 2:45 p.m.

386766 Jennifer Pichlik 10‐289 Impact of a physician and pharmacist‐driven antimicrobial stewardship (AMS) program at a community hospital


12:30 p.m. ‐ 1:30 p.m.

387366 Elizabeth Pickren 8‐279 Impact on CDC guideline compliance after incorporating pharmacy in a pneumococcal vaccination screening process


10:00 a.m. ‐ 11:00 a.m.

382727 Kara Piechowski 11‐314 Evaluation of methylnaltrexone use at a large academic medical center


1:45 p.m. ‐ 2:45 p.m.

385813 Vanessa Pierre 10‐118 Efficacy of a dihydropyridine calcium channel blocker auto‐substitution on blood pressure control in a 445‐bed community hospital


12:30 p.m. ‐ 1:30 p.m.

385420 Chelsea Pintz 8‐047 Implementation of a pharmacist‐managed refill program within an adult medicine clinic


10:00 a.m. ‐ 11:00 a.m.

389527 Ethan Pippin 12‐019 Exploring the risk factors for community acquired Clostridium difficile


3:00 p.m. ‐ 4:00 p.m.


Page | 182

Session ID


Title Date Time

385662 Ameen Pirasteh 1‐390 Impact of Rapid Identification of Gram‐Positive Organisms with the Implementation of an Antimicrobial Stewardship Approach at an Adult Community and Regional Pediatric Hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388834 Ryan Platz 9‐222 Analysis of positive urine cultures and how they are managed in adult hospitalized patients


11:15 a.m. ‐ 12:15 p.m.

388771 Noah Ploegman 8‐048 Diltiazem in the treatment of atrial fibrillation: a single center study at CHI‐ creighton university medical center


10:00 a.m. ‐ 11:00 a.m.

388880 Abby Pollander 9‐086 Implementation and evaluation of a delirium assessment tool in an intensive care unit


11:15 a.m. ‐ 12:15 p.m.

389377 Katelyn Pontore 9‐148 Optimizing controlled substance discrepancy surveillance at a tertiary care hospital


11:15 a.m. ‐ 12:15 p.m.

387671 Misael Porras 1‐391 Evaluation of nurse‐driven pneumococcal and influenza vaccination protocol for appropriate patient screening, administration, and documentation at a tertiary hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384713 Amanda Porter 10‐322 Retrospective evaluation of the use of statins based on the 2013 ACC/AHA guidelines in an ambulatory clinic


12:30 p.m. ‐ 1:30 p.m.


Page | 183

Session ID


Title Date Time

388902 Blake Porter 8‐049 Evaluation of the impact of pharmacist response to sepsis alerts on time to broad‐spectrum antibiotic administration at a major medical center


10:00 a.m. ‐ 11:00 a.m.

387106 Charrell Porter 11‐019 Direct pharmacist education to enhance anticoagulant therapy initiation in patients with atrial fibrillation (DEPICT‐AF)


1:45 p.m. ‐ 2:45 p.m.

389290 Ed Portillo 1‐392 Meds to bed implementation in an extended care nursing facility

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386695 Keith Posendek 11‐020 Pharmacists' roles in patient care in an acute care urban hospital


1:45 p.m. ‐ 2:45 p.m.

386935 Ashley Potter 10‐200 Tacrolimus dose adjustments for the prevention and treatment of graft‐versus‐host disease during concomitant posaconazole invasive fungal infection prophylaxis at Avera McKennan Hospital: a retrospective review


12:30 p.m. ‐ 1:30 p.m.

385781 Anna Powers 1‐393 Preemptive warfarin dose reduction after initiation of sulfamethoxazole‐trimethoprim or metronidazole

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386780 Janelle Poyant 8‐050 Evaluation of warfarin therapy management within a tertiary referral hospital


10:00 a.m. ‐ 11:00 a.m.

389547 Hannah Pratt 8‐342 Cost‐justification of a transition of care pharmacist.


10:00 a.m. ‐ 11:00 a.m.


Page | 184

Session ID


Title Date Time

387131 Jacqueline Pratt 1‐394 Automated software platform to assess pre‐validated risk for opioid‐induced respiratory depression to qualify patients for in‐home naloxone

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388151 Lyle Pratt 11‐081 Effect of titrating oral diuretics prior to discharge from the hospital on the outcomes of heart failure patients


1:45 p.m. ‐ 2:45 p.m.

384772 Vanessa Prendergast

11‐171 Evaluation of Ertapenem Utilization in a Large Community Hospital


1:45 p.m. ‐ 2:45 p.m.

386532 Brian Price 9‐149 System‐wide bowel protocol: an analysis of standardizing bowel management


11:15 a.m. ‐ 12:15 p.m.

388384 Katlin Pritchett 8‐177 Design and implementation of protocols for chemotherapy regimens


10:00 a.m. ‐ 11:00 a.m.

387170 Kristin Progar 10‐243 Renal function after conversion to mTOR‐Inhibitor in liver transplant recipients


12:30 p.m. ‐ 1:30 p.m.

384712 Ali Pryne 9‐223 Retrospective evaluation of safety and efficacy in the treatment of cervical artery dissection at a large, multi‐site, healthcare system.


11:15 a.m. ‐ 12:15 p.m.

388331 Lukasz Przychodzien

11‐296 Utilization of customized automated data capture and data processing for antimicrobial stewardship to increase quantity and acceptance rate of pharmacists' interventions


1:45 p.m. ‐ 2:45 p.m.

388883 Gina Puglisi 1‐395 Evaluating the effectiveness of clinical video telehealth services in the delivery of anticoagulation care for rural veterans

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 185

Session ID


Title Date Time

385724 Benjamin Pullinger

12‐067 Tolerance of enteral nutrition co‐administered with vasopressors in surgical and trauma intensive care unit patients


3:00 p.m. ‐ 4:00 p.m.

388695 Mitchell Purse 9‐087 Adherence to non‐formulary and restricted‐use medication consults


11:15 a.m. ‐ 12:15 p.m.

387608 John Puryear 1‐396 Evaluation of an argatroban dosing protocol at a regional hospital.

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389139 Eric Pyles 10‐119 Dexmedetomidine medication use evaluation in adult patients in a community hospital setting


12:30 p.m. ‐ 1:30 p.m.

386683 Azhin Qadir 12‐275 Pharmacist focused approach to improve blood glucose control in patients receiving basal insulin


3:00 p.m. ‐ 4:00 p.m.

387237 Lina Qasem 1‐397 Clinical and economic outcomes of warfarin versus direct oral anticoagulants (DOACs) following alteplase for the treatment of pulmonary embolism (PE)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386821 Andrew Quach 1‐398 Comparing provider adherence to antimicrobial dosing recommendations in pediatric inpatients before and after implementation of a sequential non‐interruptive and interruptive clinical decision support strategy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385392 Stephanie Quach 8‐071 Urinary tract infections caused by ESBL‐producing Enterobacteriaceae in a Medically Underserved Population


10:00 a.m. ‐ 11:00 a.m.


Page | 186

Session ID


Title Date Time

386260 Kathryn Qualls 12‐276 Evaluation of albumin utilization in hospitalized adults


3:00 p.m. ‐ 4:00 p.m.

389398 Jennifer Quevedo

11‐082 Medication use evaluation of intravenous methocarbamol


1:45 p.m. ‐ 2:45 p.m.

386727 Alison Quinn 10‐323 Effect of CYP2D6 gene variation on opiate dose requirement in sickle cell disease patients


12:30 p.m. ‐ 1:30 p.m.

387813 Jeydie Quinones 8‐280 Impact of pharmacist‐led, hospital‐based discharge medication reconciliation service


10:00 a.m. ‐ 11:00 a.m.

386022 Kelly Racette 10‐041 Impact of pharmacist involvement and clinical decision support on vaccination errors and missed opportunities in a pediatric primary care clinic


12:30 p.m. ‐ 1:30 p.m.

388410 Megan Radigan 10‐005 Alcohol withdrawal treatment: outcomes in patients receiving a symptom‐triggered regimen with or without scheduled chlordiazepoxide


12:30 p.m. ‐ 1:30 p.m.

386785 Elizabeth Radloff 11‐248 Comparison of vasopressor treatments in the setting of severe septic shock in a mixed bed community hospital intensive care unit


1:45 p.m. ‐ 2:45 p.m.

382975 Andrea Rai 11‐021 Impact of pharmacist interventions on readmission rates for chronic obstructive pulmonary disease (COPD)


1:45 p.m. ‐ 2:45 p.m.

387635 Karan Raja 12‐277 Review of medication communication scores and hospital rating on a telemetry unit without dedicated pharmacist managed discharge counseling


3:00 p.m. ‐ 4:00 p.m.


Page | 187

Session ID


Title Date Time

387193 Whitney Ralph 8‐051 Developing an antibiotic de‐escalation protocol at a rural community teaching hospital


10:00 a.m. ‐ 11:00 a.m.

389631 Kelley Ramey 8‐343 Evaluate the implementation of transitional care pharmacy services on key patient outcomes in a small community hospital


10:00 a.m. ‐ 11:00 a.m.

389339 Andrea Ramos 8‐344 Evaluating the use of ertapenem at a community teaching hospital


10:00 a.m. ‐ 11:00 a.m.

387517 Taylor Ramsdell 11‐210 Compliance with updated sepsis bundles to meet new sepsis core measure in a tertiary care hospital


1:45 p.m. ‐ 2:45 p.m.

386729 Bradlee Rea 8‐178 Retrospective analysis of histamine 2‐receptor antagonist and proton pump inhibitor use for stress ulcer prophylaxis (SUP) from patient admission through discharge


10:00 a.m. ‐ 11:00 a.m.

389558 Aimrie Ream 1‐399 Implementation and evaluation of pharmacist involvement in transitions of care services for chronic obstructive pulmonary disease (COPD) patients in a community, teaching hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389084 Jacob Reaser 10‐201 Evaluation of pharmacy education on reducing refill requests of discontinued medications at a federally qualified health center


12:30 p.m. ‐ 1:30 p.m.


Page | 188

Session ID


Title Date Time

388356 Tyler Redelico 9‐271 Management of bleeding using recombinant factor VIIa and 4‐factor prothrombin complex concentrate in patients with liver disease


11:15 a.m. ‐ 12:15 p.m.

388615 Susana Redondo Capafons

11‐172 Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome


1:45 p.m. ‐ 2:45 p.m.

385688 Brittany Reed 9‐310 Timing of antimicrobial administration in patients presenting with sepsis, severe sepsis, and septic shock


11:15 a.m. ‐ 12:15 p.m.

385667 Ellen Reed 1‐401 Opioid overdose education and naloxone distribution to veterans admitted for detoxification at the Battle Creek Veterans Affairs Medical Center (VAMC)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389637 Lindsey Reeder 8‐345 Drug‐induced nephrotoxicity in hospitalized patients with vancomycin in combination with piperacillin‐tazobactam or meropenem


10:00 a.m. ‐ 11:00 a.m.

388706 Racquel Reese 11‐112 Audit of a pharmacist‐driven piperacillin/tazobactam dosing protocol: a drug‐use evaluation


1:45 p.m. ‐ 2:45 p.m.

384800 Lisa Rehs 1‐402 Retrospective analysis of antibiotic prescribing in the emergency department, identifying opportunities for pharmacy involvement

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389604 Ashle Reid 10‐120 Changes in patient demographics at a student‐run free clinic: the effects of the Affordable Care Act


12:30 p.m. ‐ 1:30 p.m.


Page | 189

Session ID


Title Date Time

387673 Stefanie Reid 8‐281 Use of Intravenous and Intrapulmonary Recombinant Factor VIIa for Diffuse Alveolar Hemorrhage Secondary to Disseminated Strongyloides Infection: A Case Report


10:00 a.m. ‐ 11:00 a.m.

387863 Ashley Reller 1‐403 Evaluation of the efficacy and safety of rituximab in kidney transplant patients for the treatment of antibody mediated rejection in conjunction with plasmapheresis and intravenous immune globulin

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386324 Adrianne Remigio

9‐311 Predicting unbound phenytoin concentrations from total phenytoin concentrations using revised Winter‐Tozer (WT) equations at a large, academic medical center


11:15 a.m. ‐ 12:15 p.m.

389346 Kayla Renner 8‐282 Prophylactic antibiotic duration and Clostridium difficile infection rates in a trauma population


10:00 a.m. ‐ 11:00 a.m.

387496 Rachel Renwick 10‐244 Physician knowledge and self‐efficacy of new anticoagulants: a targeted needs assessment


12:30 p.m. ‐ 1:30 p.m.

386571 Claire Reuter 9‐017 Evaluation of the use of antibiotics for surgical prophylaxis among patients receiving antibiotics for active infection at a tertiary medical center


11:15 a.m. ‐ 12:15 p.m.

387279 Jose Luis Revuelta

9‐088 Off‐label use of filgrastim in the management of non‐chemotherapy drug induced neutropenia


11:15 a.m. ‐ 12:15 p.m.


Page | 190

Session ID


Title Date Time

389294 Caralyn Reyenga 1‐404 Medication use evaluation of intravenous levetiracetam at a large community hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386745 Inmaculada Reyes

11‐173 Neurotoxicity as dose‐limiting factor in oxaliplatin‐based chemotherapy in a tertiary hospital


1:45 p.m. ‐ 2:45 p.m.

387308 Miguel Reyes Malia

10‐275 EQUATION FOR THE PREDICTION OF SERUM DRUGS LEVEL OF DIGOXIN IN STEADY STATE


12:30 p.m. ‐ 1:30 p.m.

389035 Megan Rhoten 10‐202 Medication use evaluation of the diagnosis and management of asymptomatic bacteriuria in a community hospital


12:30 p.m. ‐ 1:30 p.m.

387021 Amber Rice 12‐278 Pain management evaluation of long‐bone fractures in the emergency department of an acute care hospital that is part of an integrated health care system


3:00 p.m. ‐ 4:00 p.m.

387137 Emily Richards 1‐405 Use of prophylactic ondansetron with intravenous opiates in emergency department patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386466 Patsy Richards 1‐406 Assessment of appropriate antibiotic selection and duration of therapy for the treatment of urinary tract infections and the impact on readmission in a community hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388231 Joshua Rickard 10‐203 Adherence with monitoring guidelines for amiodarone and dofetilide in ambulatory patients


12:30 p.m. ‐ 1:30 p.m.


Page | 191

Session ID


Title Date Time

386156 Taylor Rider 8‐179 Incidence of contrast‐induced nephropathy and the preventative effect of intravenous hydration in an at‐risk population at a large community hospital


10:00 a.m. ‐ 11:00 a.m.

385588 Krista Rieger 12‐020 Oral antibiotics for bacteremic Enterobacteriaceae urinary tract infection


3:00 p.m. ‐ 4:00 p.m.

387601 Jacob Rigdon 11‐174 Influence of documented or reported beta‐lactam allergies on clinical outcomes in patients that present with septic shock


1:45 p.m. ‐ 2:45 p.m.

388297 Angela Righi 11‐083 The impact of liposomal bupivacaine on efficacy and safety outcomes in the setting of cardiothoracic surgery.


1:45 p.m. ‐ 2:45 p.m.

388471 Margaret Riley 11‐249 Vitamin A supplementation for prevention of chronic lung disease in neonates


1:45 p.m. ‐ 2:45 p.m.

389508 Derrick Rinehart 10‐121 Intracerebral hemorrhage after external ventricular drain placement: an evaluation of risk factors for post‐procedural hemorrhagic complications


12:30 p.m. ‐ 1:30 p.m.

386689 Stephanie Ring 1‐407 Comparison of sustained virologic response with hepatits c virus treatments in the veteran population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386124 Lori Rio 8‐052 Assessing the impact on antimicrobial therapy for patients with bacterial pneumonia infection before and after implementation of required indications for use on all antimicrobial orders


10:00 a.m. ‐ 11:00 a.m.


Page | 192

Session ID


Title Date Time

387142 Kyle Rising 10‐276 Risk of Elevated Creatine Phosphokinase with High‐dose Daptomycin (8 mg/kg) versus Traditional Doses (6 mg/kg)


12:30 p.m. ‐ 1:30 p.m.

387545 April Risner 8‐320 Integration of a clinical pharmacy team into the patient centered medical home to improve transitions of care for Missouri Medicaid patients


10:00 a.m. ‐ 11:00 a.m.

387118 Karleen Ritchie 11‐084 Beyond Cost Savings: The Impact of a Medication Assistance Program on Hemoglobin A1Cs


1:45 p.m. ‐ 2:45 p.m.

388624 Johanna Rivera Anazagasty

1‐408 Design of a pharmacy residency interview rubric based on the most desirable characteristics in prospective candidates identified by pharmacy residency preceptors

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

382637 Attiya Rizwan 11‐175 Modeling of Pharmacist Role In Patient Safety For Least Developed Countries ‐ Pakistan


1:45 p.m. ‐ 2:45 p.m.

386248 Amy Robacheski 10‐245 Development of a risk assessment tool to identify patients at high risk for medication related 30 day hospital readmissions


12:30 p.m. ‐ 1:30 p.m.

389661 Shannon Robb 8‐346 Implementation of a pharmacist directed pain management stewardship program at Munson Medical Center


10:00 a.m. ‐ 11:00 a.m.

389179 Taylor Roberson 1‐409 Calcium monitoring and replacement across three phases of massive transfusion in a trauma population at a Level I Trauma Center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 193

Session ID


Title Date Time

388123 Jenna Roberts 8‐321 Clinical and economic impact of antimicrobial choice and duration of therapy for inpatient, non‐intensive care unit (ICU) community‐acquired pneumonia (CAP)


10:00 a.m. ‐ 11:00 a.m.

387858 Steven Robinette 12‐279 Mechanical ventilation as an isolated risk factor for multi‐drug resistant organisms in respiratory cultures in intensive care units at an academic medical center


3:00 p.m. ‐ 4:00 p.m.

384744 Amanda Robinson

10‐122 Effects of a pharmacy driven preoperative antibiotic dosing protocol on surgical site infection rates and adverse drug reactions


12:30 p.m. ‐ 1:30 p.m.

382611 Ellen Robinson 10‐246 Case report: Staphylococcus aureus bacteriuria as an indicator for non‐urinary infections


12:30 p.m. ‐ 1:30 p.m.

384664 Kaitlyn Robinson 11‐085 Review of medication utilization during rapid sequence intubation in an intensive care unit


1:45 p.m. ‐ 2:45 p.m.

386949 Bradley Rocco 11‐315 Evaluation of the relationship between HbA1c reduction and primary provider encounter time versus intensive diabetes management service encounter time


1:45 p.m. ‐ 2:45 p.m.

389137 Melissa Rock 8‐180 Evaluation of the appropriateness of ceftriaxone utilization in the emergency department for urinary tract infections


10:00 a.m. ‐ 11:00 a.m.


Page | 194

Session ID


Title Date Time

385738 Meghan Roddy 11‐176 Use of intravenous acetaminophen for post‐operative pain in the neonatal intensive care unit


1:45 p.m. ‐ 2:45 p.m.

388779 Brittany Rodriguez

1‐410 Children's hospital retrospective review of medication discrepancies identified at the time of discharge

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387110 Colleen Rogers 8‐144 Implementation of a pharmacist‐led discharge counseling service in a small urban teaching hospital


10:00 a.m. ‐ 11:00 a.m.

389629 Lesley Rogers 10‐290 Implementation of education plus provider prescribing reports and the effects on antipsychotic polypharmacy in children and adolescents in the outpatient setting


12:30 p.m. ‐ 1:30 p.m.

386530 Whitney Rogers 9‐224 Dexmedetomidine versus propofol for intraoperative sedation in carotid endarterectomy


11:15 a.m. ‐ 12:15 p.m.

387611 Marissa Rogoff 1‐412 Pharmacist impact on patients with diabetes as part of a multidisciplinary team in a primary care setting

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385292 Whitney Rohlman

9‐225 Evaluation of automated medication dispensing machine overrides and development of policies to promote improvement


11:15 a.m. ‐ 12:15 p.m.

386197 Bertha Rojas 9‐312 Evaluation of candidemia prevalence and treatment cost comparison in a community‐based hospital


11:15 a.m. ‐ 12:15 p.m.


Page | 195

Session ID


Title Date Time

388937 Glenn Roma 8‐181 Evaluation of a pharmacist driven post‐discharge education for patients following acute myocardial infarction.


10:00 a.m. ‐ 11:00 a.m.

387636 Konstantyn Romadin

8‐283 The effect of inhaler to nebulizer conversion on hospital readmission rates in patients with chronic obstructive pulmonary disease (COPD)


10:00 a.m. ‐ 11:00 a.m.

385207 Dana Roman 8‐347 Assessment of antibiotic prescribing practices in patients with penicillin allergy at a community teaching hospital


10:00 a.m. ‐ 11:00 a.m.

385754 Stephanie Romano

11‐177 Evaluation of the prevalence of intracranial hemorrhage between anticoagulants, antiplatelets, and nonsteroidal anti‐inflammatory drugs


1:45 p.m. ‐ 2:45 p.m.

387068 Rosa Maria Romero‐Jimenez

10‐204 Individualizing biological therapies dose based on patients response: cost effectiveness of moderate to severe psoriasis treatment


12:30 p.m. ‐ 1:30 p.m.

387519 Benjamin Rosati 1‐413 Meds to beds: an evaluation and expansion of an existing component of transitions of care in a tertiary care hospital

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388315 Philip Roszel 11‐113 Impacts of a newly implemented pharmacy driven medication reconciliation protocol


1:45 p.m. ‐ 2:45 p.m.

389156 Nechama Rothberger

10‐123 Ceftriaxone and SPICE: a recipe for disaster?


12:30 p.m. ‐ 1:30 p.m.


Page | 196

Session ID


Title Date Time

386181 Nicole Rubio 9‐150 Pharmacy resident participation in vaccination clinics in a hospital setting


11:15 a.m. ‐ 12:15 p.m.

387117 Whitney Ruddock

9‐151 Assessing the appropriateness of inpatient leuprolide use at Memorial Hospital West (MHW)


11:15 a.m. ‐ 12:15 p.m.

387378 Nicole Ruggiero 1‐414 Evaluation of hepatitis C virus (HCV) treatment outcomes with new direct‐acting antiviral agents

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386805 Diandra Ruidera 12‐068 Safety and efficacy of anti‐inhibitor coagulant complex in treating novel oral anticoagulant reversals


3:00 p.m. ‐ 4:00 p.m.

388339 Cristina Ruiz 10‐277 Use of ipilimumab for pretreated patients with advanced melanoma


12:30 p.m. ‐ 1:30 p.m.

383720 Abigail Russell 12‐280 Assessment of ventilator sedation practices following intubation in the emergency department


3:00 p.m. ‐ 4:00 p.m.

389419 Gabrielle Russell 9‐226 Evaluation of levetiracetam for early posttraumatic seizure prophylaxis in pediatric patients with traumatic brain injury


11:15 a.m. ‐ 12:15 p.m.

385571 HollyAnn Russell 11‐250 Retrospective analysis of the safety and efficacy of high dose cefepime in pediatric cystic fibrosis pulmonary exacerbations


1:45 p.m. ‐ 2:45 p.m.

389205 Lindsey Ruth 1‐415 Role of fosfomycin in the treatment of acute uncomplicated cystitis caused by resistant uropathogens

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 197

Session ID


Title Date Time

388850 Amanda Ryan 1‐416 Development of a pharmacist‐run new patient orientation clinic in an outpatient Veterans Affairs (VA) pharmacy

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389323 Ann Ryan 8‐182 Evaluation of a role for pharmacists in culture follow‐up at a community hospital emergency department.


10:00 a.m. ‐ 11:00 a.m.

387023 Keenan Ryan 8‐087 The Next Step in PrEP: Evaluating outcomes of a pharmacy run HIV pre‐exposure prophylaxis (PrEP) clinic


10:00 a.m. ‐ 11:00 a.m.

387342 Dimitrae Rynsburger

12‐281 Effectiveness of liposomal bupivacaine versus standard therapy for post‐surgical pain in patients who underwent video assisted thoracoscopy or thoracotomy


3:00 p.m. ‐ 4:00 p.m.

386133 Ahmad Saad 1‐417 Pharmacists' experience with a medication safety committee's structure, responsibilities, and roles

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387546 Mahmoud Sabawi

11‐251 Effect of pharmacist‐provided clinical interventions on quality of care and cost avoidance in an emergency department


1:45 p.m. ‐ 2:45 p.m.

385936 Alicia Sacco 1‐418 Evaluating protocol adherence during anti‐inhibitor coagulant complex administration for reversal of factor Xa inhibitors for life‐threatening bleeding

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388010 Bryan Sackey 1‐243 Evaluation of empiric antibiotic therapy for urosepsis in spinal cord injury patients at a Veteran Affairs medical center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 198

Session ID


Title Date Time

388470 Areeman Saed 10‐205 Pharmacist driven antimicrobial stewardship implementation in a community hospital


12:30 p.m. ‐ 1:30 p.m.

385199 Marla Saez 1‐419 Outcomes of anticoagulation prophylaxis in patients undergoing total knee replacement (TKR) or total hip replacement (THR) at VACHS

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385664 Ali Saghaian 10‐324 Impact of a six‐month piperacillin/tazobactam shortage at a rural community hospital


12:30 p.m. ‐ 1:30 p.m.

387700 Kelly Saha 1‐420 Efficacy of proton pump inhibitors in preventing gastrointestinal bleeding in patients receiving direct oral anticoagulants

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386045 Sarith Saju 8‐183 A cross‐sectional study ascertaining the prevalence of appropriate treatment for pre‐diabetes in the US adult population


10:00 a.m. ‐ 11:00 a.m.

387338 Helin Salama 8‐284 Incidence of hypotension associated with dexmedetomidine versus propofol used for sedation in mechanically ventilated adult medical intensive care unit (ICU) patients


10:00 a.m. ‐ 11:00 a.m.

387233 Nouran Salem 1‐421 Apixaban major bleeding: patient characteristics, management and outcomes

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387715 Alok Salgia 9‐313 Evaluation of transition from patient controlled analgesia to oral analgesia in post surgical patients


11:15 a.m. ‐ 12:15 p.m.


Page | 199

Session ID


Title Date Time

389066 Mehrnoosh Samimi‐Gharai

8‐184 Medication use evaluation of ceftaroline fosamil in a community hospital


10:00 a.m. ‐ 11:00 a.m.

387784 Chelsea Sampadian

1‐422 Dipeptidyl‐peptidase‐IV inhibitors for treatment of type 2 diabetes mellitus: a pilot study

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388281 Jed Sana 11‐086 Implementation of a billing process for inpatient clinical pharmacy services


1:45 p.m. ‐ 2:45 p.m.

389209 Michelle Sandberg

1‐423 Non‐dihydropyridine calcium channel blocker use in stable heart failure patients

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

384709 Ashley Sanders 10‐247 Improving Patient Outcomes by Using Social Media to Deliver Diabetes Educational Videos in a Community Pharmacy


12:30 p.m. ‐ 1:30 p.m.

386735 Janice Sanders 1‐424 Assessment of patient characteristics and barriers to treatment of hepatitis C in a veteran population

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387031 Omeka Sanders 1‐425 Evaluation of the duration of antipsychotics prescribed for intensive care unit (ICU) delirium

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388715 Phillip Sanshuck 9‐314 Establishing safety and efficacy of high dose unfractionated heparin compared to traditional dosing in obese patients for venous thromboembolism prophylaxis


11:15 a.m. ‐ 12:15 p.m.

388952 Maressa Santarossa

9‐014 Impact of a rapid‐diagnostic tied antimicrobial stewardship intervention on clinical outcomes in patients with bloodstream infections


11:15 a.m. ‐ 12:15 p.m.


Page | 200

Session ID


Title Date Time

387830 Melissa Santibanez

1‐426 Pharmacokinetic/pharmacodynamic derived predictions of efficacy and clinical outcomes in obese and non‐obese patients with Enterobacteriaceae bloodstream infections

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387570 Ibinson Sarah 9‐227 Impact of therapeutic interventions on thrombocytopenia in patients on histamine‐2 receptor antagonists


11:15 a.m. ‐ 12:15 p.m.

385231 Nidhi Saraiya 11‐316 Evaluation of the management of positive bacterial urine cultures 2 years after guideline implementation


1:45 p.m. ‐ 2:45 p.m.

389109 Jonathan Sarky 11‐087 Evaluating prescribing practices for hepatitis B immunization based on Advisory Committee on Immunization Practices(ACIP) recommendations for patients with diabetes


1:45 p.m. ‐ 2:45 p.m.

387783 Stefanie Sarratt 8‐053 Evaluation of safety outcomes of apixaban compared to warfarin in patients with end‐stage renal disease.


10:00 a.m. ‐ 11:00 a.m.

388966 Gabriele Sasso 10‐325 Impact of an interprofessional hypoglycemia response team on prevention of recurrent insulin induced severe hypoglycemia in a 431‐bed community teaching hospital in Syracuse, NY


12:30 p.m. ‐ 1:30 p.m.

388846 Evan Sasson 1‐104 Possible rivaroxaban induced full body rash: a case report

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 201

Session ID


Title Date Time

388750 Burton Saunders 9‐228 Physician utilization of pediatric dosage calculators in the outpatient setting


11:15 a.m. ‐ 12:15 p.m.

388507 Stephen Saw 9‐315 Sternal wound infection following delayed sternal closure at a large academic medical center


11:15 a.m. ‐ 12:15 p.m.

388770 Catherine Scalley 1‐129 Evaluation of naloxone use and expansion of an overdose education and naloxone distribution program (OEND) in a rural Veterans Affairs (VA) healthcare system

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

385704 Gianni Scappaticci

12‐209 Recurrent Clostridium difficile infection in adult hematology patients


3:00 p.m. ‐ 4:00 p.m.

389327 Joseph Schafer 1‐130 The effectiveness of ascorbic acid in the prevention of atrial fibrillation after cardiothoracic surgery

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

387321 Obadiah Scheich 12‐282 Development of a standardized clinical support matrix acros a health system


3:00 p.m. ‐ 4:00 p.m.

386662 Ashley Schenk 11‐317 Utilization of intravenous tranexamic acid in total knee or total hip arthroplasty: retrospective analysis of effectiveness and safety


1:45 p.m. ‐ 2:45 p.m.

384644 Matthew Scherrer

11‐114 Code sepsis: the impact of time to therapy on clinical outcomes


1:45 p.m. ‐ 2:45 p.m.

387988 Alex Schickli 1‐145 Evaluation of pharmacy‐driven dexmedetomidine stewardship and appropriate use guidelines in a community hospital setting

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.


Page | 202

Session ID


Title Date Time

388673 Lindsay Schieb 10‐326 Optimization of a vancomycin dosing and monitoring protocol in an inpatient, teaching hospital


12:30 p.m. ‐ 1:30 p.m.

384277 Zachary Schlei 1‐148 Impact of clinical pharmacists in investigational drug services at a comprehensive cancer center

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

386637 Lindsay Schmees 1‐154 Comparison of the incidence of nephrotoxicity in pediatric patients receiving vancomycin with piperacillin‐tazobactam or cefepime

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389108 Kristen Schmerbeck

8‐185 Impact of a Collaborative Strategy to Reduce the Inappropriate Use of Stress Ulcer Prophylaxis in Hospitalized Non‐ICU Patients


10:00 a.m. ‐ 11:00 a.m.

389123 Laura Schmidt 1‐158 Evaluation of group A Streptococcal (GAS) pharyngitis treatment at a community teaching health system

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

389376 Michael Schmidt 10‐206 Characterizing Clostridium difficile infection rates, risk factors, and outcomes in hematopoietic stem cell transplant recipients


12:30 p.m. ‐ 1:30 p.m.

384769 Sierra Schmidt 10‐124 Impact of time to initiation of parenteral nutrition on duration of mechanical ventilation


12:30 p.m. ‐ 1:30 p.m.

387125 Tanya Schmidt 10‐042 Design and implementation of a pharmacy‐led post‐fall medication consultation service


12:30 p.m. ‐ 1:30 p.m.

386655 Nicole Schneider 8‐104 Evaluation of vitamin K dose and route on warfarin reversal in a community hospital setting


10:00 a.m. ‐ 11:00 a.m.


Page | 203

Session ID


Title Date Time

386378 Rebecca Schoen 12‐312 Pharmacist adherence to an extended interval of international normalized ratio follow‐up protocol


3:00 p.m. ‐ 4:00 p.m.

387192 Sydney Schrammeck

9‐174 Evaluation of outcomes in patients with malignancy receiving direct oral anticoagulants (DOACs)


11:15 a.m. ‐ 12:15 p.m.

387920 Sara Schroedl 12‐313 Evaluation of anticholinergic polypharmacy in the elderly population in an outpatient setting: a medication use evaluation at the Minneapolis Veterans Affairs Health Care System (MVAHCS)


3:00 p.m. ‐ 4:00 p.m.

388502 Jamie Schuber 12‐314 Integration and evaluation of an adherence monitoring tool for patients using target specific oral anticoagulants


3:00 p.m. ‐ 4:00 p.m.

386305 Thomas Schuetz 11‐115 Evaluation of antimicrobial stewardship efforts on the utilization of piperacillin/tazobactam


1:45 p.m. ‐ 2:45 p.m.

388348 Courtney Schultz 1‐139 Influence of tyrosine kinase inhibitors on renal function and evaluation of current monitoring procedures at the Cincinnati Veterans Affairs Medical Center (VAMC)

Sunday, December 6

3:45 p.m.‐ 5:15 p.m.

388193 Jacob Schultz 12‐316 Validation of a population estimate based vancomycin kinetics calculator at the Minneapolis Veterans Affairs Medical Center (MVAMC)


3:00 p.m. ‐ 4:00 p.m.

387444 Sara Schulz 11‐088 Effect of darbepoetin alfa on mortality and transfusion independence in critically ill trauma patients


1:45 p.m. ‐ 2:45 p.m.


Page | 204

Session ID


Title Date Time

386733 Kaitlyn Schumacher

11‐211 The safety and efficacy of outpatient parenteral antimicrobial therapy for the treatment of hip and knee prosthetic joint infections


1:45 p.m. ‐ 2:45 p.m.

388434 Natalie Schwarber

11‐252 Outcomes of Pseudomonas aeruginosa urinary tract infections


1:45 p.m. ‐ 2:45 p.m.

386013 Brittina Schwarz 11‐253 Retrospective evaluation of patients diagnosed with sepsis to determine impact of converting empiric therapy from cefepime to piperacillin‐tazobactam at a 180‐bed community hospital


1:45 p.m. ‐ 2:45 p.m.

387479 Jaime Schwendenmann

8‐285 Reducing dual antipsychotic therapy upon patient discharge


10:00 a.m. ‐ 11:00 a.m.

385146 Caitlyn Schwirian 10‐043 Vancomycin troughs in pediatrics: how low can you go?


12:30 p.m. ‐ 1:30 p.m.

388693 Abigale Scott 12‐210 Incidence of major bleed and cardiovascular events in dialysis patients with newly diagnosed atrial fibrillation and the correlation with CHADS2‐VASc and HAS‐BLED scores.


3:00 p.m. ‐ 4:00 p.m.

387895 Rachel Scott 9‐229 Alteplase dosing for acute ischemic stroke


11:15 a.m. ‐ 12:15 p.m.

387634 Jordan Sedlacek 12‐317 Assessment of electronically retrievable risk factors in the outpatient setting for thirty day readmission


3:00 p.m. ‐ 4:00 p.m.

387167 Ravin Seewah 11‐178 Evaluation of acute kidney injury in patients on concurrent piperacillin‐tazobactam and vancomycin


1:45 p.m. ‐ 2:45 p.m.


Page | 205

Session ID


Title Date Time

389004 Lydia Seger 11‐254 Safety evaluation of cephalosporin and penicillin use in beta‐lactam allergic patients: a pharmacy‐led initiative to reduce utilization of non‐preferred antibiotics in surgery and obstetrics


1:45 p.m. ‐ 2:45 p.m.

387285 Nathan Seligson 12‐304 Retrospective analysis of cladribine use in acute myeloid leukemia induction treatment


3:00 p.m. ‐ 4:00 p.m.

388150 Jade Senger 11‐089 Implementation of pharmacist counseling to improve the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) medication‐related scores in heart surgery patients


1:45 p.m. ‐ 2:45 p.m.

386691 Kelly Sennett 9‐230 Review of dexmedetomidine usage for process improvement in alcohol withdrawal at a community level one trauma center


11:15 a.m. ‐ 12:15 p.m.

384576 Kristen Senyk 9‐152 Establishing a health system program to implement new credentialing requirements and maximize reimbursement for the Washington pharmacist provider status legislation


11:15 a.m. ‐ 12:15 p.m.

388120 Sun Seo 9‐316 Survey of community pharmacists opinions after implementation of a company‐wide program to help improve Medicare Part D Star Ratings quality measures


11:15 a.m. ‐ 12:15 p.m.


Page | 206

Session ID


Title Date Time

386931 Roseanne Seok 12‐184 Evaluation of the Compliance Rate of the Modified CAM‐ICU Protocol and the Appropriateness of Provider Interventions at San Francisco Veterans Affairs Healthcare System (SFVAHCS)


3:00 p.m. ‐ 4:00 p.m.

388528 Alexandra Serafino

9‐027 Thromboembolism associated with the use of tranexamic acid


11:15 a.m. ‐ 12:15 p.m.

385627 Lianna Serbas 10‐125 Evaluation of fall risk in dementia patients on an atypical antipsychotic in the Veterans Affairs population.


12:30 p.m. ‐ 1:30 p.m.

387687 Jason Serna 9‐015 Establishing Key Antibiotic Utilization Metrics for an Antimicrobial Stewardship Dashboard


11:15 a.m. ‐ 12:15 p.m.

384502 Regan Sevinsky 10‐291 Assessment of febrile neutropenia management in hospitalized adult cancer patients: a retrospective review


12:30 p.m. ‐ 1:30 p.m.

386496 Emma Sew Hoy 11‐049 Pharmacists' authority to furnish nicotine replacement therapy in California: evaluation of community pharmacists' impact on smoking cessation medication access and use


1:45 p.m. ‐ 2:45 p.m.

388408 Jeanna Sewell 10‐044 Comparison of pharmacist‐run to physician‐only Medicare wellness services


12:30 p.m. ‐ 1:30 p.m.


Page | 207

Session ID


Title Date Time

384750 Rebecca Shaffer 8‐286 Retrospective review of the development of acute kidney injury in patients receiving vancomycin in combination with either piperacillin/tazobactam or another broad spectrum beta‐lactam antibiotic


10:00 a.m. ‐ 11:00 a.m.

388785 Iffat Shafiq 10‐126 Evaluating procalcitonin level management as a marker for antimicrobial utilization


12:30 p.m. ‐ 1:30 p.m.

388497 Abhishek Shah 11‐212 Evaluating inappropriate use of low dose statin therapy based on VA/DoD practice guidelines for the management of dyslipidemia.


1:45 p.m. ‐ 2:45 p.m.

389403 Ami Shah 8‐088 Evaluation of the use of liposomal bupivacaine in gynecologic oncology surgery


10:00 a.m. ‐ 11:00 a.m.

388213 Hiren Shah 12‐318 Evaluation of bridging anticoagulation practices in critically‐ill patients with atrial fibrillation


3:00 p.m. ‐ 4:00 p.m.

386892 Janki Shah 11‐050 Assessment of the clinical impact of a pharmacist managed diabetes clinic


1:45 p.m. ‐ 2:45 p.m.

387918 Jasmine Shah 9‐231 Working smarter: optimizing medication batching workflow in order to reduce intravenous drug waste in a pediatric setting


11:15 a.m. ‐ 12:15 p.m.

385950 Tanvi Shah 11‐255 Evaluating the use of eptifibatide and abciximab at Loyola University Medical Center


1:45 p.m. ‐ 2:45 p.m.


Page | 208

Session ID


Title Date Time

384655 Suhail Shaikh 10‐248 Rational use of rasburicase in the treatment and management of tumor lysis syndrome


12:30 p.m. ‐ 1:30 p.m.

388733 Madeline Shanko

8‐287 Questionnaire to assess the attitudes and perceptions of nurses and pharmacists satisfaction with pharmacy services before and after implementation of the decentralized pharmacy service model


10:00 a.m. ‐ 11:00 a.m.

388600 Monica Sharma 10‐021 Anti‐epileptic prophylaxis in traumatic brain injury (TBI): a comparison of fosphenytoin/phenytoin vs. levetiracetam


12:30 p.m. ‐ 1:30 p.m.

384208 Bethany Sharpless

11‐030 Implementation of a novel auditing report to improve compliance to joint commission therapeutic duplication standards


1:45 p.m. ‐ 2:45 p.m.

386287 Rachel Sharpton 10‐292 QTc interval monitoring for chronic azithromycin therapy in patients with cystic fibrosis


12:30 p.m. ‐ 1:30 p.m.

385854 Suhair Shawar 12‐283 Derivation and validation of a predictive scoring system to identify patients at high risk of infection due to extended‐spectrum‐beta‐lactamase‐producing Enterobacteriaceae


3:00 p.m. ‐ 4:00 p.m.

386764 Kailee Shearer 11‐022 Evaluation of empiric antibiotic use and subsequent de‐escalation as a proponent for developing a pharmacist managed antimicrobial stewardship de‐escalation protocol


1:45 p.m. ‐ 2:45 p.m.


Page | 209

Session ID


Title Date Time

388969 Jeffrey Shearin 10‐327 Implementation of a procalcitonin protocol at a community hospital to aid in the de‐escalation of vancomycin in intensive care unit (ICU) patients presenting with sepsis.


12:30 p.m. ‐ 1:30 p.m.

388194 Sara Shearin 9‐317 Expansion of an antimicrobial stewardship program in a 135 bed community hospital, with a focus on intravenous to oral conversion of antimicrobial therapy


11:15 a.m. ‐ 12:15 p.m.

388045 Amrit Sheena 11‐090 Evaluation of empiric antimicrobial therapy for urinary tract infections in the emergency department


1:45 p.m. ‐ 2:45 p.m.

384312 Shelby Shemanski

12‐069 Evaluation of clinical efficacy utilizing adjusted body weight for daptomycin dosing


3:00 p.m. ‐ 4:00 p.m.

387202 Stephanie Sheng 12‐319 Appropriate target‐specific oral anticoagulant utilization within a community hospital


3:00 p.m. ‐ 4:00 p.m.

387400 Liliana Sherman 10‐022 Number of encounters required to achieve blood pressure (BP) control in hypertensive patients: a retrospective study


12:30 p.m. ‐ 1:30 p.m.

384643 Sahil Sheth 8‐288 Incidence of acute kidney injury after treatment with vancomycin in combination with piperacillin‐tazobactam or cefepime for non‐ICU patients at a community hospital


10:00 a.m. ‐ 11:00 a.m.

389395 Samantha Shi 12‐320 Impact of pharmacist involvement in an interdisciplinary palliative care team at an acute care hospital


3:00 p.m. ‐ 4:00 p.m.


Page | 210

Session ID


Title Date Time

389249 Yi Shi 12‐321 Pilot Project to Investigate Role of Clinical Pharmacist in Screening High‐risk Hypoglycemic Patients at the San Francisco Veterans Affairs Health Care System (SFVAHCS)


3:00 p.m. ‐ 4:00 p.m.

386613 Olga Shimunova 10‐207 Evaluation of micafungin and tigecycline use: a pre‐post analysis


12:30 p.m. ‐ 1:30 p.m.

386815 Jae Shin 12‐322 Evaluation of vaccine standardization compliance throughout medical group offices within a community health system


3:00 p.m. ‐ 4:00 p.m.

386359 Naon Shin 11‐256 Development and implementation of a sleep protocol for mechanically ventilated patients in the critical care unit


1:45 p.m. ‐ 2:45 p.m.

385702 Denver Shipman 9‐090 Embedding pharmacists in primary care clinics: factors increasing provider acceptance and utilization of newly‐established collaborative drug therapy management (CDTM) services


11:15 a.m. ‐ 12:15 p.m.

386651 Clare Siebenberger

10‐249 Utilization of sodium ferric gluconate at a community hospital


12:30 p.m. ‐ 1:30 p.m.

386167 Kelsey Siebold 10‐250 Duration of anticoagulation after provoked VTE: a review of current practices


12:30 p.m. ‐ 1:30 p.m.

385884 Sarah Sienko 12‐284 Characterization of tranexamic acid use in trauma and surgery


3:00 p.m. ‐ 4:00 p.m.


Page | 211

Session ID


Title Date Time

387231 Alison Sigler 10‐251 Evaluating the impact of an emergency medicine pharmacist (EMP) in a community hospital with an existing pharmacy technician led medication reconciliation pilot program


12:30 p.m. ‐ 1:30 p.m.

389355 Amanda Sihabout

12‐323 Evaluating perioperative antibiotic prescribing patterns for transurethral resection of prostate (TURP) and bladder resection procedures at a VA healthcare facility


3:00 p.m. ‐ 4:00 p.m.

388225 Francisco Silva 9‐016 Impact of bariatric surgery on chronic disease, healthcare costs, and quality of life in a native american population


11:15 a.m. ‐ 12:15 p.m.

387264 Katelyn Simmons 9‐053 Review of the management of the hepatitis C population being treated with ledipasvir/sofosbuvir in an ambulatory setting


11:15 a.m. ‐ 12:15 p.m.

388412 Samuel Simon 11‐318 Ceftazidime/avibactam for carbapenem resistant hospital acquired pneumonia: a case series


1:45 p.m. ‐ 2:45 p.m.

387258 Brent Simpkins 9‐232 Evaluation of an insulin infusion protocol for diabetic ketoacidosis at a rural, community teaching hospital


11:15 a.m. ‐ 12:15 p.m.

385217 Rachel Simpkins 8‐289 Comparing fracture risk assessment tool (FRAX) prediction with and without bone mineral density (BMD) in male veterans with previous fracture


10:00 a.m. ‐ 11:00 a.m.


Page | 212

Session ID


Title Date Time

385756 Amrita Singh 12‐070 Evaluation of the appropriate use of eculizumab at two academic medical centers


3:00 p.m. ‐ 4:00 p.m.

382643 Amanda Singrey 8‐089 Access to breathing medications in an uninsured and underinsured patient population


10:00 a.m. ‐ 11:00 a.m.

385858 Alyssa Sinkov 9‐153 Discordance between aPTT and anti‐Xa levels during heparin infusion: outcomes in cirrhotic and renal failure patients


11:15 a.m. ‐ 12:15 p.m.

387078 Heather Sirek 12‐324 Comparison of ceftriaxone plus either doxycycline or azithromycin in the treatment of non‐ICU Veteran patients with community‐acquired pneumonia: a non‐inferiority study


3:00 p.m. ‐ 4:00 p.m.

389535 Dennis Sison 9‐318 Evaluation of the Impact of Medication Therapy Management on Opioid Overutilization


11:15 a.m. ‐ 12:15 p.m.

386833 Danny Situ 12‐021 Characterization of liposomal bupivacaine's impact upon orthopedic surgery outcomes


3:00 p.m. ‐ 4:00 p.m.

387476 Nicholas Skezas 8‐072 ACE inhibitor induced angioedema: selecting appropriate therapies


10:00 a.m. ‐ 11:00 a.m.

389499 Mark Skildum 11‐091 Impact of the presence of a pharmacist in the emergency department on ischemic stroke outcomes in patients receiving tissue plasminogen activator (tPA).


1:45 p.m. ‐ 2:45 p.m.


Page | 213

Session ID


Title Date Time

389385 Melissa Slattery 11‐257 Developing an assessment tool and protocol to decrease the rates of Clostridium difficile infection in a community hospital setting


1:45 p.m. ‐ 2:45 p.m.

389005 Aaron Sloan 12‐325 Clinical outcomes of generic warfarin manufacturer substitution in the Department of Veterans Affairs


3:00 p.m. ‐ 4:00 p.m.

383298 Lindsey Slusher 9‐319 Retrospective analysis of extended infusion piperacillin‐tazobactam in morbidly obese patients in a community hospital


11:15 a.m. ‐ 12:15 p.m.

385214 Stephen Small 10‐127 Comparison of adverse effects and efficacy of two continuous nafcillin infusion regimens


12:30 p.m. ‐ 1:30 p.m.

386684 Bethany Smith 12‐071 Impact of a critical care pharmacist in a multidisciplinary ventilator optimization initiative in a community hospital intensive care unit


3:00 p.m. ‐ 4:00 p.m.

384383 Danielle Smith 9‐233 Evaluation of the efficacy and safety of tolvaptan in adult patients with refractory SIADH secondary to traumatic brain injury or non‐traumatic intracranial hemorrhage.


11:15 a.m. ‐ 12:15 p.m.

384388 Hilary Smith 8‐186 Pharmacist Involvement in Pre‐operative and Post‐operative Optimization of Medication Therapy


10:00 a.m. ‐ 11:00 a.m.

387785 Katherine Smith 12‐326 Interruption of warfarin therapy in patients undergoing procedures: a quality improvement project


3:00 p.m. ‐ 4:00 p.m.


Page | 214

Session ID


Title Date Time

388438 Matthew Smith 10‐208 Evaluation of the impact of pharmacist‐driven utilization of oritavancin in a community hospital emergency department


12:30 p.m. ‐ 1:30 p.m.

388898 Melissa Smith 10‐278 Implementation of barcode verification for sterile product compounding


12:30 p.m. ‐ 1:30 p.m.

388097 Sean Smithgall 8‐187 Influence on readmission rates after participation in an interprofessional transitional care clinic


10:00 a.m. ‐ 11:00 a.m.

385566 Julie Smithson 12‐327 Comprehensive review of the utilization of IV unfractioned heparin


3:00 p.m. ‐ 4:00 p.m.

386366 Jessica Snead 10‐293 Evaluation of mycophenolate dosing for orthotopic heart transplant recipients


12:30 p.m. ‐ 1:30 p.m.

385904 Andy Snyder 12‐328 Incorporation of a novel vancomycin nomogram into a standard vancomycin dosing protocol at a community hospital: effect on vancomycin utilization and safety


3:00 p.m. ‐ 4:00 p.m.

388032 Shirley So 9‐154 Impact of pharmacy services on discharge medication reconciliation and improving transitions of care for pneumonia and COPD patients


11:15 a.m. ‐ 12:15 p.m.

387950 Jennifer Sobeck 12‐329 Design and implementation of a pre‐diabetes pathway to assist in diabetes diagnosis prevention and proper alignment of care


3:00 p.m. ‐ 4:00 p.m.

385801 minoosh sobhanian

11‐297 Risk factors for the development of venous thromboembolisms in neurocritical care patients


1:45 p.m. ‐ 2:45 p.m.


Page | 215

Session ID


Title Date Time

387792 Kristine Sobolewski

9‐234 Implementation of antibiotic stewardship practices targeting urinary tract infections through a real time reporting system


11:15 a.m. ‐ 12:15 p.m.

387726 Loriel Solodokin 12‐330 Safety profile of carfilzomib when infused over 10 minutes versus 30 minutes: a cohort study


3:00 p.m. ‐ 4:00 p.m.

389242 Cassandra Song 12‐331 Impact of implementing the CHA2DS2‐VASc for stroke risk evaluation in veterans with atrial fibrillation in a Veterans Administration anticoagulation clinic


3:00 p.m. ‐ 4:00 p.m.

387760 Matthew Song 12‐332 Analgesia, sedation, and delirium monitoring practices and patient outcomes following the implementation of an order set and provider education: a clinical practice improvement project


3:00 p.m. ‐ 4:00 p.m.

387507 Vincent Soriano 12‐072 Characterization of free phenytoin concentrations in end stage renal disease using the modified Winter‐Tozer equation


3:00 p.m. ‐ 4:00 p.m.

385690 Cindi Sounthonevat

12‐333 Utilization of therapeutic interchanges to improve access to medications in a low‐income uninsured population


3:00 p.m. ‐ 4:00 p.m.

386170 Elizabeth Spears 9‐155 Effect of maintenance intravenous fluids on new‐onset atrial fibrillation in critically ill adults


11:15 a.m. ‐ 12:15 p.m.


Page | 216

Session ID


Title Date Time

386039 Samantha Spishock

9‐156 Comparison of pediatric outpatient antibiotic prescribing patterns for specified indications in primary care practices


11:15 a.m. ‐ 12:15 p.m.

389169 Stevan Squires 12‐334 Pharmacist implementation of a chronic heart failure pharmacotherapy clinic using 2013 ACCF/AHA guidelines to optimize medication therapy


3:00 p.m. ‐ 4:00 p.m.

389331 Kirbie St. James 10‐210 Effects of a medication history process refinement using pharmacy technicians in the emergency department


12:30 p.m. ‐ 1:30 p.m.

385580 Martin St. John 11‐179 Effects of pharmacist intervention on post‐discharge antibiotic therapy and pneumonia readmission rates


1:45 p.m. ‐ 2:45 p.m.

386649 Brooke Stanton 9‐157 Utilization of iron dextran and iron sucrose at a community hospital


11:15 a.m. ‐ 12:15 p.m.

389181 Kelly Starman 12‐335 Evaluation of the Boise VAMC pharmacist‐managed smoking cessation clinic


3:00 p.m. ‐ 4:00 p.m.

388644 Lauren Stauffer 11‐258 Evaluation of the efficiency of a pharmacy‐managed admission medication reconciliation program


1:45 p.m. ‐ 2:45 p.m.

384389 Kenneth Stearns 12‐336 Implementation and evaluation of an antimicrobial stewardship program (ASP) at Claremore Comprehensive Indian Health Care Facility.


3:00 p.m. ‐ 4:00 p.m.

386713 Kathryn Stecklein

11‐051 Impact of rapid detection of respiratory viruses in adult inpatients on anti‐infective use


1:45 p.m. ‐ 2:45 p.m.


Page | 217

Session ID


Title Date Time

387253 Katie Steele 8‐348 Development of a pharmacy technician training program to incorporate walk‐in immunizations into the workflow of a community pharmacy


10:00 a.m. ‐ 11:00 a.m.

388893 Kevin Steele 8‐188 Medication use Evaluation: Assessing prescribing patterns and infusion methods at a large community hospital system.


10:00 a.m. ‐ 11:00 a.m.

385642 Molly Steen 12‐305 Pharmacy and behavioral health: assessing the impact of interdisciplinary collaboration and pharmacy‐driven informatics interventions on a subset of the American Indian/Alaska Native population


3:00 p.m. ‐ 4:00 p.m.

388877 Teodora Cristina Stefan

12‐337 Evaluation of use of benzodiazepines in the treatment of post‐traumatic stress disorder


3:00 p.m. ‐ 4:00 p.m.

386698 Caitlin Stehling 8‐189 The use of intravenous proton pump inhibitors for stress ulcer prophylaxis in pediatric intensive care patients


10:00 a.m. ‐ 11:00 a.m.

386948 Matthew Stephens

11‐092 Emergency department and urgent care antibiotic prescribing patterns for children with acute otitis media


1:45 p.m. ‐ 2:45 p.m.

388985 James Stergios III 12‐285 Evaluation of antibiotic therapy duration in complicated intra‐abdominal infections


3:00 p.m. ‐ 4:00 p.m.


Page | 218

Session ID


Title Date Time

389538 Diana Stewart 10‐294 Knowledge, skills and attitudes regarding medication management in patients with advanced illnesses: an educational needs assessment for surveyors in the state of Maryland


12:30 p.m. ‐ 1:30 p.m.

386375 Zachary Stewart 9‐158 Evaluation of the safety and efficacy of bolus three percent sodium chloride in the management of cerebral edema in adults with stroke


11:15 a.m. ‐ 12:15 p.m.

389145 Cassandra Stith 10‐128 Implementation of clinical pharmacy services at a healthcare for the homeless clinic


12:30 p.m. ‐ 1:30 p.m.

384330 Ashley Stocker 12‐339 Effect of pharmacist‐led Medicare annual wellness visits (AWV) on health maintenance personal prevention plans, medication discrepancies, and health care utilization


3:00 p.m. ‐ 4:00 p.m.

385933 Robyn Stoianovici

8‐290 Evaluation of a vancomycin dosing protocol in adult inpatients with renal impairment


10:00 a.m. ‐ 11:00 a.m.

388606 Nicole Stone 11‐259 Clinical outcomes of 3 different dosing schemes of dabigatran in adults 75 years of age or older: hospital based cohort study


1:45 p.m. ‐ 2:45 p.m.

387665 Carly Stoneman 9‐235 Effect of vancomycin versus linezolid on hospital length of stay in patients with influenza and bacterial pneumonia


11:15 a.m. ‐ 12:15 p.m.


Page | 219

Session ID


Title Date Time

385604 Carolyn Stout 11‐023 Assessing clinical outcomes after a 12‐week pharmacist‐driven, interdisciplinary health and wellness program


1:45 p.m. ‐ 2:45 p.m.

388718 Samantha Straits 11‐052 Efficacy of pharmacist facilitated transitions of care


1:45 p.m. ‐ 2:45 p.m.

386184 Micheal Strein 8‐291 Evaluation of appropriate analgesia and sedation pre versus post implementation of an analgosedation protocol in critically ill patients


10:00 a.m. ‐ 11:00 a.m.

386258 Melissa Striglio 12‐340 Evaluating inpatient empiric antibiotic selection for the treatment of skin and soft tissue infections


3:00 p.m. ‐ 4:00 p.m.

388595 Matthew Stryker 8‐190 Evaluating the off‐label use of once‐weekly exenatide in combination with basal insulin therapy in patients with type 2 diabetes mellitus


10:00 a.m. ‐ 11:00 a.m.

386716 Candi Sturges 10‐052 Medication use evaluation of the pediatric asthma protocol in the emergency department


12:30 p.m. ‐ 1:30 p.m.

388607 Samantha Su 9‐236 Albuterol versus levalbuterol in patients with a history of atrial fibrillation


11:15 a.m. ‐ 12:15 p.m.

384333 Jenny Suen 8‐191 Inpatient pharmacy pain consult to improve patient outcome


10:00 a.m. ‐ 11:00 a.m.

386543 Brandi Sugonis 12‐341 Workflow redesign in a VA outpatient pharmacy to improve prescription wait times and veteran satisfaction


3:00 p.m. ‐ 4:00 p.m.


Page | 220

Session ID


Title Date Time

384630 Christina Suguitan

12‐342 Evaluation of anti‐methicillin‐resistant Staphylococcus aureus therapy continuation and discontinuation based on MRSA nares testing in Veteran patients admitted with pneumonia


3:00 p.m. ‐ 4:00 p.m.

387236 Rand Sulaiman 10‐211 Evaluation of de‐escalation of empirically initiated broad‐spectrum antibiotics in patients diagnosed with healthcare‐associated pneumonia


12:30 p.m. ‐ 1:30 p.m.

388745 Danine Sullinger 11‐260 Development and implementation of a delirium protocol in the surgical trauma intensive care unit


1:45 p.m. ‐ 2:45 p.m.

389132 Nataliya Sulyk 10‐129 Evaluation of the clinical and economic impact of ideal body weight dosing for intravenous immune globulin in idiopathic thrombocytopenic purpura (ITP)


12:30 p.m. ‐ 1:30 p.m.

388817 Michele Summerville

10‐130 Nephrogenic diabetes insipidus as a result of historic lithium use precipitated by poor oral intake


12:30 p.m. ‐ 1:30 p.m.

385365 Jacob Sumner 9‐091 Improving appropriate proton‐pump inhibitor use in patients on dual antiplatelet therapy


11:15 a.m. ‐ 12:15 p.m.

387297 Yihan Sun 12‐286 Optimization of renal sparing immunosuppression to prevent renal failure in liver transplant patients


3:00 p.m. ‐ 4:00 p.m.


Page | 221

Session ID


Title Date Time

388245 Hanna Sung 10‐045 Clinical outcomes of NPH/regular 70/30 versus insulin glargine in insulin‐naive type 2 patients with diabetes uncontrolled by oral antidiabetics in the outpatient setting


12:30 p.m. ‐ 1:30 p.m.

386895 Emily Supenia 10‐212 Evaluation of pharmacist impact on an emergency department culture follow‐up program


12:30 p.m. ‐ 1:30 p.m.

385685 Steven Swank 12‐287 Competency outcome evaluation before and after international exchanges of pharmacy faculty and practicing pharmacists from developing countries


3:00 p.m. ‐ 4:00 p.m.

387548 Gary Sweet 8‐292 Effects of home psychotropic medication reinitiation in ICU patients with a history of mental illness


10:00 a.m. ‐ 11:00 a.m.

385888 Michelle Sweet 8‐192 Thrombus risk reduction in antiphospholipid syndrome patients monitored by factor II activity assay


10:00 a.m. ‐ 11:00 a.m.

388813 Alexa Szelc 9‐159 Retrospective review of patients receiving intravenous acyclovir and the incidence of nephrotoxicity


11:15 a.m. ‐ 12:15 p.m.

386797 Michael Ta 9‐320 Effect of morphine and hydromorphone on blood pressure after a single intravenous dose in critically ill patients


11:15 a.m. ‐ 12:15 p.m.


Page | 222

Session ID


Title Date Time

386582 Thanh Ta 11‐213 Assessing the impact of pre‐discharge bundle on reducing 30‐day readmissions of patients with chronic obstructive pulmonary disease (COPD)


1:45 p.m. ‐ 2:45 p.m.

384771 Menilik Tadesse 8‐193 Impact of pharmacist‐led medication education on the pharmacy care experience of high‐risk hospitalized patients


10:00 a.m. ‐ 11:00 a.m.

384721 Khalid Taher 11‐193 Impact of restrictive ciprofloxacin susceptibility reporting on resistance and utilization in gram‐negative bacteria in a tertiary care hospital


1:45 p.m. ‐ 2:45 p.m.

386106 Lindsey Takara 8‐322 Intravenous heparin therapy for full dose and cardiac protocols: dose optimization in elderly and obese patients


10:00 a.m. ‐ 11:00 a.m.

387933 Bryson Tamanaha

12‐343 Assessing provider adherence to recommendations against the use of combination angiotensin‐converting enzyme inhibitor and angiotensin receptor blocker therapy at a Veterans Affairs medical center


3:00 p.m. ‐ 4:00 p.m.

389579 Diana Tamer 8‐194 Impact of time to antibiotic initiation on mortality in septic patients admitted through the emergency department at a community hospital system


10:00 a.m. ‐ 11:00 a.m.

387524 Kathy Tang 12‐344 Managing albumin use in the ICU: using a collaborative approach


3:00 p.m. ‐ 4:00 p.m.


Page | 223

Session ID


Title Date Time

389666 Shidie Tang 12‐073 Acquired methemoglobinemia secondary to lidocaine injection


3:00 p.m. ‐ 4:00 p.m.

389357 Stephanie Tang 8‐195 Development of a pharmacist‐driven transitions of care model in an acute care community hospital


10:00 a.m. ‐ 11:00 a.m.

387511 Heather Tanner 12‐345 Evaluation of diabetes outcomes in a pharmacist‐managed insulin titration program


3:00 p.m. ‐ 4:00 p.m.

388743 Natalie Tapley 9‐237 Evaluating the appropriateness of dosing for select novel oral anticoagulants and risk of complications in an inpatient setting


11:15 a.m. ‐ 12:15 p.m.

385429 Christopher Tassen

11‐261 Use of electronic tracking system to decrease missing medications


1:45 p.m. ‐ 2:45 p.m.

386491 Morgan Taylor 10‐328 Evaluation of current prescribing patterns for Clostridium difficile infection and the implementation of an order‐set.


12:30 p.m. ‐ 1:30 p.m.

387966 Sarah Teasdale 12‐346 Enhancing antibiotic stewardship in a private not‐for‐profit tertiary care hospital


3:00 p.m. ‐ 4:00 p.m.

387108 Shannon Tellier 11‐262 Baseline characteristics of oral anticoagulant use in an urban academic medical center


1:45 p.m. ‐ 2:45 p.m.

389194 Gene Terkoski 10‐295 Return on investment (ROI) analysis for medication therapy management (MTM) services provided within a commercial patient population


12:30 p.m. ‐ 1:30 p.m.


Page | 224

Session ID


Title Date Time

384720 Erin Terranova 11‐319 Incidence of Acute Kidney Injury Before and After the Implementation of an Extended Interval Infusion for Zosyn and a CHI Health standardized Vancomycin Dosing Protocol


1:45 p.m. ‐ 2:45 p.m.

387172 Salma Tewfik 9‐238 Utilizing lean principles to implement a pharmacist‐led discharge counseling program


11:15 a.m. ‐ 12:15 p.m.

387152 Khushbu Thaker 12‐211 Evaluation of physician and nursing adherence to a sedation and analgesia protocol in mechanically ventilated patients


3:00 p.m. ‐ 4:00 p.m.

388931 Alexis Thayer 8‐349 Perioperative factors associated with surgical site infection in patients undergoing peripheral vascular bypass surgery


10:00 a.m. ‐ 11:00 a.m.

384715 Samantha Themas

8‐293 Use of oritavancin for treatment of acute bacterial skin and skin structure infections (ABSSSIs) in outpatients: a retrospective quality analysis


10:00 a.m. ‐ 11:00 a.m.

385677 Meghan Thibeaux

12‐347 Comparison of a multi‐modal blood glucose control plan before and after initiation in diabetic open vascular surgery patients


3:00 p.m. ‐ 4:00 p.m.

384292 Kaci Thiessen 8‐323 Prescribing practices for community‐acquired pneumonia in the Sooner Health Access Network Medicaid population: identifying opportunities for antimicrobial stewardship


10:00 a.m. ‐ 11:00 a.m.


Page | 225

Session ID


Title Date Time

387754 Ryan Thimes 12‐074 Implementation of the blue ocean leadership strategy in the pharmacy setting and the impact on employee engagement and satisfaction


3:00 p.m. ‐ 4:00 p.m.

385676 Ashley Thomas 12‐348 Limiting warfarin tablet strengths in veterans


3:00 p.m. ‐ 4:00 p.m.

386040 Lindsey Thomas 8‐196 Evaluation of suspected heparin‐induced thrombocytopenia (HIT) management in a community hospital


10:00 a.m. ‐ 11:00 a.m.

389010 Sarah Thomas 10‐329 Real‐world effectiveness of an 8‐week course of fixed‐dose ledipasvir and sofosbuvir therapy for the treatment of Hepatitis C in a specialty pharmacy setting


12:30 p.m. ‐ 1:30 p.m.

388920 Shanada Thomas 12‐350 Evaluation of physician led oral chemotherapy management within a large health‐systems outpatient cancer center


3:00 p.m. ‐ 4:00 p.m.

387325 Rebecca Thompson

10‐252 Outcomes from implementation of rapid identification test for detection of gram‐positive and gram‐negative bacteria into a pharmacist‐directed antimicrobial stewardship protocol for pediatric patients


12:30 p.m. ‐ 1:30 p.m.

387884 Tonisha Thompson

8‐197 Pharmacists impact on increasing cure rates among hepatitis C patients in an outpatient setting


10:00 a.m. ‐ 11:00 a.m.

385134 Kyle Thorner 8‐324 Evaluation of a warfarin dosing nomogram at a large community hospital


10:00 a.m. ‐ 11:00 a.m.


Page | 226

Session ID


Title Date Time

388004 Megan Tibbitts 9‐321 Evaluating antibiotic administration times in the emergency department at an academic medical center


11:15 a.m. ‐ 12:15 p.m.

385934 Elizabeth Tien 12‐075 Implementation and promotion of Better Health Pharmacy: a county medication repository program


3:00 p.m. ‐ 4:00 p.m.

388873 Matthew Timmons

9‐322 Evaluation of clinician utilization of a respiratory PCR panel in conjunction with procalcitonin and BNP to guide antimicrobial therapy in hospitalized patients with suspected respiratory tract infections: A before and after study.


11:15 a.m. ‐ 12:15 p.m.

384575 Samad Tirmizi 8‐090 Evaluation of interactions with anti‐infective agents and immunosuppressive therapy in a tertiary care center


10:00 a.m. ‐ 11:00 a.m.

387166 Lauren Titterington

12‐288 Induced hypothermia and shivering: an evaluation of two management strategies in an urban health system


3:00 p.m. ‐ 4:00 p.m.

386138 Krystal Titus‐Rains

12‐351 Durations of treatment response in veterans with multiple myeloma at the Durham Veteran's Administration Medical Center


3:00 p.m. ‐ 4:00 p.m.

388990 Allison Todd 11‐263 Implementation of a pharmacy pain management service to improve patient safety and overall pain outcomes


1:45 p.m. ‐ 2:45 p.m.

387181 Matthew Todd 12‐076 Development of a Dynamic Drug Procurement Process in a Closed System Dispensing Pharmacy


3:00 p.m. ‐ 4:00 p.m.


Page | 227

Session ID


Title Date Time

385300 Alec Toews 10‐296 Comparison of acute kidney injury in the neonatal population between treatment with piperacillin/tazobactam or piperacillin/tazobactam plus vancomycin


12:30 p.m. ‐ 1:30 p.m.

385872 Tara Tokar 10‐131 Safety and efficacy of rapid intravenous titration of sodium nitroprusside to oral vasodilators in advanced low‐output heart failure


12:30 p.m. ‐ 1:30 p.m.

386120 Rebecca Tokarski 12‐352 Evaluation of Pharmacy Services in the Emergency Department at Magee‐Womens Hospital of UPMC


3:00 p.m. ‐ 4:00 p.m.

388396 Diem Ton 8‐198 Impact of pharmacists providing bedside discharge prescription service at a pediatric hospital


10:00 a.m. ‐ 11:00 a.m.

386213 Nicholas Torney 11‐264 Implementation of a pharmacist‐managed penicillin skin testing service at a community teaching hospital


1:45 p.m. ‐ 2:45 p.m.

385425 Annie Torosyan 8‐199 Pharmacist‐managed bacteremia treatment compared to the historical standard of care in a community hospital emergency department


10:00 a.m. ‐ 11:00 a.m.

387094 Meghan Toth 10‐213 Evaluation of meropenem use in a free‐standing pediatric hospital: a retrospective chart review


12:30 p.m. ‐ 1:30 p.m.

384781 Maria Tovar 8‐200 Prostate specific antigen as predictive factor of response to abiraterone in real‐life conditions


10:00 a.m. ‐ 11:00 a.m.


Page | 228

Session ID


Title Date Time

387128 Caroline Townley

11‐180 Comparison of grade IV neutropenia with pegfilgrastim administered by two delivery methods: on‐body injector and manual injection with a prefilled syringe


1:45 p.m. ‐ 2:45 p.m.

388603 Aaron Tran 12‐353 Antipsychotic‐induced urinary incontinence with a focus on risperidone


3:00 p.m. ‐ 4:00 p.m.

383709 Ann Tran 10‐046 The effect of cefepime intravenous push versus intravenous piggyback on time to administration of vancomycin in the emergency department


12:30 p.m. ‐ 1:30 p.m.

387956 Emmeline Tran 9‐175 Prescribing accuracy of novel oral anticoagulant (NOAC) dosing for venous thromboembolism (VTE) treatment and prophylaxis


11:15 a.m. ‐ 12:15 p.m.

387802 Hai Quyen Tran 9‐028 Safety and efficacy of liposomal bupivacaine for postoperative pain management in pediatric patients undergoing spinal surgery


11:15 a.m. ‐ 12:15 p.m.

387574 Jennifer Tran 12‐306 Evaluation of procalcitonin for antibiotic streamlining in critically ill patients


3:00 p.m. ‐ 4:00 p.m.

386304 Loan Tran 11‐265 Utilization of lean six sigma methodology to improve pharmacy workflow in an oncology clinic


1:45 p.m. ‐ 2:45 p.m.

386642 Nhi Tran 10‐214 Design of a pilot pharmacist‐driven inpatient pain consult service and opioid stewardship program at a Veterans Affairs (VA) medical center


12:30 p.m. ‐ 1:30 p.m.


Page | 229

Session ID


Title Date Time

389091 Tam Tran 10‐297 Assessment of albuterol metered‐dose inhaler versus albuterol nebulizer in pediatric patients with asthma


12:30 p.m. ‐ 1:30 p.m.

389282 Trang Tran 12‐354 Case of cardiomyopathy likely induced by clozapine


3:00 p.m. ‐ 4:00 p.m.

386504 Victor Tran 8‐201 Integration of medication therapy management into a complex care management program at a federally qualified health center


10:00 a.m. ‐ 11:00 a.m.

386693 Gregory Trietley 10‐330 Prevalence of drug therapy problems related to urinary tract infection treatment after positive urinalysis in the emergency department


12:30 p.m. ‐ 1:30 p.m.

388372 Ken Trinh 12‐077 Evaluation of a Heparin Infusion Protocol Dosed Using Adjusted Body Weight in Acute Patients with Venous Thromboembolism or Cardiovascular Indications


3:00 p.m. ‐ 4:00 p.m.

388178 TUAN TRINH 12‐355 Implementation of a nursing education program to improve patient satisfaction with pain management in a community teaching hospital


3:00 p.m. ‐ 4:00 p.m.

387245 Gia Troisi 12‐356 Implementation of a Guideline for PPI Use on the General Medical Floors of a Community Health System


3:00 p.m. ‐ 4:00 p.m.

386828 Deni Trone 9‐323 Analysis of predictive factors leading to delayed clearance in pediatric patients who received high dose methotrexate


11:15 a.m. ‐ 12:15 p.m.


Page | 230

Session ID


Title Date Time

386412 Carly Trowbridge 11‐320 Comparing time to readmission or mortality in inpatients with dementia: antipsychotic use versus no antipsychotic use for behavioral disturbances


1:45 p.m. ‐ 2:45 p.m.

387622 Sabrina Truc 12‐357 Comprehensive review of the perioperative bridge protocol utilized at the Veterans Affairs Western New York (VA WNY) Healthcare System


3:00 p.m. ‐ 4:00 p.m.

388682 Lance Trujillo 10‐132 Evaluation of time to first antibiotic dose administered in patients presenting to the emergency department at a community hospital


12:30 p.m. ‐ 1:30 p.m.

385225 Elaine Truong 8‐325 Cardiovascular outcomes related to testosterone supplementation in a male veteran population (CORTS)


10:00 a.m. ‐ 11:00 a.m.

386912 Huong Truong 12‐358 Development of an evidence‐based, cost‐effective, step‐wise practice guideline for mucositis assessment, prevention and management


3:00 p.m. ‐ 4:00 p.m.

388635 Sean Truong 12‐359 Impact of an interventional group appointment regarding opioid safety and distribution of naloxone kits in a veteran population


3:00 p.m. ‐ 4:00 p.m.

386112 Stacy Tse 12‐185 Evaluating the efficacy, appropriateness, and tolerability of saxagliptin in patients with type 2 diabetes mellitus in an outpatient setting


3:00 p.m. ‐ 4:00 p.m.


Page | 231

Session ID


Title Date Time

389014 Melissa Tsiu 10‐133 Effect of adequate fluid resuscitation and appropriate antibiotic therapy on mortality and length of stay in patients with sepsis


12:30 p.m. ‐ 1:30 p.m.

387011 Mandi Tsoi 8‐202 Evaluating the use of intrathecal chemotherapy to achieve remission and transplant eligibility in patients with neoplastic meningitis


10:00 a.m. ‐ 11:00 a.m.

386672 Patrick Tu 12‐360 Avoidance of double anaerobic coverage while improving outcomes in clostridium difficile infections at a veterans affairs medical center


3:00 p.m. ‐ 4:00 p.m.

387169 Brittany Turner 10‐263 Evaluation of symptom management and patient outcomes following total hip and knee arthroplasties


12:30 p.m. ‐ 1:30 p.m.

389551 Jazmin Turner 9‐029 Impact of a pharmacist on reducing use of proton pump inhibitors in high risk elderly populations in an ambulatory care setting


11:15 a.m. ‐ 12:15 p.m.

386585 Kyle Turner 11‐024 A multiple health system approach to improve the quality of care transitions through medication management


1:45 p.m. ‐ 2:45 p.m.

389261 Alyssa Tuttle 8‐350 Impact of a pharmacy driven protocol for methicillin resistant Staphylococcus aureus nucleic acid amplification nasal swab test on the duration of therapy with vancomycin


10:00 a.m. ‐ 11:00 a.m.


Page | 232

Session ID


Title Date Time

385716 June Twiggs 12‐361 Conservative versus moderate intensity blood glucose management in postoperative cardiac surgery patients


3:00 p.m. ‐ 4:00 p.m.

388768 Kelsey Tyson 8‐294 Efficacy and safety of basal bolus insulin order set in non‐critically ill hospitalized patients


10:00 a.m. ‐ 11:00 a.m.

387589 Kathleen Ubina 11‐266 Impact of pharmacist‐led diabetic education on 30 day‐readmission rates


1:45 p.m. ‐ 2:45 p.m.

388363 Stepan Uhlyar 8‐295 Implementation of a pharmacy driven hyperglycemia optimization for diabetic patients in an acute care inpatient psychiatric setting


10:00 a.m. ‐ 11:00 a.m.

387718 Brantley Underwood

10‐253 Medication adherence rates utilizing a community pharmacy‐based mobile application


12:30 p.m. ‐ 1:30 p.m.

387470 Kelsi Upmann 11‐267 Assessment of impact for patients who are concurrently on antiretroviral therapy (ART) and a P2Y12 inhibitor


1:45 p.m. ‐ 2:45 p.m.

385880 Amulya Uppala 9‐324 Cost‐savings associated with pharmacist‐driven intravenous to oral interchange policy


11:15 a.m. ‐ 12:15 p.m.

387874 Lourie Ann Urbano

12‐362 Evaluation of antimicrobial prophylaxis for preventing surgical site infection at a Veterans Affairs hospital


3:00 p.m. ‐ 4:00 p.m.

387923 Eric Urnoski 12‐078 Impact of oral vancomycin prophylaxis on the occurrence of Clostridium difficile infection in allogeneic hematopoietic stem cell transplant recipients


3:00 p.m. ‐ 4:00 p.m.


Page | 233

Session ID


Title Date Time

385140 Natalia Uzal 12‐363 Pharmacists Impact on Discharge Medication Reconciliation and Patient Satisfaction


3:00 p.m. ‐ 4:00 p.m.

386286 Nina Vadiei 9‐239 Impact of norepinephrine weight‐based dosing compared to non‐weight‐based dosing in achieving time to goal mean arterial pressure in obese patients with septic shock


11:15 a.m. ‐ 12:15 p.m.

389325 Dreana Valenciano

9‐333 Evaluation of a cost‐savings initiative for use of lipoglycopeptide antibiotics in the emergency department (ED)


11:15 a.m. ‐ 12:15 p.m.

388455 Natalie Valentino

12‐364 Increasing utilization of overdose education and naloxone distribution (OEND) in a Veterans Affairs (VA) primary care clinic


3:00 p.m. ‐ 4:00 p.m.

386886 Anuja Vallabh 9‐030 Improving transitions of care through pharmacist led discharge counseling on an acute inpatient psychiatric unit


11:15 a.m. ‐ 12:15 p.m.

385887 Kelsey Van Gorkom

12‐365 Risk of bleeding and systemic embolism: a comparison of target‐specific oral anticoagulants and warfarin in a setting with increased time in therapeutic range


3:00 p.m. ‐ 4:00 p.m.

388070 Michael Van Sistine

9‐092 Effects of sedative selection and dose for emergency department procedural sedation on adverse events and length of stay


11:15 a.m. ‐ 12:15 p.m.


Page | 234

Session ID


Title Date Time

387377 Brenden Van Slyke

9‐160 Evaluation of a pharmacy resident impact on venous thromboembolism prophylaxis and treatment in a community teaching hospital


11:15 a.m. ‐ 12:15 p.m.

387816 Jocelyn Van Vickle

10‐279 Management of diabetic ketoacidosis (DKA) in the emergency department: a retrospective analysis


12:30 p.m. ‐ 1:30 p.m.

387383 Derek VanderHorst

12‐289 Implementation of a health‐system wide antimicrobial stewardship program at two remote community hospitals


3:00 p.m. ‐ 4:00 p.m.

385606 Jennifer Vanderploeg

11‐093 Use of sub‐dissociative dose ketamine to reduce opioid use in the emergency department for patients with moderate‐to‐severe pain


1:45 p.m. ‐ 2:45 p.m.

386701 Lauren VanHook 12‐079 Evaluation of a newly implemented pharmacist driven warfarin collaborative practice: assessing uptake, quality, and outcomes in an inpatient setting


3:00 p.m. ‐ 4:00 p.m.

388170 Erin VanMeter 10‐254 Expansion of pharmacy services through implementation of an interdisciplinary diabetes shared medical appointment


12:30 p.m. ‐ 1:30 p.m.

385749 Valana Vannoy 11‐268 Retrospective evaluation of initial maintenance caffeine dose and successful first‐time extubation


1:45 p.m. ‐ 2:45 p.m.

389130 Jocelyn VanOpdorp

9‐093 Patient reported outcomes from a ritonavir to cobicistat simplification study.


11:15 a.m. ‐ 12:15 p.m.


Page | 235

Session ID


Title Date Time

389073 Alexandra Varga 11‐298 Impact of the implementation of matrix‐assisted laser desorption ionization time‐of‐flight (MALDI‐TOF) mass spectrometry on time to effective and optimal antimicrobial therapy in gram‐positive bacteremias


1:45 p.m. ‐ 2:45 p.m.

386563 Yhanique Vassell, PharmD

11‐025 Utilization of a Pharmacist on geriatric rounds to evaluate and assess the dispensing of inappropriate mediations and 30 day readmissions.


1:45 p.m. ‐ 2:45 p.m.

388242 Allie Vecchiet 10‐255 Measuring the impact of in‐house specialty pharmacy services on medication adherence in a cystic fibrosis population


12:30 p.m. ‐ 1:30 p.m.

387278 Evan Venturella 12‐022 Efficacy of fosfomycin for the treatment of vancomycin‐resistant enterococci urinary tract infections.


3:00 p.m. ‐ 4:00 p.m.

385837 Martein Vernon 12‐366 Effectiveness and safety of hepatitis C treatment with direct‐acting antivirals (DAAs) in a veteran population


3:00 p.m. ‐ 4:00 p.m.

389045 Egor Veselov 12‐307 Implementation of a resident‐led pharmacy technician certification program in a teaching hospital


3:00 p.m. ‐ 4:00 p.m.

389526 Katherine Viale 8‐351 Medication reconciliation and discharge counseling for patients on the cardiac step‐down unit: expansion of transitions of care services at PeaceHealth Southwest Medical Center


10:00 a.m. ‐ 11:00 a.m.


Page | 236

Session ID


Title Date Time

387859 Laine Vicarel 8‐054 Peri‐procedural international normalized ratio (INR) control in patients receiving continuous warfarin therapy for catheter ablation of atrial fibrillation


10:00 a.m. ‐ 11:00 a.m.

385591 Katherine Vicinanza

12‐367 A retrospective evaluation of iron supplementation practices in an outpatient pharmacy‐run Erythropoietin Clinic at a VA facility


3:00 p.m. ‐ 4:00 p.m.

386680 Jennifer Vidal 11‐056 Multicenter evaluation of the impact of weight estimations on anticoagulation reversal with 4‐factor prothrombin complex concentrate (PCC) in the emergency department


1:45 p.m. ‐ 2:45 p.m.

387607 Jessica Vigneau 8‐203 Warfarin overlap with parenteral anticoagulation for venous thromboembolism: a targeted intervention to improve measure compliance


10:00 a.m. ‐ 11:00 a.m.

387262 Isabel Viguera‐Guerra

8‐352 Influence of ribavirin on peginterferon‐free direct‐acting antiviral based regimens in nave patients chronically infected by hepatitis C virus genotype 1: a systematic review and meta‐analysis.


10:00 a.m. ‐ 11:00 a.m.

388529 Juan Villanueva 12‐368 Evaluation of the appropriate use of posaconazole at an academic medical center following the implementation of criteria to guide use


3:00 p.m. ‐ 4:00 p.m.


Page | 237

Session ID


Title Date Time

389600 Jill Anne Villarosa

10‐215 Impact on adherence to sepsis bundles following implementation of a revised sepsis order set and multidisciplinary education


12:30 p.m. ‐ 1:30 p.m.

387147 Alexis Villarreal 11‐181 Evaluating transitions of care services performed by pharmacists in high risk patients


1:45 p.m. ‐ 2:45 p.m.

385238 Zakarri Vinson 11‐299 Evaluation of MIC data to determine the potential benefit of double coverage of Pseudomonas aeruginosa and other gram negative bacilli at a large academic center


1:45 p.m. ‐ 2:45 p.m.

387208 Jennifer Vipond 8‐296 Impact of adverse events related to the co‐administration of diazepam with protease inhibitors or cobicistat


10:00 a.m. ‐ 11:00 a.m.

389596 Cassandra Vo 9‐054 Evaluation of fixed‐dose scheme for 4‐factor prothrombin complex concentrate (4F‐PCC) on urgent warfarin reversal


11:15 a.m. ‐ 12:15 p.m.

389033 Kim Vo 12‐186 Initiation of target‐specific oral anticoagulants for atrial fibrillation and venous thromboembolism: impact on time to hospital discharge


3:00 p.m. ‐ 4:00 p.m.

387976 Ngoc (Kathy) Vo 9‐094 Efficacy of a pharmacist driven vancomycin dosing service in a community hospital


11:15 a.m. ‐ 12:15 p.m.

384764 Trang Vo 8‐297 Impact of a clinical decision support system (CDSS) on time to ordered appropriate antibiotic therapy in gram negative bacteremia


10:00 a.m. ‐ 11:00 a.m.


Page | 238

Session ID


Title Date Time

387539 Calla Vodoor 12‐290 Clinical outcomes and costs associated with pre and post initiation of cystic fibrosis transmembrane conductance regulator potentiating agents in managed care medicaid plans


3:00 p.m. ‐ 4:00 p.m.

386043 Tiffany Vogeler 11‐182 Proton pump inhibitor (PPI) use: impact of in‐service education to health care providers on prescribing patterns


1:45 p.m. ‐ 2:45 p.m.

389625 Julia Vorotnikova 11‐116 Improving assessment of pain management in patients receiving intravenous patient‐controlled analgesia (PCA) at a community hospital.


1:45 p.m. ‐ 2:45 p.m.

388051 Betty Vu 8‐055 Medication use evaluation of daptomycin: streamlining therapy in an academic medical center


10:00 a.m. ‐ 11:00 a.m.

385163 khanh vu 12‐291 Improving human immunodeficiency virus (HIV) screening at Gallup Service Unit


3:00 p.m. ‐ 4:00 p.m.

387826 Lamanh Vu 9‐240 Optimization of empiric therapy for urinary tract infections in the emergency department: striking the balance between appropriate therapy while avoiding unnecessary exposures


11:15 a.m. ‐ 12:15 p.m.

386560 Vera Vulaj 9‐325 Electrolyte abnormalities in ICU patients receiving parenteral nutrition: incidence and associated outcomes


11:15 a.m. ‐ 12:15 p.m.


Page | 239

Session ID


Title Date Time

389401 Alexa Vyain 10‐134 Assessment of prescribing habits for the treatment of hepatitis B virus (HBV) in patients co‐infected with human immunodeficiency virus (HIV) and evaluation of renal decline


12:30 p.m. ‐ 1:30 p.m.

386850 Rose Wade 12‐369 Evaluation of outpatient and inpatient treatment of skin and soft tissue infections in a veteran population


3:00 p.m. ‐ 4:00 p.m.

385583 Nicolle Waetjen 10‐135 Reducing congestive heart failure and chronic obstructive pulmonary disease readmission rates by pharmacist directed education and counseling


12:30 p.m. ‐ 1:30 p.m.

388266 Lauren Wagner 12‐370 Pharmacist interventions to reduce the risk of Clostridium difficile infection


3:00 p.m. ‐ 4:00 p.m.

388378 Dyson Wake 9‐095 UF Health Personalized Medicine Program: value of preemptive pharmacogenetic testing


11:15 a.m. ‐ 12:15 p.m.

385375 Amber Walker 10‐136 Credentialing and privileging pharmacists in a community medical center


12:30 p.m. ‐ 1:30 p.m.

387512 Elizabeth Walker 12‐371 Evaluation of blood factor prescribing and monitoring in patients with hemophilia


3:00 p.m. ‐ 4:00 p.m.

388135 Kristy Walker 10‐216 Clinical outcomes of extended spectrum beta‐lactamase‐producing Enterobacteriaceae among levofloxacin, cefepime, and carbapenems


12:30 p.m. ‐ 1:30 p.m.


Page | 240

Session ID


Title Date Time

386775 Jessica Wallace 12‐292 Evaluation of the efficacy and safety of bosentan in infants with chronic pulmonary hypertension


3:00 p.m. ‐ 4:00 p.m.

386606 Takova Wallace 11‐053 Monitoring of proton pump inhibitor (PPI) use in an outpatient clinic setting


1:45 p.m. ‐ 2:45 p.m.

384670 Stephanie Walters

12‐187 Evaluating the impact of the pharmacists patient care process on medication adherence in the pharmacist‐led geriatric evaluation and management (GEM) clinic


3:00 p.m. ‐ 4:00 p.m.

382630 Nan Wang 12‐293 Conspiracy theory: Are our SPaCE bugs really a thing to be feared?


3:00 p.m. ‐ 4:00 p.m.

388163 Stanley Wang 10‐256 Retrospective analysis of estimated cost avoidance from pharmacist interventions in a pharmacist‐led ambulatory care clinic over a one‐year period


12:30 p.m. ‐ 1:30 p.m.

386113 Yuchen Wang 8‐353 Evaluation of overlapping pro re nata (PRN) medications based on indication in psychiatric patients


10:00 a.m. ‐ 11:00 a.m.

386809 Sheena Wanke 8‐056 Evaluation of collection of lactate levels and the administration of resuscitation fluids in patients with severe sepsis or septic shock


10:00 a.m. ‐ 11:00 a.m.

387598 Victor Warne 10‐270 Effects of a nursing‐driven emergency department pain protocol on number of doses of pain medication received, degree of pain reduction, and length of stay


12:30 p.m. ‐ 1:30 p.m.


Page | 241

Session ID


Title Date Time

386189 Caleb Warner 12‐372 Institution of a pharmacy‐led basal/bolus insulin protocol and rates of within range blood glucose readings in hospitalized patients


3:00 p.m. ‐ 4:00 p.m.

389081 Ryan Warren 9‐241 Evaluating the appropriateness of target‐specific oral anticoagulant (TSOAC) prescribing in the outpatient setting


11:15 a.m. ‐ 12:15 p.m.

389471 Staci Warren 8‐354 Neonatal early‐onset sepsis risk calculator validation and assessment of current guideline adherence within two tertiary healthcare centers


10:00 a.m. ‐ 11:00 a.m.

386688 Melissa Waterhouse

12‐373 Efficacy and Tolerability of Every‐Other‐Day Statin Administration in Patients with Previous Statin Intolerance: A Retrospective Chart Review


3:00 p.m. ‐ 4:00 p.m.

386183 Kacie Waters 10‐217 Evaluation of 4‐factor prothrombin complex concentrate (PCC) in hospitalized patients


12:30 p.m. ‐ 1:30 p.m.

387618 Kristin Waters 12‐080 Utilization of as‐needed haloperidol, risperidone, olanzapine, quetiapine, lorazepam, or alprazolam in patients not taking these medications prior to admission to a hospitalist service


3:00 p.m. ‐ 4:00 p.m.

388519 Lori Watkins 9‐242 Evaluating the management of candidemia at four community hospitals: a comparison of micafungin versus fluconazole


11:15 a.m. ‐ 12:15 p.m.


Page | 242

Session ID


Title Date Time

388129 Lucas Watson 12‐374 The concurrent use of three or more antidepressant agents in the Iowa City VA Healthcare System


3:00 p.m. ‐ 4:00 p.m.

387374 Troy Watson 12‐375 Retrospective review of antithrombotic therapy post‐percutaneous coronary intervention


3:00 p.m. ‐ 4:00 p.m.

385307 Bethany Wattles 9‐326 Evaluation of risk factors for high vancomycin troughs in pediatric patients


11:15 a.m. ‐ 12:15 p.m.

386520 Ashley Weber 11‐117 Assessing the treatment of active mycobacteria infections with rifabutin in HIV patients receiving pharmacokinetic‐boosted anti‐retroviral therapy (ART)


1:45 p.m. ‐ 2:45 p.m.

386746 Kathy Weekes‐Plante

11‐321 Lacosamide vs. Levetiracetam for Primary Prophylaxis of Early Seizures in Neurocritical Care Patients


1:45 p.m. ‐ 2:45 p.m.

388504 Erica Wegrzyn 12‐376 Evaluation of a pharmacist co‐managed interdisciplinary education of emergency department providers and nurses for the implementation of a naloxone layperson education program


3:00 p.m. ‐ 4:00 p.m.

388023 Jarod Weidner 11‐094 Implementation of a computerized surveillance program among clinical pharmacy staff to improve antimicrobial prescribing practices at Mercy Medical Center‐‐North Iowa


1:45 p.m. ‐ 2:45 p.m.


Page | 243

Session ID


Title Date Time

386756 Kylie Weigel 10‐331 Evaluation of low molecular weight heparin dosing and risk of bleeding in a lung transplant population


12:30 p.m. ‐ 1:30 p.m.

386413 Julie Weiner 12‐023 Clinical and economic evaluation of multimodal pain management implementation in the surgical setting


3:00 p.m. ‐ 4:00 p.m.

386858 Rachel Weingartner

12‐377 Effect of multidisciplinary group classes and telephone follow‐up on congestive heart failure (CHF) exacerbations in Veterans with CHF


3:00 p.m. ‐ 4:00 p.m.

386132 Kevin Welch 10‐048 Evaluation of modified del Nido versus Buckberg solution for cardioplegia during coronary artery bypass graft surgery


12:30 p.m. ‐ 1:30 p.m.

386891 Eric Weldon 12‐294 Appropriateness the use of intravenous iron sucrose in treatment of iron deficiency anemia in pregnancy


3:00 p.m. ‐ 4:00 p.m.

387877 Keith Wellman 12‐378 Implementation of a symptom‐triggered alcohol withdrawal treatment protocol and the effect on duration of therapy at a Veterans Affairs hospital


3:00 p.m. ‐ 4:00 p.m.

386239 Dominique Werge

9‐327 Evaluation of the appropriate use of piperacillin‐tazobactam and metronidazole used simultaneously to treat infections at a rural community hospital


11:15 a.m. ‐ 12:15 p.m.

384739 Jessica Wesolek 12‐379 Implementation of a code sepsis pathway in the emergency department to improve early treatment of severe sepsis and septic shock


3:00 p.m. ‐ 4:00 p.m.


Page | 244

Session ID


Title Date Time

387183 Marissa West 11‐183 Steroid‐Induced Hyperglycemia in Patients Receiving EPOCH‐containing Chemotherapy Regimens: A Medication Use Evaluation


1:45 p.m. ‐ 2:45 p.m.

388143 Christy Westbrook

8‐204 Development and implementation of a sepsis protocol and algorithm to facilitate early goal directed therapy in a small community hospital


10:00 a.m. ‐ 11:00 a.m.

387743 Sara Wettergreen

9‐055 Comparison of faculty assessment and students self‐assessment of performance during clinical case discussions in a capstone course


11:15 a.m. ‐ 12:15 p.m.

384765 Allyson Wexler 12‐380 Alvimopan medication use evaluation and pharmacist impact on appropriate discontinuation


3:00 p.m. ‐ 4:00 p.m.

388661 William Wheeler, IV

11‐095 Impact of demographics and comorbidities on inpatient warfarin sensitivity for patients admitted on warfarin therapy


1:45 p.m. ‐ 2:45 p.m.

384336 Taylor White 11‐322 Assessment of the effect of reduced dose novel oral anticoagulants (NOACs) on ischemic events in patients with nonvalvular atrial fibrillation


1:45 p.m. ‐ 2:45 p.m.

389013 Lauren Whitfield 12‐381 Effect of capped heparin dosing on time to exceed lower limit of therapeutic activated partial thromboplastin time (aPTT) threshold for treatment of venous thromboembolism (VTE)


3:00 p.m. ‐ 4:00 p.m.


Page | 245

Session ID


Title Date Time

389111 Jennifer Wiafe 11‐096 Blood cultures and broad‐spectrum antibiotics: evaluation of compliance to surviving sepsis campaign bundle in a community health system


1:45 p.m. ‐ 2:45 p.m.

385409 Julie Wiechert 10‐023 Development and evaluation of a pharmacist managed culture and sensitivity review practice for discharged emergency department patients


12:30 p.m. ‐ 1:30 p.m.

385574 Emily Wiener 12‐024 Improving time to antibiotic administration in sepsis patients in the emergency department


3:00 p.m. ‐ 4:00 p.m.

386860 Micah Wilcox 10‐049 Management and Transition of Care for the Hospitalized Type 2 Diabetic Patient: Pharmacist's Role


12:30 p.m. ‐ 1:30 p.m.

388189 Michael Wilcox 9‐328 Implementation of process improvement strategies to optimize medication inventory in a pharmacy carousel system at a large academic medical center


11:15 a.m. ‐ 12:15 p.m.

382628 Kent Wilin 10‐218 Heparin induced thrombocytopenia: a retrospective assessment of patient evaluation and management at an academic medical center


12:30 p.m. ‐ 1:30 p.m.

388550 Holly Wilkerson 12‐081 Influence of an educational intervention designed to enhance participants' knowledge of and self‐efficacy towards enrolling in medicare part d drug plans


3:00 p.m. ‐ 4:00 p.m.


Page | 246

Session ID


Title Date Time

387096 Samantha Will 8‐073 Evaluation of a pharmacist‐led monitoring program for renally dose adjusted medications in a patient‐centered medical home


10:00 a.m. ‐ 11:00 a.m.

384414 Chelsea Williams 10‐271 Treatment of delirium in critically ill pediatric patients with second generation antipsychotics


12:30 p.m. ‐ 1:30 p.m.

388531 Germaine Williams

9‐329 Impact of a mental health pharmacist on primary care in a Federally Qualified Health Center


11:15 a.m. ‐ 12:15 p.m.

386004 Krista Williams 12‐082 Effect of prolonged postoperative antibiotic utilization on patient outcomes


3:00 p.m. ‐ 4:00 p.m.

388488 Whitney Williams

9‐243 An Evaluation of a Pharmacist Driven Hematology/Oncology Stewardship Program


11:15 a.m. ‐ 12:15 p.m.

387878 Sarah Williford 8‐298 Hyperosmotic Therapy in Severe Traumatic Brain Injury


10:00 a.m. ‐ 11:00 a.m.

388556 Austin Wilson 8‐205 Evaluating the effect of an expanded discharge medication reconciliation process on discharge medication discrepancy rates and types


10:00 a.m. ‐ 11:00 a.m.

389326 Kaitlyn Wilson 10‐257 Efficacy of dementia medications in controlling behavior symptoms and reducing use of psychotropic medications in dementia patients


12:30 p.m. ‐ 1:30 p.m.

384572 Lindsay Wilson 9‐161 Serotonin‐modulating antidepressants and risk of bleeding after trauma


11:15 a.m. ‐ 12:15 p.m.


Page | 247

Session ID


Title Date Time

388790 Mark Wilson 10‐137 Impact of early identification using a rapid PCR test with antimicrobial stewardship intervention in patients with blood cultures contaminated by coagulase‐negative staphylococci


12:30 p.m. ‐ 1:30 p.m.

386001 Bradly Winter 9‐244 Assessing the need and opportunity for clinical pharmacist involvement in dosing of direct oral anticoagulants (DOACs)


11:15 a.m. ‐ 12:15 p.m.

384657 Sara Winters 9‐096 Evaluation of the use of rivaroxaban for non‐FDA approved indications


11:15 a.m. ‐ 12:15 p.m.

387219 Andrea Winterswyk

8‐355 Evaluation of concurrent oral antipsychotic use in patients treated with long‐acting injectable antipsychotics


10:00 a.m. ‐ 11:00 a.m.

386793 Bethany Withycombe

8‐299 Implementation and quality analysis of a standardized chemotherapy verification and centralized product check workflow process


10:00 a.m. ‐ 11:00 a.m.

387148 Kurt Wittig 12‐212 Retrospective review of drug therapy opportunities in HIV patients within an ambulatory care setting


3:00 p.m. ‐ 4:00 p.m.

385678 Lisa Wohlford 12‐382 Differences in opioid analgesic prescribing trends by patient characteristics in adults presenting to US emergency departments for injury


3:00 p.m. ‐ 4:00 p.m.

385601 Kirre Wold 9‐330 Implementation and evaluation of a formal antimicrobial stewardship committee at Mercy Medical Center ‐ North Iowa


11:15 a.m. ‐ 12:15 p.m.


Page | 248

Session ID


Title Date Time

385250 Anna Wolf 10‐332 Evaluation and implementation of statewide antimicrobial stewardship initiatives at two community‐based hospitals


12:30 p.m. ‐ 1:30 p.m.

384748 Lauren Wolf 12‐083 Evaluation of the appropriateness of antibiotic and anticoagulant discharge prescription practices in a community hospital emergency department


3:00 p.m. ‐ 4:00 p.m.

386032 Lauren Wolfe 9‐331 Evaluation of the impact of pharmacist‐led tobacco cessation classes on abstinence rates in patients of a Patient‐Centered Medical Home (PCMH) practice


11:15 a.m. ‐ 12:15 p.m.

387256 Sujin Wolff 12‐383 Impact of inpatient discharge counseling by trained pharmacists on 30‐day and 90‐day hospital and emergency department readmission rates


3:00 p.m. ‐ 4:00 p.m.

383724 Daniel Wolverton

12‐084 Impact of transition of care pharmacy interventions on orthopedic hospital readmissions


3:00 p.m. ‐ 4:00 p.m.

389638 Anthony Wong 12‐085 Initiation of a computerized insulin drip dosing recommendation tool in the emergency department for the management of adult hyperglycemic emergencies


3:00 p.m. ‐ 4:00 p.m.

383168 Cecilia Wong 10‐333 The impact of pharmacist‐initiated interventions at discharge on 30 day readmission rates


12:30 p.m. ‐ 1:30 p.m.


Page | 249

Session ID


Title Date Time

385560 Courtney Wong 12‐384 Use of probiotics in the prevention of Clostridium difficile infection associated with broad‐spectrum antibiotics


3:00 p.m. ‐ 4:00 p.m.

387026 Edward Wong 11‐269 Visual assessment tool to evaluate performance and improve pharmacy quality and productivity: operational and educational measures


1:45 p.m. ‐ 2:45 p.m.

385699 Kong Wong 8‐206 The relationship between antipsychotic polypharmacy and hospital readmissions at the Washington DC, Veterans Affairs Medical Center (DC VAMC)


10:00 a.m. ‐ 11:00 a.m.

388827 Shan Wong 8‐207 Evaluation of albumin utilization before and after implementation of an electronic ordering restriction within a community health system


10:00 a.m. ‐ 11:00 a.m.

385901 Robert Woods 8‐300 Evaluation of the clinical outcomes associated with concomitant use of ketamine and dexmedetomidine for adult procedural sedation and analgesia in the emergency department


10:00 a.m. ‐ 11:00 a.m.

385750 Jessica Wooster 9‐097 Impact of community pharmacist‐performed medication reconciliations in Medicare patients post‐discharge on 30‐day hospital readmission rates


11:15 a.m. ‐ 12:15 p.m.


Page | 250

Session ID


Title Date Time

384387 Kelsi Worthy 11‐323 Impact of pharmacists within a multidisciplinary team on sepsis management in the emergency department


1:45 p.m. ‐ 2:45 p.m.

387572 Margaret Wovkulich

12‐188 Evaluation of a newly implemented 7‐day automatic stop‐order for parenteral antibiotics


3:00 p.m. ‐ 4:00 p.m.

389436 Crystal Wright 8‐356 Prescribing and deprescribing of potentially inappropriate medications in older adults in an advanced urgent care setting: a retrospective before‐and‐after analysis


10:00 a.m. ‐ 11:00 a.m.

387562 Dana Wright 10‐219 Cost effective analysis of regadenoson versus adenosine in an outpatient stress test lab


12:30 p.m. ‐ 1:30 p.m.

388444 Emily Wright 12‐086 Long‐acting injectable antipsychotics versus oral therapy in adult behavioral health patients


3:00 p.m. ‐ 4:00 p.m.

385686 Jordan Wright 8‐301 Combate la diabetes: a community pharmacist's approach to diabetes education among the Hispanic population in rural Tennessee


10:00 a.m. ‐ 11:00 a.m.

386763 Laurie Wright 11‐270 Efficacy of a pharmacist‐managed epoetin alfa protocol for anemia of prematurity


1:45 p.m. ‐ 2:45 p.m.

388587 Robert Wright 9‐162 Pharmacist Impact on Pain Management in Long‐Bone Fractures


11:15 a.m. ‐ 12:15 p.m.

388317 Sarah Wright 9‐163 Intravenous versus oral acetaminophen for elderly trauma patients with rib fractures


11:15 a.m. ‐ 12:15 p.m.


Page | 251

Session ID


Title Date Time

386008 Jessica Cho Kiu Wu

12‐385 Adverse cardiac events associated with patients receiving trimethoprim‐sulfamethoxazole and renin‐angiotensin‐aldosterone‐system inhibitors


3:00 p.m. ‐ 4:00 p.m.

385863 Matthew Wu 11‐184 Polymerase chain reaction (PCR) testing and antimicrobial stewardship among hospitalized patients with staphylococcus bacteremia


1:45 p.m. ‐ 2:45 p.m.

385621 Timothy Wu 12‐386 Impact of a pharmacist led concierge/bedside encounter service on medication‐related Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores


3:00 p.m. ‐ 4:00 p.m.

386941 Yunuo Wu 11‐118 Implementing a medication synchronization program in community pharmacies


1:45 p.m. ‐ 2:45 p.m.

385252 Stephanie Wuerffel

8‐057 Pharmacist‐supported implementation of a protocol for low‐dose ketamine analgesia by a paramedic level rural emergency medical service


10:00 a.m. ‐ 11:00 a.m.

387528 Jenny Wulf 12‐087 Evaluating the impact of pharmacist intervention within transitions of care roles on patients admitted with chronic obstructive pulmonary disease


3:00 p.m. ‐ 4:00 p.m.

385979 Jordan Wulz 12‐387 Does health literacy‐directed pharmacist‐led diabetes education improve educational outcomes?


3:00 p.m. ‐ 4:00 p.m.


Page | 252

Session ID


Title Date Time

384711 Pin Xiang 11‐185 Outcomes and cost impacts of a pharmacist‐led medication management program for high risk diabetic patients in Central Texas


1:45 p.m. ‐ 2:45 p.m.

387643 Kevin Xie 11‐026 Retrospective study of patient outcomes and process adherence in diabetic ketoacidosis


1:45 p.m. ‐ 2:45 p.m.

389276 Jenny Xiong 8‐208 Medication use evaluation of direct oral anticoagulants at a large 425‐bed community hospital


10:00 a.m. ‐ 11:00 a.m.

384528 Fuwang Xu 12‐189 Decentralized pharmacy technicians to improve medication delivery and nursing satisfaction


3:00 p.m. ‐ 4:00 p.m.

386581 David Yabusaki 12‐213 Effect of skilled nursing facility (SNF) to home medication reconciliation on hospital readmission rates as part of a multicomponent care model redesign


3:00 p.m. ‐ 4:00 p.m.

388249 Mina Yacoub 10‐258 MRSA nasal cultures in patients diagnosed with cellulitis: current utility & role in antimicrobial stewardship


12:30 p.m. ‐ 1:30 p.m.

385263 Lily Yam 12‐388 Assessment of enoxaparin thromboprophylaxis dosing and anti‐factor Xa levels in low‐weight patients


3:00 p.m. ‐ 4:00 p.m.

387764 Amy Yan 11‐119 Assessing impact of opioid use for the treatment of chronic nonmalignant pain on COPD readmission rates at a teaching hospital


1:45 p.m. ‐ 2:45 p.m.


Page | 253

Session ID


Title Date Time

387868 Eric Yancey 9‐245 Tolerance rates for intraperitoneal taxane/platinum doublet for ovarian and peritoneal cancer: a single center retrospective analysis.


11:15 a.m. ‐ 12:15 p.m.

385637 Linda Yang 12‐389 Evaluation of the appropriateness of empiric community acquired pneumonia (CAP) regimens in a heterogeneous population


3:00 p.m. ‐ 4:00 p.m.

386555 Pamela Yang 10‐050 Impact of pharmacist intervention on the appropriateness of therapeutic monitoring of vancomycin in a veteran population


12:30 p.m. ‐ 1:30 p.m.

388012 Sendra Yang 12‐390 Outcomes of pharmacy‐led hepatitis C direct‐acting antiviral (DAA) utilization management at a Veterans Affairs Medical Center


3:00 p.m. ‐ 4:00 p.m.

387762 Stanislav Yavid 12‐308 Impact of evidence based therapy on unscheduled healthcare contacts in acute coronary syndrome patients treated with percutaneous coronary intervention


3:00 p.m. ‐ 4:00 p.m.

386285 Nastaran Yazdi 11‐271 Heart failure transition of care Wednesday, December 9

1:45 p.m. ‐ 2:45 p.m.

386159 Julianne Yeary 11‐097 Utilization of IV loop diuretics in systolic heart failure with volume overload


1:45 p.m. ‐ 2:45 p.m.

384770 Bo Young Yen 12‐392 Characterization of IV erythromycin use as a prokinetic agent in the treatment of post‐operative delayed gastric emptying


3:00 p.m. ‐ 4:00 p.m.


Page | 254

Session ID


Title Date Time

385403 Alannah Yoder 11‐272 Evaluation of the non‐formulary use of codeine and codeine‐containing products in pediatric patients in an academic pediatric hospital


1:45 p.m. ‐ 2:45 p.m.

387531 Carol Yoon 12‐393 Implementation of a medication management telephone clinic for veterans newly entering the VA healthcare system prior to their initial primary care physician visit


3:00 p.m. ‐ 4:00 p.m.

386675 Jessica Yost 10‐138 Multicenter retrospective review of characteristics associated with bleeding secondary to the direct oral anticoagulants


12:30 p.m. ‐ 1:30 p.m.

388271 Nicole Young 10‐298 Implementation and evaluation of the effects of an oral hypoglycemic to insulin protocol for glucose management in hospitalized patients with type 2 diabetes mellitus


12:30 p.m. ‐ 1:30 p.m.

384647 Tramaine Young 11‐186 Methodological Study of Vancomycin Dosing in Elderly Patients using Actual Serum Creatinine versus Rounded Serum Creatinine


1:45 p.m. ‐ 2:45 p.m.

387695 Benjamin Yu 9‐164 Evaluation of the use of emergency department services


11:15 a.m. ‐ 12:15 p.m.

387566 Chi Fai Yuen 11‐273 Retrospective evaluation of procalcitonin utilization in reducing antibiotic exposure and adverse clinical outcomes in patients with lower respiratory tract infections


1:45 p.m. ‐ 2:45 p.m.


Page | 255

Session ID


Title Date Time

383307 Justin Zacharias 10‐051 Impact of medication education service by pharmacy interns on HCAHPS scores in a pediatric hospital


12:30 p.m. ‐ 1:30 p.m.

389317 Jessica Zacher 11‐324 Retrospective review of INR management by pharmacist versus non‐pharmacist providers in post‐operative total hip and total knee arthroplasty patients


1:45 p.m. ‐ 2:45 p.m.

386547 Maryam Zaeem 8‐209 Impact of a pharmacist driven insulin education program to enhance patient safety and healthcare provider knowledge


10:00 a.m. ‐ 11:00 a.m.

387606 Michelle Zaepfel 8‐302 Characterization of reported vaccine‐related errors at UR Medicine


10:00 a.m. ‐ 11:00 a.m.

388081 Veronica Zafonte 8‐210 Treatment of asymptomatic bacteriuria in transplant patients


10:00 a.m. ‐ 11:00 a.m.

388633 Dalia Zall 8‐303 Health plan strategies for improving medication adherence in Medicare Part D beneficiaries: the implementation and evaluation of a mail order medication synchronization program


10:00 a.m. ‐ 11:00 a.m.

389270 Bin Zang 11‐274 Evaluation of stress ulcer prophylaxis in the intensive care settings of a tertiary care teaching institution


1:45 p.m. ‐ 2:45 p.m.

388121 Tanya Zapolskaya

8‐357 Utility of carboplatin intradermal testing in gynecology‐oncology patients


10:00 a.m. ‐ 11:00 a.m.


Page | 256

Session ID


Title Date Time

389102 Htet Htet W Zaw 9‐098 Impact of pharmacist‐led discharge counseling and medication reconciliation on high‐risk patients in the emergency department


11:15 a.m. ‐ 12:15 p.m.

388071 Lindsey Zawierucha

12‐295 Impact of pharmacy‐led patient education on pneumococcal and influenza vaccination rates in the inpatient setting


3:00 p.m. ‐ 4:00 p.m.

385816 Yelena Zaychik 9‐165 Efficacy of and adherence to diabetic ketoacidosis protocol in the Medical Intensive Care Unit


11:15 a.m. ‐ 12:15 p.m.

387707 Renjbar Zebari 8‐211 The Impact of Pharmacy Resident Interventions on Drug Related Costs in a Community Teaching Hospital


10:00 a.m. ‐ 11:00 a.m.

388620 Julia Zecchini 9‐246 Quality improvement of vancomycin trough level collection


11:15 a.m. ‐ 12:15 p.m.

386100 Amanda Zeek 12‐394 Evaluating the change in body weight and risk factors for heart disease in patients treated with low‐dose quetiapine for sleep


3:00 p.m. ‐ 4:00 p.m.

389453 Qian Ya Zeng 8‐212 Optimizing therapy: pharmacist involvement versus usual care in a heart failure population


10:00 a.m. ‐ 11:00 a.m.

386784 Sonya Zhan 9‐332 Evaluation of pharmacist order verification changes between medical residents, mid‐level practitioners, and hospitalists


11:15 a.m. ‐ 12:15 p.m.

384321 Chloe Zhang 12‐088 Implementation of inhaled epoprostenol for acute pulmonary hypertension after cardiac surgery and acute respiratory distress syndrome


3:00 p.m. ‐ 4:00 p.m.


Page | 257

Session ID


Title Date Time

383718 Junyu Zhang 12‐395 Rate of nephrotoxicity in morbidly obese and obese patients using an adjusted body weight vancomycin dosing protocol


3:00 p.m. ‐ 4:00 p.m.

386973 Crystal Zhou 10‐334 Comparison of outcomes between Veterans with and without mental illness enrolled in a pharmacist managed telephone tobacco cessation clinic


12:30 p.m. ‐ 1:30 p.m.

389608 Julia Zhu 9‐056 Evaluation of treatment adherence, severity of illness, and incidence of adverse events in deep vein thrombosis treated in the inpatient compared to the outpatient setting.


11:15 a.m. ‐ 12:15 p.m.

386686 Weiyun Zhu 11‐187 Implementation of a proton pump inhibitor monitoring protocol in a community hospital and its impact on hospital acquired Clostridium difficile infection


1:45 p.m. ‐ 2:45 p.m.

386191 Kelsea Ziegler 8‐304 Analysis of cholesterol management in a pharmacist‐run clinic


10:00 a.m. ‐ 11:00 a.m.

386322 Brianna Zinser 12‐309 Evaluating the Utilization of the Confusion Assessment Method for the Intensive Care Units on Delirium Management


3:00 p.m. ‐ 4:00 p.m.

386589 Olga Zirka 12‐025 Implementation of a pharmacist‐driven pain management service for patients at high risk for respiratory depression


3:00 p.m. ‐ 4:00 p.m.


Page | 258

Session ID


Title Date Time

386028 Kimberly Zitko 12‐026 Evaluating non‐insulin dual therapy of individuals with type 2 diabetes mellitus in a primary care clinic


3:00 p.m. ‐ 4:00 p.m.

389040 Emily Zoelle 12‐396 Retrospective review of psychiatrist response to pharmacist recommendations regarding treatment of dyslipidemia in psychiatric inpatients


3:00 p.m. ‐ 4:00 p.m.

387944 Antoine Zogbi 9‐166 Retrospective quality assurance analysis of chronic concomitant use of opioids and benzodiazepines in the Veteran Affairs Portland Health Care System


11:15 a.m. ‐ 12:15 p.m.

Resident Poster Listing by Primary Author Last Name ...2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT...

Documents

Transcript of Resident Poster Listing by Primary Author Last Name ...2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT...